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Abstract 
 
Tubulointerstitial inflammation and fibrosis is frequently seen in patients with 
progressive renal failure, irrespective of the aetiology, and may represent a common 
pathway to renal failure. However, the role and function of tubulointerstitial 
lymphocytes in the pathogenesis of renal fibrosis is unknown. Using the well-
characterised mouse model of unilateral ureteric obstruction (UUO) I determined the 
phenotype of infiltrating lymphocytes and by sequencing the complementarity-
determining region 3 (CDR3) of the variable β-chain examined whether there were 
clonal populations of T cells within UUO and normal kidney. 
There was a strong correlation between lymphocyte infiltration and tubulointerstitial 
expansion, α-SMA staining and collagen I deposition. A population of these infiltrating 
CD4+ and CD8+ lymphocytes also displayed the surface makers CD69 and CD44, and 
the nuclear proliferation marker Ki67. This suggests activation and proliferation of T 
cells in response to self-antigen recognition and the loss of immunological tolerance. 
Infiltrating T cells within UUO kidney demonstrated over expression of certain TRVβ 
gene segments in particular TRVβ3, suggesting a clonal population of lymphocytes. In 
normal and sham operated kidney over expression of T cells with the TRVβ13.2, 29 and 
1 gene segments suggested populations of resident NKT cells expressing an invariant T 
cell receptor. 
On sequence analysis of the CDR3 region of infiltrating lymphocytes, large clonal 
populations of T cells were seen in individual UUO kidneys at 7 and 14 days after 
obstruction but not 28 days. These clonal populations in UUO kidney that were also in 
normal kidney had an identical amino acid motif within the CDR3 region. This suggests 
a population of T cells in normal kidney proliferate in response to injury. 
These lymphocytes could be a potential target for therapeutic interventions to prevent 
fibrosis in renal diseases that are not characteristically believed to be immune mediated. 
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Chapter 1. Introduction 
 
My thesis focuses on the function of T lymphocytes in the development of renal 
tubulointerstitial injury. I will describe the development of the T cell response to 
antigen, in particular the development of the α:β T cell and the β-chain in the mouse. I 
will then go on to describe the process of T cell activation and lymphocyte effector 
functions. Subsequently, I will demonstrate how a loss of tolerance to self can cause 
autoimmunity. The final part of the introduction reviews the current literature regarding 
tubulointerstitial kidney injury and fibrosis. 
1.1 Role of lymphocytes in the adaptive immune response 
Lymphocytes form part of the adaptive immune response and are critical in the host’s 
defences against foreign antigen and thus infection. In order for lymphocytes to detect 
foreign pathogens they have unique receptors capable of recognising individual 
antigens. Immunological memory also develops after exposure to a foreign antigen such 
that a more rapid and effective response occurs on a second encounter with the 
pathogen. Ordinarily lymphocytes are tolerant to self antigens however, when tolerance 
mechanisms fail, autoimmunity develops. 
1.2 T cell development  
T cells develop and mature in the thymus by a process of positive and negative 
selection, which is termed central tolerance. Any autoreactive T cells not deleted in this 
way can also be prevented from activation in the periphery by the process of peripheral 
tolerance. This allows the development of T cells which are tolerant to self but are able 
to recognise harmful non-self, however, this is not absolute. 
1.2.1. Central tolerance   
Positive selection occurs first in the thymic cortex where pre-T cells, which are CD8 
and CD4 double negative, are positively selected when they recognise self MHC on 
cortical epithelial cells which express self class I and II major histocompatability 
complex (MHC) molecules. This also defines which pre-T cells become CD8+ and 
CD4+ cells, depending upon whether they recognise class I or II MHC respectively. 
This generates many autoreactive T cells which have a high affinity for self MHC 
antigens. Therefore the process of negative selection follows in the thymic medulla, 
where CD8+ and CD4+ T cells are deleted if they bind to self peptide: self MHC on an 
antigen presenting cell (APC) with high enough affinity to allow T cell activation. 
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Negative selection of such activated T cells occurs by apoptosis. Many antigens present 
within the medullary thymus have been generated at this ectopic location due to the 
presence of the AIRE transcription factor which regulates the ectopic expression of 
peripheral tissue restricted antigens.  
After the process of positive and negative central selection, single positive self MHC 
restricted naive T cells (CD8+ or CD4+), which are predominantly not autoreactive, 
egress from the thymus. 
1.2.2. Peripheral tolerance 
Just as central tolerance involves the positive selection/survival of T cells which 
recognise self MHC and negative selection/deletion of autoreactive T cells recognising 
self peptide: self MHC, similar mechanisms occur in the periphery. The process of 
negative selection in the thymus is not a perfect one, allowing some autoreactive T cells 
to escape the thymus, since not all autoantigens are expressed in or can reach the 
thymus. Therefore these emigrating autoreactive T cells require negative selection in the 
periphery either by elimination or inactivation. When lymphocytes do encounter and 
bind strongly to their cognate self antigen in the periphery for the first time, three 
possible mechanisms are able to induce tolerance; anergy, deletion and 
survival/ignorance. 
Anergic T cells develop when antigen is presented to a T cell in the absence of a co-
stimulation (Macian, Im et al. 2004). Co-stimulation is absent when there are no innate 
immune signals to the APC to activate it. Therefore when an autoreactive T cell 
recognises a self peptide: self MHC complex in the absence of inflammation, the T cell 
is rendered anergic. Anergic T cells are fully inactivated and even when they do 
encounter antigen in the presence of full co-stimulation they are still unable to initiate a 
response. They are unable to produce IL-2 due to a failure to generate nuclear factor of 
activated T cells (NFAT) and therefore unable to divide.  They may also have the ability 
to inhibit/suppress/regulate other positive immune responses. The second alternative is 
that instead of anergy, T cells undergo activation-induced death and are deleted after a 
short period of activation and cell division. 
Another alternative is that T regulatory cells (Tregs) can modulate the activation and 
proliferation of autoreactive T cells which have escaped central tolerance. The exact 
mechanisms by which they exert their effects are unclear. However, these suppressive 
effects may be mediated by direct contact between the Treg and lymphocyte (Ng, 
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Duggan et al. 2001) or indirectly by soluble mediators such as IL-10 and TGF-β acting 
at short distances from the cell or bound to the cell surface (Dieckmann, Bruett et al. 
2002; Nakamura, Kitani et al. 2004). 
Survival of naive T cells in the periphery occurs by positive selection. It is dependent 
upon covert T cell receptor signalling after weak interactions with self MHC +/- self- 
antigen, along with the IL-7 and IL-15 cytokines (Surh and Sprent 2008). Lymphocytes 
probably encounter their positively selected ligands on lymphoid dendritic cells (DCs) 
in T-cell zones of secondary lymphoid organs. These specific dendritic cells lack 
sufficient co-stimulatory potential to induce full T cell activation however contact does 
allow signalling to the naive T cell which promotes survival. 
1.3 T cell receptor generation 
The T cell receptor (TCR) on the T lymphocyte recognises antigen only when it is 
presented on the surface of an antigen presenting cell with self MHC. Individual T cells 
have numerous copies of a single TCR which has a unique antigen-binding site. This 
determines which antigens that lymphocyte can recognise. Billions of different T 
lymphocytes, each with unique TCRs, are required to produce responses to an almost 
unlimited range of antigens. In order to generate such a diverse TCR repertoire for the 
wide range of antigen specificities, the TCR is made up of two chains with both variable 
(V) regions and invariant constant (C) regions.  
A complex mechanism has evolved for generating these highly variable TCR proteins. 
Each TCR variant cannot be coded in full by the genome, as this would require more 
genes for TCRs alone than there are genes in the whole genome. V-regions are encoded 
by two or three gene segments which assemble in the developing lymphocyte by 
somatic recombination to form the complete V-region sequence. This mechanism is 
called gene rearrangement. There are multiple different subtypes of each gene segment 
in the germ-line genome and the complete V-region is generated by a single subtype of 
each gene segment. The large number of different possible recombinations account for 
the huge diversity of TCRs that can be generated. 
The majority of T cells have antigen receptor molecules on their surface made from two 
different polypeptide chains, alpha (α) and beta (β), which form the α:β TCR. This is the 
T cell population focused on during this thesis and when the term TCR is used will refer 
to those of the α:β subtype, unless specified. There is also a minority population of T 
cells which have a TCR made of a gamma (γ) and delta (δ) chain and these are named 
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γ:δ T cells. T cells with a γ:δ TCR are able to bind antigen directly without processing 
and without MHC presentation. They are specialised to bind ligands including heat 
shock proteins and non-peptide ligands. They also differ from α:β T cells in their pattern 
of expression of CD4 and CD8 co-receptors, are distributed differently in the periphery 
and have different functions. 
1.3.1 Structure of the α:β T cell receptor 
The α:β TCR is a heterodimer comprised of an α and β-chain. The β-chain (gene locus 
on chromosome 7) is encoded by three gene segments that make up the V-region; Vβ, 
Dβ, and Jβ. Gene rearrangement of these gene segments generates a functional VDJβ V-
region exon that is transcribed and spliced to join to a single Cβ gene (Figure 1.1). This 
Cβ gene segment is comprised of four exons which encode for the constant and hinge 
domains as well as for the cytoplasmic and transmembrane regions. The resulting 
mRNA is translated to yield the TCR β-chain.  
The diversity of the β-chain is generated by the combinational diversity created by there 
being twenty two known functional Vβ gene segments, 2 Dβ, and 13 Jβ in the mouse 
however, just one of each gene segment combines to form the VDJβ V-region exon as 
already explained (Table 1.1). Furthermore, junctional diversity is generated by non 
germ-line encoded contact sequences being incorporated between the V-D and D-J 
regions- this results in the hypervariable region or complementarity-determining region 
3 (CDR3).  Once the functional β-chain has been produced, it pairs with a pre-TCR α-
chain (pTα) to create the pre-T cell receptor (β:pTα). Subsequently, the α-chain gene 
segments rearrange. The α-chain (gene locus on chromosome 14) is very similar to the 
β-chain but its variable domain is only encoded by two gene segments; Vα and Jα. 
Again rearrangement of these gene segments generates a functional VJα V-region exon 
that is transcribed and spliced to join to the single Cα gene segment. The resulting 
mRNA is translated to yield the T-cell receptor α-chain. The combinational and 
junctional diversity of the α-chain is created in a similar way to that of the β-chain, but 
there are different numbers of each functional gene segment, as listed in Table 1.1. 
Subsequently any one α-chain can combine with any one β-chain to further increase the 
α:β TCR repertoire. 
The CDR3 loops of the α and β-chains are the main contact domains with the MHC 
presented peptide, whereas the CDR1 and 2 regions predominantly contact the residues 
of the MHC (Davis and Bjorkman 1988). 
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Figure 1.1- T cell receptor α and β-chain gene rearrangement 
The α and β-chains of the TCR are formed by combining gene segments to produce the 
functional gene. The resulting mRNA is then translated to yield the α:β TCR. 
 
 
Table 1.1- Number of mouse T cell receptor functional gene segments for the α and 
β-chains 
The TCR variable region of the α-chain is made up of the V and J gene segments, 
whereas the β-chain is also comprised of a D segment. There are multiple recognised 
functional subtypes of gene segment however, only one is ultimately expressed by an 
individual T cell. 
Functional gene segments Beta chain Alpha chain 
V 22 50 - 100 
D 2 0 
J 13 ~ 50 
C 2 1 
T cell 
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1.3.2 Nomenclature for T cell receptor gene segments of the immune system 
Different groups have used different names to classify the different V-region gene 
segments of the TCR (Table 1.2). Therefore an international committee was assigned to 
work out the principles of TCR nomenclature and a compilation of all available mouse 
(Arden, Clark et al. 1995) and human (Arden, Clark et al. 1995) TCR gene segment 
sequences were published by Arden et al. Subsequently the ImMunoGeneTics (IMGT) 
database devised nomenclature for germ line immunoglobulin and T cell receptor gene 
segments for human and other vertebrates (Giudicelli, Chaume et al. 2005). This has 
become the international reference for the immunoglobulin and T cell receptor gene 
nomenclature and is freely available at http://imgt.cines.fr. This is the numbering 
system used throughout this thesis, unless stated otherwise.  
1.3.3 Structure of the γ:δ T cell receptor 
A minority population of T cells have a γ:δ heterodimer TCR, which are of a distinct but 
similar lineage to the α:β T cells and thought to arise from a common precursor. The γ-
chain is comprised of V, J and C gene segments. However, the δ-chain is encoded by 
the V, D, J and C gene segments which are found between the Vα and Jα gene segments 
of the TCRα locus. There are fewer V gene segments at the γ and δ loci and so less 
combinational diversity is created. In comparison there is increased junctional diversity 
of the δ-chain, with almost all the variability arising from the junctional region. 
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Table 1.2- Correlation between the Arden and IMGT nomenclature for the TCR 
β-chain V and J gene segments  
The two dominant nomenclature classification systems used for the gene segments of 
the β-chain of the TCR were generated by Arden and IMGT however, they can be 
correlated as illustrated below. 
 
  Arden      =     IMGT      Arden     =     IMGT    Arden     =     IMGT  
Vβ 1.1 TRBV5 Vβ 8.3 TRBV13-1 Vβ 20.1 TRBV23 
Vβ 2.1 TRBV1 Vβ 9.1 TRBV17 Vβ 21.1 TRBV25 
Vβ 3.1 TRBV26 Vβ 10.1 TRBV4 Vβ 22.1 TRBV22 
Vβ 4.1 TRBV2 Vβ 11.1 TRBV16 Vβ 23.1 TRBV18 
Vβ 5.1 TRBV12-2 Vβ 12.1 TRBV15 Vβ 24.1 TRBV9 
Vβ 5.2 TRBV12-1 Vβ 13.1 TRBV14 Vβ 25.1 TRBV10 
Vβ 5.3 TRBV12-3 Vβ 14.1 TRBV31 Vβ 26.1 TRBV6 
Vβ 6.1 TRBV19 Vβ 16.1 TRBV3 Vβ 28.1 TRBV8 
Vβ 7.1 TRBV29 Vβ 17.1 TRBV24 Vβ 29.1 TRBV11 
Vβ 8.1 TRBV13-3 Vβ 18.1 TRBV30 Vβ 30.1 TRBV27 
Vβ 8.2 TRBV13-2 Vβ 19.1 TRBV21 Vβ 31.1 TRBV28 
 
Arden     =     IMGT  
Jβ 1.1 TRBJ1-1 
Jβ 1.2 TRBJ1-2 
Jβ 1.3 TRBJ1-3 
Jβ 1.4 TRBJ1-4 
Jβ 1.5 TRBJ1-5 
Jβ 1.6 TRBJ1-6 
Jβ 2.1 TRBJ2-1 
Jβ 2.2 TRBJ2-2 
Jβ 2.3 TRBJ2-3 
Jβ 2.4 TRBJ2-4 
Jβ 2.5 TRBJ2-5 
Jβ 2.6 TRBJ2-6 
 
 
 
 22 
1.4 T cell mediated immunity and antigen processing 
T cells form part of the adaptive immune defence system by recognising cells which are 
infected with viruses or have internalised pathogens or their products. The diverse 
repertoire of lymphocytes do this by being able to recognise peptide fragments of 
pathogen when presented to them by MHC molecules on the surface of an APC with the 
necessary adjunctive co-stimulatory surface protein signals. This subsequently induces 
the activation, proliferation and differentiation of the naive T cell into an armed effector 
cell which contributes to the removal of the pathogen or death of the infected cell. 
1.4.1 The antigen 
B cells recognised intact protein through their B cell receptor (BCR) however, T cell 
responses are generated after antigens have been denatured into short linear peptide 
sequences. Infectious agents replicate in two distinct intracellular compartments: viruses 
and certain bacteria replicate in the cytosol and the contiguous nuclear compartment, 
whereas many pathogenic bacteria replicate in endosomes and lysosomes which form 
part of the vesicular system.  
Cells infected with viruses and bacteria living within the cytosol are eliminated by 
cytotoxic CD8+ T cells, whose function is to kill the infected cells. In comparison 
pathogens and their products in the vesicular compartment are detected by CD4+ T 
cells. This leads to the activation of appropriate immune effector mechanisms, which 
include macrophage activation resulting in the killing of intravesicle pathogens and B 
cell activation allowing the production of antibodies to eliminate or neutralise 
extracellular pathogens. Microbial antigens enter the vesicular compartment in two 
ways. Firstly, pathogens and their antigens/toxins can be engulfed by phagocytes 
(macrophages, neutrophils or dendritic cells) by the process of phagocytosis or 
endocytosis. Innate surface bound receptors recognise these foreign proteins and trigger 
phagocytosis. Pathogen derived protein can also bind to immunoglobulins on the 
surface of B cells, causing the protein to be internalised by endocytosis. Alternatively, 
immature dendritic cells can internalise pathogens by macropinocytosis, a receptor 
independent method.  Subsequently cytosolic and intravesicle proteins are degraded and 
displayed on the surface of the cell as peptides. 
1.4.1.1 Class I MHC presentation of peptide 
In order for intracellular cytosolic proteins to be displayed on the surface of a cell with 
class I MHC, they are digested in the cytosol into short peptides. Proteins within all 
 23 
cells are continually being degraded and replaced by newly synthesised proteins. Much 
of this degradation is carried out in the cytosol by large multimeric complexes called 
proteosomes, where large proteins are degraded and released as short peptides. The 
proteosome is also responsible for the production of peptides ligands for MHC class I 
molecules. From here these short peptide fragments are transported into the 
endoplasmic reticulum (ER) by an ATP dependent peptide transporter ‘transporter 
associated with antigen processing’ (TAP) where they bind class I MHC. The MHC-
peptide complex then moves to the cell surface for recognition by CD8+ T cells. IFN-γ, 
produced by virally infected cells, is able to transform the constitutive proteosome 
found in all cells into the immunoproteosome, whose protease activity creates peptide 
fragments which are ideally suited for transport by TAP and binding to class I MHC, as 
well as increasing the rate at which peptides can be released. 
It is not just foreign intracellular pathogens in the cytosol or nuclear compartments 
which are presented on the cell surface with class I MHC, but peptides from all 
intracellular proteins are presented to allow CD8+ T cell surveillance.   
1.4.1.2 Class II MHC presentation of peptides 
Components taken up into the vesicular compartment by professional antigen presenting 
cells are broken down within the vesicle by proteases under conditions of low 
intracellular pH to produce peptide fragments. Class II MHC is assembled in the ER 
where it is bound to an invariant chain which prevents the abundant endogenous peptide 
fragments present in the ER binding the class II MHC. The invariant chain also targets 
delivery of the MHC class II proteins to the vesicular compartment. Here the invariant 
chain is cleaved by the acid proteases to leave CLIP (class II-associated invariant chain 
peptide) bound to class II MHC. Subsequently CLIP dissociates leaving the class II 
MHC protein free to bind the peptide within the vesicular compartment. This class II 
MHC-peptide complex is then presented on the surface of the APC to CD4+ T cells. 
Extracellular components from the environment, not just pathogens, can be internalised 
into endocytic vesicles and the peptides formed by protein degradation presented with 
class II MHC. 
1.4.1.3 Cross presentation 
Antigen presented by DCs is the most effective way to stimulate naive T cells however, 
pathogens which do not infect DCs can still stimulate naive CD8+ cells. DCs have the 
ability to engulf exogenous antigens from dying cells and present them with class I 
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MHC thus activating naive CD8+ cells (Bevan 1976). In order to do this the peptide 
fragment must be transported from the endocytic vesicle to the cytosol, whereby the 
peptide is taken up into the ER and bound to class I MHC (Rodriguez, Regnault et al. 
1999). This is known as cross presentation. 
1.4.2 Major histocompatibilty complex (MHC) 
The function of MHC molecules, which are either class I or II, is to bind peptide 
fragments derived from pathogens and display then on the cell surface, for recognition 
by the appropriate T lymphocyte. This will only occur if the specific TCR recognises a 
complex of antigen fragment and a molecule of self MHC. This is termed MHC 
restriction. Class I MHC molecules are transmembrane proteins found on the surface of 
nearly all cells, whereas class II MHC is found only on specialised cells. The MHC is 
located on chromosome 6 in humans and 17 in the mouse. In humans it contains over 
200 genes and these genes are called human leukocyte antigen (HLA) genes.  
The class I molecule is comprised of a polymorphic α-chain encoded within the MHC 
complex and is associated with non-polymorphic, non MHC encoded β2 microglobulin, 
to form a 4 domain structure. There are three class I α-chain genes in the human called 
HLA-A, -B and –C and in the mouse called H2-K, -D and –L.  The α1 and α2 subunits 
form the peptide binding cleft and are able to bind a peptide fragment 8-10 amino acids 
in length. MHC class I molecules are recognised by CD8+ cells.  
This is in comparison to the class II MHC molecules which are made from α and β-
chains which are both polymorphic and MHC encoded. There are three pairs of MHC 
class II α and β chain genes in the human called HLA-DR, -DP and –DQ and in the 
mouse two pairs called H-2A and –E. The α and β-chains create a 4 domain 
heterodimeric structure with the distal α1 and β1 domains forming the peptide binding 
cleft what is capable of binding >12-14 amino acids. MHC class II molecules are 
recognised by CD4+ lymphocytes. 
It is difficult for pathogens to adapt such that they can escape presentation by MHC and 
evade immune responses. This is because MHC is polygenic: it contains several 
different class I and II genes, so that an individual has a set of MHC molecules with 
different peptide binding specificities. Also it is polymorphic: there are multiple 
variants of each gene within the population as a whole, therefore most individuals will 
be heterozygous at MHC loci. 
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1.4.3 The professional antigen presenting cell 
There are three main cell types of professional antigen presenting cells which have the 
potential to express both MHC class I and II and co-stimulatory cell surface molecules 
for activation of lymphocytes; dendritic cells, macrophages and B cells.  
Dendritic cells are the most important professional APCs and their only functions are in 
antigen ingestion, processing and presentation. They are the first cell type to take up 
antigen and present it to naive T cells. In vivo mature DCs initiate almost all naive T 
cell responses, with macrophages and B cells playing a larger role in antigen 
presentation to effector T cells. Immature dendritic cells migrate from the bone marrow 
to the peripheries where they survey the local environment for pathogens and peptides. 
They express low levels of class II MHC and co-stimulatory molecules. However, after 
engulfing pathogens they can be activated by the innate immune system (as described 
later (1.5.1.1)). This induces migration back to the regional lymph nodes and their 
maturation, with the upregulation of surface bound co-stimulatory and adhesion 
molecules such that they become highly effective at presenting antigen to naive 
lymphocytes.  
Macrophages and B cells are professional antigen cells but differ from DCs because 
they are not only involved in antigen presentation but perform other immune functions, 
which also rely on antigen presentation. Macrophages originate in the bone marrow, 
circulate in blood and have few or no MHC class II or co-stimulatory molecules on their 
surface in the resting state. However, they differentiate and become activated in the 
tissues, increasing their expression of class II MHC and co-stimulatory molecules. 
Predominantly they are phagocytic cells, they ingest opsonised bacteria and particulate 
antigens by phagocytosis (rather than soluble antigens) using both Fc and complement 
receptors. The macrophage would then usually destroy the microorganism without T 
cell help in the intravesicle compartment however if these pathogens are able to avoid 
elimination then the adaptive immune system is required. Activated macrophages 
present these ingested pathogens as processed antigens with class II MHC to CD4+ T 
cells however, are less efficient than DCs at activating naive T cells. Once activated, T 
cells can provide both secreted (e.g. cytokines IFN-γ and TNF-α/β) and membrane 
bound signals (CD40 ligand) to macrophages to activate them further and improve their 
ability to act as APCs. Activated macrophages are then able to ingest foreign protein 
more efficiently, to kill ingested pathogens, release soluble inflammatory mediators 
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(e.g. TNF, IL-1, IL-12) and upregulate the expression of MHC and co-stimulatory 
molecules. 
B cells act as professional APCs and can bind soluble pathogen components and 
bacterial toxins to the B cell surface immunoglobulin (i.e. the BCR), which are then 
internalised, processed and presented. They constitutively express MHC class II 
molecules but not co-stimulatory molecules. Again B cells can activate naive T cells 
when they express co-stimulation but are again less efficient than DCs. Generally B 
cells present antigen to antigen specific effector CD4+ T cells which drive B cell 
differentiation.  
1.5 T cell activation 
1.5.1 The primary response by naive T cells 
Naïve T cells attach with low avidity to APCs they encounter using the T cell integrin 
‘lymphocyte function-associated antigen-1’ (LFA-1) which binds the intercellular 
adhesion molecules (ICAMs) present on APCs. Other adhesion molecules are also 
involved which include CD2 on the T cell binding to CD58 on the APC. This provides 
the T cell with time to sample MHC molecules on the APC for the presence of their 
specific cognate peptide. Rarely the naive T cell recognises its peptide-MHC ligand and 
there is signalling through the TCR to produce a conformational change such that LFA-
1 increases the avidity of its binding to ICAM-1 and 2 on the APC. This stabilises the 
interaction between the antigen-specific T cell and the APC, but the recognition by the 
naive T cell of this foreign peptide-MHC complex on the antigen presenting cell is 
insufficient on its own to stimulate T cell activation. This interaction only provides the 
first signal: antigen specific clonal expansion of naive T cells requires a second co-
stimulatory signal. This second signal must be delivered by the same APC on which the 
peptide-MHC complex has been recognised. The best characterised and principle co-
stimulatory molecules involved are B7.1/CD80 and B7.2/CD86 found on the APC 
which bind CD28 on the T cell surface allowing T cell activation and the expression of 
other proteins which contribute to sustaining the co-stimulatory signal (Figure 1.2) e.g. 
CD40 ligand (CD40L) which binds to CD40 on the APC. This binding has bidirectional 
effects: it transmits activating signals to the T cell and also activates the APC to express 
more B7 family molecules. Another pair of proteins which contribute to co-stimulation 
is the 4-1BB ligand on the APC and T cell 4-1BB molecule. CD28 related proteins are 
also induced on activated T cells. CTLA-4 closely resembles CD28 however delivers an 
inhibitory signal to the activated T cell reducing their proliferative response by limiting 
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IL-2 generation. A second CD28 related protein, inducible co-stimulator (ICOS) is 
induced on activated T cells and binds the ligand of ICOS (LICOS) on the activated 
APC and helps to drive T cell growth. 
1.5.1.1 Upregulating co-stimulatory molecules on antigen presenting cells 
The initial adaptive immune response by naive T cells does not occur in the tissues at 
the site of infection but in the draining lymphatic tissue. This presentation is aided by 
the innate immune system which has two roles. Firstly it directs APCs to travel from the 
infected tissue to the local lymphoid tissues and secondarily aids their maturation into 
cells which express high levels of co-stimulatory and adhesion molecules necessary for 
T cell activation. 
At the site of infection direct microbial stimulation of non-clonal receptors on the APC 
takes place with the recognition of molecular patterns associated with pathogens but not 
with host cells. These pattern recognition receptors (PRRs), an example of which are the 
toll-like receptors (TLRs) (Medzhitov and Janeway 1997), recognise pathogen-
associated molecular patterns (PAMPs). PAMPs can be components of the pathogen 
such as lipopolysaccharide. Stimulation of these innate receptors directs the DC towards 
the draining lymph node and induces the expression of co-stimulatory and adhesion 
molecules, which are required for naive T cell activation. Macrophages and B cells can 
also be induced by the same innate receptors to express co-stimulatory molecules and 
function as mature APCs. 
Injured cells dying by necrosis, such as those exposed to pathogens, toxins or 
mechanical injury, can release danger or alarm signals in the form of molecules called 
danger associated molecular patterns (DAMPs). Examples of such DAMPs include heat 
shock proteins and fragments or components of the extracellular matrix e.g. fibronectin 
and heparin sulphate. DAMPs are also recognised by PRRs on APCs. The subsequent 
binding of the DAMPs to the PRRs has the same effect as PAMPs binding, with the 
development of mature APCs. They also stimulate the production of proinflammatory 
cytokines which contributes to the local inflammation by attracting leukocytes.  
Self antigens released from injured cells, which are recognised by autoreactive T cells 
not deleted during negative selection in the thymus, would not ordinarily be able to 
activate naive T cells on their own. This is because a second signal is not generated and 
so the T cell becomes anergic. This is one method of peripheral negative selection as 
described earlier (1.2.2) to prevent autoimmunity. However, when naive T cells 
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recognise self antigen on mature APCs with the appropriate second signal, generated as 
a consequence of the DAMP-PRR interaction, then instead of inducing tolerance these 
T cells are activated. This is the principal behind the danger signal hypothesis proposed 
by Matzinger (Matzinger 2002). It allows self antigens to become immunogenic and 
activate autoreactive naive T cells when present in an inflammatory environment, such 
as when mixed with bacteria. These bacteria can be termed adjuvants. This was shown 
experimentally by injecting myelin basic protein with M. tuberculosis in susceptible 
animals resulting in experimental allergic encephalitis (EAE). This illustrates the 
importance of requiring multiple signals before T cells can be activated to ensure 
discrimination of self from non-self. However even this system is not perfect. 
Figure 1.2- Interaction between the naive T cell and antigen presenting cell 
The activation of naive T cells requires two activation signals delivered by the same 
antigen presenting cell. Binding of the peptide:MHC complex to the TCR provides the 
first signal. The second signal is transmitted by the co-stimulation and adhesion 
molecules on the APC which bind to their ligands on the naive T cell. This subsequently 
results in T cell activation. 
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1.5.1.2 Naive CD8+ T cells 
Almost all cells display surface class I MHC. This allows the surveillance of all 
intracellular cytosolic proteins to prevent intracellular pathogens from evading immune 
responses. Some intracellular viral pathogens infect professional APCs and so can be 
recognised by a naive CD8+ T cell and activated in a similar way to that described 
earlier for naive CD4+ cells. Also intracellular components released from dying 
infected cells can be taken up by dendritic cells and these proteins cross-presented by 
the DC with MHC class I antigen. These antigens are then recognised by naive CD8+ T 
cells, which can be activated once the DC has matured. 
Naive CD8+ T cells require more co-stimulation, compared to naive CD4+ cells, to 
allow activation. The expression of higher levels of co-stimulatory signals can be 
facilitated by activated CD4+ T cells when they recognise related antigen to that 
recognised by a naive CD8+ T cell on the surface of the presenting cell. Signals are sent 
through CD40L on the activated CD4+ T cell to CD40 on the presenting cell to induce 
B7 family expression. Expression of the B7 family of molecules on the presenting cell 
generates the second signal for the naive CD8+ T cell to be activated. Other co-
stimulatory molecules can be upregulated by the effector CD4+ T cell, including 4-IBB 
ligand.  
1.5.2 Role of interleukin-2 (IL-2) in T cell activation 
The cytokine IL-2 plays a role in the proliferation and differentiation of T cells. All 
resting T cells have a cell surface IL-2 receptor with a β and γ-chain which can bind IL-
2 with moderate affinity. However, it is not until naive T cells are activated by 
peptide:MHC binding to the TCR that two events take place. Firstly, an α-chain is 
synthesised which binds with the β and γ-chain of the IL-2R to generate a high affinity 
IL-2 receptor, also called CD25. Secondly, IL-2 secretion is promoted by the activated 
T cell. The recognition by the TCR of a peptide:MHC complex induces nuclear 
translocation and activation of the transcription factor NFAT, which binds the IL-2 
promoter gene and increases IL-2 transcription by the T cell. Not until the second signal 
is achieved by B7-CD28 ligation is IL-2 RNA stabilised and IL-2 synthesis increased. 
Binding of IL-2 to the high affinity receptor stimulates T cell proliferation, allowing 
activated T cells to divide 2-3 times per day and also promotes the differentiation to 
armed effector T cells. The immunosuppressant calcineurin inhibitors inhibit IL-2 
production by disrupting signalling through the TCR whereas rapamycin disrupts 
signalling through the IL-2 receptor. 
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1.5.3 The secondary response by effector T cells 
After T cell activation and clonal expansion, T cells are induced by IL-2 to differentiate 
into armed effector cells. Armed effector cells are able to synthesise effector molecules 
and perform specialised functions in cell mediated and humoral immunity. These armed 
effector cells undergo changes which distinguish then from naive T cells and no longer 
require the second co-stimulatory signal for activation when they recognise a 
peptide:MHC complex on an APC. This is important for CD8+ T cells since some of 
the cells which present antigen to them may not be professional APCs and cannot 
display co-stimulatory molecules. Also CD4+ cells must be able to activate both B cells 
and macrophages that have taken up antigen even if they are not expressing co-
stimulatory molecules.  
Effector T cells change their cell surface adhesion molecules to favour binding to APCs 
at sites of inflammation. This involves higher expression of the adhesion molecules 
LFA-1 and CD2 and the loss of homing L-selectin which is important to guide naive T 
cells from the blood to lymph nodes. Instead they express the integrin VLA-4 which 
facilitates binding to vascular endothelium with the surface molecule VCAM-1, 
expressed at sites of inflammation.  
1.5.4 T cell effector functions 
All effector T cells interact with their target peptide:MHC complex on a presenting cell 
but their functions differ depending on the membrane and secreted proteins which they 
express or release. This is so that the adaptive immune system can deal with different 
types of pathogen and cause distinct effects on the target cells. Effector T cells can be 
distinguished from naive and memory cells by their cell surface molecules which 
include CD25 and CD69. Proliferating cells can be distinguished by positive staining 
for Ki67. The presence of these cell surface molecules will be exploited within this 
thesis. 
1.5.4.1 Effector CD8+ T cells 
Armed effector CD8+ T cells are important in host defence against cytosolic pathogens, 
the commonest being viruses, which are not accessible to antibodies. They act by killing 
cells which harbour pathogens after recognising foreign peptide with class I MHC on 
their cell surface. These CD8+ T cells release cytotoxins such as perforin and granzyme 
from pre-stored lytic granules. Perforin forms pores in the target cell membrane lipid bi-
layer allowing granzymes to enter the cell and induce apoptosis. The membrane bound 
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FAS ligand, a member of the TNF family, is also expressed by activated CD8+ (and 
some CD4+) cells and induces apoptosis of their target cells. Apoptosis occurs when a 
cellular protease cascade is initiated causing immunologically silent cell death. The cell 
remnants are rapidly taken up and destroyed by phagocytes without the induction of 
stimulatory molecules on the phagocyte.  
CD8+ effector cells can produce the cytokine IFN-γ which blocks viral replication in 
the target cell and increased MHC class I peptide loading in the ER. It can also activate 
macrophages and recruit them as antigen presenting or effector cells. TNF-α and β are 
produced which act synergistically with IFN-γ. 
Killing cells with effector CD8+ T cells is a precise process which minimises injury to 
cells not bearing the target antigen, whilst killing the infected cell target. 
1.5.4.2 Differentiation of CD4+ T cells 
Unlike naive CD8+ T cells which are predetermined to become cytotoxic cells and form 
part of cell mediated immunity (CMI), CD4+ T cells differentiate on activation into 
different subtypes which produce different cytokines and have different effector 
functions (Table 1.3). Which subtype depends upon the cytokine environment in which 
they are produced (Constant and Bottomly 1997), along with the type of co-stimulation 
used and nature of the peptide:MHC ligand. Initially this cytokine environment is 
generated by cells of the innate system, which act to shape the adaptive response. The 
most well recognised subgroups are Th1 and Th2 cells (Mosmann, Cherwinski et al. 
1986). 
• Th1: The presence of the cytokines IFN-γ and IL-12, signalling through signal 
transduction and activator of transcription 4 (STAT-4), skews the CD4 T cell 
population towards the Th1 phenotype. Th1 cells are important in macrophage 
activation, playing a role in cell mediated immunity, and induce B cells to 
produce opsonising IgG antibodies, part of humoral immunity. Th1 cells 
produce cytokines including IFN-γ and IL-2 and are characterised by the 
expression of the transcription factor T-bet. 
• Th2: The presence of the cytokines IL-4 and IL-5, signalling through STAT-6, 
skews the CD4 T cell population towards the Th2 phenotype. These Th2 cells 
are important in activating B cells to produce neutralising antibodies such as 
IgM, A and E and form part of humoral immunity, as well as effecting 
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macrophages. Th2 cells produce IL-4 and IL-13 and are characterised by the 
expression of the transcription factor GATA-3. 
• Th17: The more recently discovered Th17 T cells develop in the presence of IL-
6 and TGF-β to produce IL-17, IL-21 and IL-23 and express the transcription 
factor ROR-γt (Bettelli, Carrier et al. 2006; Mangan, Harrington et al. 2006; 
Veldhoen, Hocking et al. 2006). IL-21 and IL-23 are responsible for maintaining 
the proliferation of Th17 cells. IL-17 produced by Th17 cells acts as a 
proinflammatory mediator and amongst other things stimulates: 
proinflammatory cytokines causing further local inflammation, chemoattractant 
molecules to recruit phagocytic cells, haematopoietic growth factors, and co-
stimulatory molecules to aid T cell activation. 
• Treg: T regulatory cells (discussed briefly in 1.2.2) also develop in a TGF-β 
cytokine environment (Bettelli, Carrier et al. 2006) but express the transcription 
factor FoxP3 and produce IL-10 and TGF-β. Their ability to regulate is still not 
absolutely defined but may include contact-dependent regulation and the release 
of soluble mediators to cause regulation. 
Importantly, subsets of T cells can reciprocally inhibit the functions of others. 
Cytokines produced by Th1 cells e.g. IFN-γ can negatively regulate Th2 cells and vice 
versa through IL-10 (Mosmann, Cherwinski et al. 1986). Also the production of IFN-γ 
and IL-17 seems mutually exclusive promoting either Th1 or Th17 cells respectively 
(Park, Li et al. 2005), as does the formation of either Th17 or Treg cells which is 
dependent upon the cytokine environment (Bettelli, Carrier et al. 2006). Commitment to 
a particular subset of Th cell may not be stable and reprogramming to attain another 
phenotype may be possible. This is known as plasticity (Yang, Nurieva et al. 2008). 
1.5.4.2.1 Effector Th1 cells provide help for macrophage activation 
The principal function of effector Th1 cells is in classical M1 macrophage activation. 
This adaptive immune response is important in host defence against intra- and 
extracellular pathogens that have resisted death after being engulfed by macrophages. 
This process of macrophage activation occurs by two means: through the production of 
IFN-γ and by forming a sensitising contact signal through the CD40L on the T cell to 
the CD40 molecule on the macrophage.  
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Th1 cells produce a range of cytokines, chemokines and surface molecules that not only 
activate macrophages but recruit phagocytes to the site of injury through the production 
of IL-3, GM-CSF, TNF-α and β and the chemokine CCL2. They can also display the 
FAS ligand and induce apoptosis of cells with the FAS surface molecule, in particular 
macrophages. Th1 cells control and coordinate host defence against some intracellular 
pathogens such as Mycobacterium and Pneumocystis carinii. 
Once the macrophage is activated by the Th1 cells to form potent microbial effector 
cells they can carry out a number of functions. These include:  
• killing pathogens within the macrophage phagosomes  
• synthesising and releasing peptides and proteases to attack extracellular 
pathogens  
• increasing their cell surface class II MHC, B7 and CD40 molecules and TNF 
receptors to become better APCs  
• producing IL-12 to direct activated CD4+ T cells towards the Th1 phenotype 
• producing nitric oxide (NO)  
• recruiting other cells to the site of inflammation 
However macrophage activation is not specific and can cause local tissue damage. 
1.5.4.2.2 Effector Th cells provide help for B cells 
The extracellular space is also protected by the humoral immune response. This relies 
upon activation of B cells to produce antibodies which can then act to destroy 
extracellular pathogens or prevent the spread of intracellular infection from one cell to 
another. Antibodies carry out these functions either by opsonising the pathogen to 
facilitate phagocytosis, with or without complement, or by binding to the cell surface of 
the pathogen and preventing spread of infection.  
The most effective B cell activation requires the help of effector Th cells, but T cell 
independent B cell activation can be triggered by antigens such as lipopolysaccharide or 
the repeated pattern of bacterial capsular polysaccharides that cross link multiple B cell 
receptors (BCRs) to cause activation. Ultimately Th cells act to regulate antibody 
production and determine the effector function of antibodies by isotype switching. 
For Th cells to provide help to a naive B cell they must both recognise a linked antigen. 
Naive B cells recognise pathogen after it binds to the Fab end of surface bound 
immunoglobulin (i.e. the BCR), which provides the first signal for B cell activation. 
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This complex is internalised and peptide processed before presention with class II MHC 
on the B cell surface. Once the B cell encounters an effector Th cell which recognises 
that peptide, the TCR binds. The Th cell then produces cell bound and secreted proteins 
to activate the B cell. This B cell:Th cell interaction triggers the CD40L to bind the 
CD40 molecule on the B cell and is critical in providing the second signal for B cell 
activation. The production of IL-4 by the Th2 cell also contributes to clonal expansion. 
However, activation is bidirectional such that the B cell also increases expression of the 
B7 family of molecules, which signal to the Th cell to sustain growth and 
differentiation. 
Signalling through the CD40 molecule on the B cell allows isotype switching. Th2 cells 
bound to the activated B cell can produce IL-4 and 5 stimulating the B cells to generate 
IgG, E and A, whereas IFN-γ production by Th1 cells triggers B cells to produce IgG2a 
and 3. After B cells proliferate and differentiate, they mature into either plasma or 
memory cells. Plasma cells produce high affinity, isotype switched antibodies and 
memory B cells are long lived cells but do not secrete antibody.  
1.5.4.2.3 T regulatory cells 
T regulatory cells have immunoregulatory capacity. They can inhibit proliferation and 
production of cytokines by CD4+ and CD8+ lymphocytes to polyclonal stimuli, as well 
as down-modulate the responses by these cells to specific antigens (Dieckmann, 
Plottner et al. 2001). This assists in the maintenance of tolerance to self components and 
allows the prevention or control of autoimmune diseases and transplant organ rejection. 
The transcription factor FoxP3 is expressed by Tregs and they develop in a TGF-β 
cytokine rich environment (Chen, Jin et al. 2003). 
The mechanisms by which Tregs elicit their immunosuppressive effects are unclear but 
may be by contact-dependent regulation and by the release of soluble mediators to act at 
short distances from the Treg to cause regulation. In vitro CD4+CD25+ Tregs require 
specific antigens or polyclonal activators to stimulate suppressive activity through their 
TCRs. The subsequent suppression of effector CD25-CD4+ or CD8+ T cells is contact-
dependent, requiring an association between the Treg and effector T cell, but is 
cytokine-independent (Takahashi, Kuniyasu et al. 1998; Thornton and Shevach 2000). 
Suppression of the effector T cell may occur by un-coupling of IL-2 signalling and 
inhibition of IL-2 production. In vivo Tregs exert their effects by both cytokine-
independent and cytokine-dependent mechanisms. Tregs respond to their cognate 
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antigen (Romagnoli, Hudrisier et al. 2002) however, IL-10 and TGF-β are also 
important indirect mediators of Treg activity: these soluble cytokines act at short 
distances from the cell or bound to the cell surface to promote regulation (Dieckmann, 
Bruett et al. 2002). 
Tregs can be generated both in the thymus and the periphery. Thymic or natural Tregs 
leave the thymus as functional MHC class II-restricted suppressor cells (Bluestone and 
Abbas 2003), essential for preventing autoimmunity and keeping immune responses to 
pathogens under control. The method of generation of peripheral/adaptive/induced 
Tregs may be similar to the mechanisms involved in Th1/Th2 polarisation and 
contribute to the development of an antigen-specific immunosuppressive response 
(Bluestone and Abbas 2003). At least three factors are important in their generation. 
The first factor involves the amount and strength of the antigen interaction on the APC 
with a CD4+ T cell, with low concentrations and weak stimuli resulting in more Treg 
generation (Thorstenson and Khoruts 2001). Secondly, the activation status of the APC 
is important, with immature or sub-optimally activated APCs/DCs being more likely to 
generate Tregs (Apostolou and von Boehmer 2004). And finally the cytokine 
environment in which the Tregs develop and are maintained is critical in their 
development, with TGF-β being instrumental in the conversion of naive T cells to Tregs 
(Chen, Jin et al. 2003). 
Some immunosuppressive drugs have been demonstrated to augment Treg function. In 
particular antithymocyte globulin (ATG) depletes T cells by complement mediated lysis 
or activation-induced apoptosis. However, it has been demonstrated that exposure to 
ATG expands the Treg population and can induce development of Treg cells rather than 
proinflammatory T cells (Lopez, Clarkson et al. 2006). The mechanism by which this 
occurs is unclear. Furthermore alemtuzumab (Campath) a monoclonal antibody to 
CD52, found on the surface of lymphocytes, can also cause the Treg population to 
expand (Watanabe, Masuyama et al. 2006). These drugs are both used to treat or 
prevent acute rejection in transplant patients and it has been observed that these patients 
have increased numbers of circulating Tregs (Ciancio, Burke et al. 2005). 
1.5.4.2.4 Th17 cells 
The initial 1986 paradigm proposed by Mosmann and Coffman with Th1 and Th2 cells 
(Mosmann, Cherwinski et al. 1986) was unable to explain why mice deficient in the 
cytokine IFN-γ could generate a proinflammatory Th1 phenotype and remained 
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susceptible to inflammatory conditions such as EAE and collagen-induced arthritis 
(CIA) (Ferber, Brocke et al. 1996; Matthys, Vermeire et al. 1998). It was subsequently 
demonstrated from murine work that IL-23 stimulated the production of IL-17 by a 
population of mature T cells and that IL-17 was linked with the inflammation seen in 
CIA and EAE (Lubberts, Joosten et al. 2002; Langrish, Chen et al. 2005). 
It is now known that IL-6, in combination with TGF-β induces a population of naive Th 
cells to differentiate into Th17 lymphocytes. ROR-γt induces the transcription of the IL-
17 gene in naive Th cells. It also allows the expression of the IL-23 receptor on the 
Th17 cells, allowing stabilisation of the IL-17 phenotype. Three publications were 
produced almost simultaneously in 2006 which demonstrated that both IL-6 and TGF-β 
were required to generate Th17 cells from naive Th cells (Bettelli, Carrier et al. 2006; 
Mangan, Harrington et al. 2006; Veldhoen, Hocking et al. 2006). In humans Th17 have 
been generated from naive Th cells with TGF-β plus IL-21 or IL-6 and 23 (Miossec, 
Korn et al. 2009). 
Th17 cells have multiple functions due to their production of the pleomorphic cytokine 
IL-17. They can initiate inflammatory reactions dominated by neutrophils in response to 
certain infectious agents but are also associated with generating and maintaining chronic 
inflammation and immunopathological diseases, such as rheumatoid arthritis, multiple 
sclerosis and inflammatory bowel disease.  
Th17 cells and FoxP3 regulatory cells are reciprocally related to generate inflammation 
and autoimmunity or regulation. TGF-β induces naive T cells to express FoxP3 and 
develop suppressor regulatory function. However, IL-6 is able to switch the 
transcriptional program initiated by TGF-β in a way that induces the development of 
Th17 cells and the expression of the ROR-γt transcription factor.  
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Table 1.3- The four main types of armed effector CD4+ T cells which produce distinct effector functions 
Subclass of CD4+ T 
cell 
Cytokine responsible 
for skewing 
Transcription factor Cytokines and effector 
molecules produced 
Effector function 
Th1 IFN-γ 
IL-12 
T-bet IFN-γ 
TNF-α 
GM-CSF 
CD40 ligand 
Fas ligand 
 
• Macrophage activation 
• Induce B cells to produce 
opsonising IgG antibodies 
• Provide help to activate 
naive CD8+ T cells 
Th2 IL-4 
IL-5, 
GATA-3 IL-4 
IL-5 
IL-13 
CD40 ligand 
• Activate B cells and allow 
isotype switching 
• Affect macrophages 
• Recruit eosinophils 
Treg TGF-β FoxP3 TGF-β 
IL-10 
• Contact dependent 
regulation 
• Release of soluble 
mediators to allow 
regulation 
Th17 IL-6 
TGF-β 
ROR-γt IL-17 
IL-21 
IL-23 
• Proinflammatory role 
• Autoimmune disease 
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1.5.5 Memory cells 
The formation of memory cells is one of the most important consequences of the 
adaptive immune response. They provide long lasting protective immunity which allows 
the rapid production of antigen specific antibodies and armed effector cells on 
subsequent encounter with the same pathogen. Both memory T and B cells exist, which 
are a small persistent pool of lymphocytes which survive after initial antigen 
recognition independent of the original antigen but are maintained in a resting state by 
IL-7 and 15. 
Memory B cells are formed after B cell activation when they become either terminally 
differentiated plasma cells secreting antibody until they die or memory B cells. The 
formation of a memory T cell arises after T cell activation and from effector T cells.  
There may be two distinct forms of memory T cell, effector and central memory cells, 
which are able to mature at different speeds into effector cells.  
Memory cells can be distinguished from naive or effector cells by the surface markers 
they display. In particular the three surface proteins L-selectin, CD45 and CD44 differ 
between the three T cell types, with memory cells displaying high levels of CD44, low 
L-selectin and a different CD45 isoform. 
1.5.6 NKT cells 
These are lymphocytes which bridge the gap between innate and adaptive immunity. 
They develop in the thymus and are positively selected after CD1d-glycoprotein 
complexes interact with double negative thymocytes. NKT cells can be activated either 
by recognising endogenous and exogenous antigens or indirectly via cytokine driven 
mechanisms. 
The NKT receptor is a semi invariant TCR which closely resembles a PRR. The Type I 
NKT cell receptor is formed by combining Vα14-Jα18 and Vβ8.2/7/2. This antigen 
specific receptor recognises glycoprotein antigen with the MHC class I-related 
glycoprotein CD1d on professional APCs. The prototype type I NKT cell recognises α-
galactosylceramide (α-GalCer) antigen. Type II NKT cells are also CD1d restricted but 
have a wider repertoire of TCRs. NKT cells in mice are either CD4+ or double negative 
cells. Alternatively NKT cells can be activated indirectly, without cognate antigen 
recognition by cytokines alone. This can occur when PRRs on a DC are upregulated in 
response to a microbial stimulus, causing DC activation and the production of cytokines 
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such as IL-12, which activate NKT cells. Alternatively, a combination of both direct 
antigen and indirect cytokine mechanisms can activate NKT cells. 
Once NKT cells are activated they produce immunoregulatory cytokines especially IL-4 
and IFN-γ. Other cytokines produced include IL-2, IL-6, IL-10, IL-13, IL-17, TGF-β 
and TNF-α. In addition, activated NKT cells can produce haematopoietic growth factors 
e.g. GM-CSF and chemokines (e.g. RANTES). They are also cytolytic, expressing high 
levels of granzymes, perforin and FasL. Once activated NKT cells display activation 
markers such as CD69 and CD44 like conventional T cells however, activation is short 
lived and they soon become anergic. Different subtypes of NKT cells have different 
cytokine profiles upon activation (determined by their mode of activation) resulting in 
their differing effector functions. 
NKT cell activation can influence both innate and adaptive immune systems: through 
the production of IFN-γ they influence macrophage inducing inflammatory responses, 
CD8+ T cell mediated cytotoxic effects against target cells and Th1 CD4+ cell 
responses.  
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1.6 Autoimmune disease 
The adaptive immune system is critically important for host defences against infection, 
but sometimes host defences are initiated against antigens not associated with infectious 
agents, such as self tissue antigens. This is termed autoimmunity and can lead to tissue 
damage.  Autoimmunity is due to loss of tolerance to self antigens and a breakdown in 
either central or peripheral tolerance. Autoimmune diseases (AIDs) develop when a 
population of self reactive, self MHC restricted T cells cause a T cell or humeral 
antibody mediated response resulting in injury. Once T cells are activated by self 
antigens they cause the same T cell effector immune responses which occur in response 
to pathogen. T cells can be directly cytotoxic or produce inflammatory cytokines and 
help B cells to produce antibodies which cause tissue damage.  
1.6.1 Self perpetuating autoimmune injury 
In normal immune responses against pathogen, the pathogen is destroyed and the 
immune response will cease but leave a population of memory lymphocytes. However, 
in autoimmunity the self antigen is not easily eliminated because it is either in vast 
excess or ubiquitous (such as chromatin in systemic lupus erythematosus (SLE)) and so 
the constant presence of autoantigen causes chronic inflammation and the further 
release of autoantigens through tissue injury. Cytokines liberated from areas of injury 
attract inflammatory cells such as macrophages and neutrophils which can cause further 
tissue injury and so a continuous and evolving self destructive process develops. Self 
antigens which were not the initial target of autoreactive T cells at the initiation of 
autoimmunity may become targets, such as DNA and other nuclear proteins in SLE. 
This is because self antigens are released into an environment with activated DCs and B 
cells that can take up and present the self antigen to autoreactive T and B cells. This 
process is called epitope spreading, where autoimmunity to a single epitope can spread 
to multiple epitopes and cause widespread autoimmunity. This has been demonstrated 
in the animal model of multiple sclerosis (MS), experimental allergic encephalitis, 
where immunisation with a single peptide of the self protein myelin basic protein 
(MBP) with adjuvant can ultimately lead to immune responses to other epitopes from 
the same protein and even to other proteins expressed in the same tissue (Lehmann, 
Forsthuber et al. 1992). 
1.6.2 Autoimmune susceptibility 
The trigger to autoimmunity is unclear but it seems that environmental factors such as 
drugs, infections and toxins and/or a genetic predisposition are required to elicit 
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autoimmune disease. These factors allow T cells to evade the mechanisms of central 
and/or peripheral tolerance which are fundamental to distinguishing self from non-self. 
1.6.2.1 Genetic susceptibility to autoimmune disease 
Many genes have been identified in which mutations or single-nucleotide 
polymorphisms (SNPs) are associated with increased susceptibility to autoimmunity.  
These include genes which are responsible for autoantigen availability and clearance, 
co-stimulatory molecule expression, cytokine gene expression, lymphocyte signalling 
and apoptosis. Well recognised examples which induce AID include mutations to the 
AIRE and Fas genes that encode proteins involved with thymic tolerance and apoptosis. 
The most consistent genetic locus associated with increased susceptibility to AID is the 
MHC genotype. In human autoimmune diseases susceptibility is most strongly linked 
with class II MHC alleles but there are some strong associations with MHC class I 
alleles. Goodpasture’s syndrome is an example where susceptibility to the condition is 
associated with the DR2 allele of class II MHC and in ankylosing spondylitis there is a 
very strong association with the class I MHC B27 allele. 
The ability of T cells to respond to an antigen depends upon the MHC genotype to 
which it is bound.  It may be the increased susceptibility to AID offered by certain 
MHC alleles is because they are better at presenting autoantigens to autoreactive T cells. 
Certain self MHC molecules may drive positive selection of T cells within the thymus 
but avoid negative selection because the MHC-self peptide complex does not bind with 
adequate avidity or are in low copy number. This is supported by the observations that 
the disease-associated MHC class II molecule I-Ag7, in non-obese diabetic (NOD) 
mice, binds many peptides poorly and may be less effective at driving negative 
selection of T cells in the thymus that bind self antigens (Carrasco-Marin, Shimizu et al. 
1996). 
1.6.2.2 Environmental susceptibility to autoimmune disease 
Environmental factors have a strong influence on autoimmunity and AID can follow 
infection, inflammation, injury or toxin exposure.  
1.6.2.2.1 Self antigens in an inflammatory environment  
T cells which have low affinity for ubiquitous self antigen and which are unable to 
cause T cell activation under normal conditions may become autoreactive in an 
inflammatory environment.  Inflammation caused by infection or injury stimulates the 
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release of inflammatory mediators and upregulation of co-stimulatory molecules on 
APCs, generating the obligate second signal required by T cells for their activation. If 
tissue damage increases the availability of self antigens then the autoantigen which 
would normally bind rarely and with low avidity to its cognate T cell may now be able 
to stimulate its activation (Matzinger 2002). 
1.6.2.2.2 Cross reactivity with pathogenic epitopes 
Certain pathogens express protein or carbohydrate antigens which resemble host self 
antigens, so T cells recognising these pathogenic peptides can also elicit a T cell 
response to self peptide from host tissue. Additionally antibodies produced against the 
pathogen epitope may cross react with the self protein. This concept is termed molecular 
mimicry and occurs in rheumatic fever where cross reactivity between streptococcal 
components and host tissue causes antibody and T cell mediated host tissue injury. 
1.6.2.2.3 Exposing self antigen from an immunologically privileged site 
There are some sites in the body including the brain and anterior chamber of the eye 
into which tissue grafting does not elicit rejection and these sites are termed 
immunologically privileged (Medawar 1948). It was originally believed that the 
privilege was due to passive immunological ignorance since retinal antigens were 
inaccessible to the immune system due to the blood:retinal barrier. However, 
subsequent studies have demonstrated that antigens interact with T cells at this site and 
do leave the eye. Therefore immune privilege must rely upon the regulation of both 
local and systemic immune responses to antigen. Within the aqueous humour of the eye 
there is local inhibition of immune responses due to a unique immunomodulatory 
environment which suppresses T cell activation and promotes regulation. Fas ligand is 
constitutively expressed in the eye and plays a major part in immune privilege by 
inducing apoptosis in inflammatory cells which enter the eye (Ferguson and Griffith 
2006). The systemic induction of Tregs has also been demonstrated (Caspi 2010). 
However, if there is trauma or infection which causes the eye to rupture an autoimmune 
response to eye proteins can develop which attacks both eyes, termed sympathetic 
opthalmitis. Sequestered eye antigens can be presented to T cells in the draining lymph 
nodes and stimulate effector T cells to enter the healthy eye to cause injury. 
A similar mechanism may occur with Dressler’s syndrome, when myocardial injury 
releases myosin from a site previously hidden to the immune system. 
 
 43 
1.6.2.2.4 Post translational modification in response to a physiological or 
inflammatory insult 
Post translational modifications (PTMs) of amino acids can generate neo-epitopes from 
self antigens. These modifications can occur in response to cell stress, inflammation or 
infection. PTMs can be by the addition of new groups to the protein such as 
phosphorylation, methylation and glycation. This method of PTM has been 
demonstrated in MS (van Stipdonk, Willems et al. 1998) and CIA (Michaelsson, 
Malmstrom et al. 1994) where phosphorylation and glycation of peptides respectively 
change their immunogenicity. Alternatively amino acid conversions can be induced 
spontaneously or enzymatically to cause deamination and citrullination. Citrulline has 
provoked interest in rheumatoid arthritis as an autoantibody target (van Boekel and van 
Venrooij 2003). Extracellular proteolysis may also occur, generating peptide fragments 
prior to either form of modification. All these mechanisms will influence recognition of 
self by affecting MHC binding, TCR affinity and antigen processing. These 
mechanisms can result in increased affinity between MHC and the TCR. It may also 
have more subtle effects promoting or limiting epitope production by impacting on 
antigen processing within APCs or extracellular degradation, which could occur when a 
cleavage site is lost (Anderton 2004; Pedersen 2007). Self-tolerance can be lost after 
PTMs induced by physiological factors such as cell stretch or pressure or be secondary 
to inflammation. 
1.6.2.2.5 Superantigens 
Superantigens, which are secreted proteins of microbial origin, are able to activate a 
polyclonal population of T cells independent of a cognate peptide-MHC-TCR 
interaction. By this mechanism up to 30% of the T cell population may become 
activated by superantigen that binds to a specific or limited number of Vβ TCR chains 
and MHC class II on the APC. This interaction drives clonal proliferation of a 
population of T cells expressing that Vβ gene (Kappler, Wade et al. 1987). The most 
commonly known superantigen in mice is encoded by the mouse mammary tumour 
virus (MMTV) (Acha-Orbea and MacDonald 1995) and in humans the toxic shock 
syndrome toxin is also a superantigen. 
1.6.2.3 Loss of T cell regulation 
Expression of the FoxP3 transcription factor is required for Tregs to function as 
immunosuppressive cells (Fontenot, Gavin et al. 2003). A spontaneous mutant strain of 
mice, known as scurfy mice, develop a fatal lymphoproliferative disease with chronic 
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multi-organ inflammation. The genetic mutation in these mice disrupts the FoxP3 gene 
and when wild type Tregs are transferred to newborn scurfy mice the condition is 
prevented (Brunkow, Jeffery et al. 2001). Humans with ‘immunodysregulation 
polyendocrinopathy enteropathy X-linked’ (IPEX) have a mutation in the FoxP3 gene 
causing chronic inflammation and AID, treatment options include immunosuppressive 
therapies and bone marrow transplantation (van der Vliet and Nieuwenhuis 2007).  
In AID there may be a dysregulated immune response with a loss of Treg function and a 
shift towards the Th1/Th17 phenotype, caused by the cytokine environment which has 
developed and the DC population present. Generation of proinflammatory cells may 
either be due to the loss of skewing towards the Treg phenotype (with the default 
production of proinflammatory Th1/Th17 cells) or a positive shift towards these 
pathways. IL-6 is the pivotal cytokine in this pathway which diverts the T cell 
population towards a proinflammatory rather than regulatory role, with the production 
of potent proinflammatory Th17 cells. 
1.6.3 Classification of autoimmune disease 
AID is classified as either organ specific or systemic.  Mechanisms that mediate 
autoimmune injury are similar to those used against invading pathogens, involving both 
antibodies and T cells, but in autoimmunity these are autoreactive. The three dominant 
mechanisms of tissue injury can be classified in a similar way to hypersensitivity 
reactions. Autoantibodies are able to bind soluble or tissue bound self antigen and 
mediate injury via the Fc and complement receptor pathways. Alternatively, 
autoreactive T cells destroy self tissue in a similar way to destroying a virally infected 
cell. An important difference between the immune response against pathogens and self 
antigen is that in most cases self proteins are not easily eliminated.  
1.6.3.1 Surface bound or matrix self antigens mediating autoimmune disease 
Autoimmunity that causes damage by mechanisms analogous to type II hypersensitivity 
reactions occurs when IgM and IgG autoantibodies bind to cell surface or matrix 
antigens. Injury is caused by mechanisms involving complement activation and when 
the Fc component of IgG binds to Fc receptors on phagocytic cells. 
Activation of the classical complement cascade can occur when either IgM or IgG 
autoantibodies bind cell surface or matrix antigens, leading to production of 
chemoattractant (C5a) and opsonizing molecules (C3b) and the membrane attack 
complex. Nucleated cells are relatively resistant to lysis by complement however 
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sublytic levels provide a powerful activating stimulus to the cell, causing cytokine 
release and generation of prostaglandin and leukotriene precursors that are the lipid 
mediators of inflammation (Hansch 1992). This occurs in Hashimoto’s thyroiditis. 
Secondly, the Fc portion of IgG, with self antigen bound to the Fab end, can bind to the 
Fc receptor on phagocytic cells such as macrophages and neutrophils and cause their 
activation. If the self antigen-antibody complex is of an appropriate size it may be 
phagocytosed: this occurs in autoimmune haemolytic anaemia when red blood cells are 
destroyed in phagocytic vesicles (Domen 1998). Otherwise phagocytic cells release 
lysosomal enzymes, cytokines and complement to cause tissue injury. This occurs in 
Goodpasture’s disease when autoantibody binds the α3 chain of type IV collagen, a 
matrix protein, causing severe glomerular and often pulmonary injury (Lerner, Glassock 
et al. 1967). 
Autoantibodies targeted at cell surface receptors can cause disease by stimulating or 
blocking them. In Graves’ disease autoantibody binds the thyroid stimulating hormone 
receptor causing excessive thyroid hormone production (Bahn and Heufelder 1993) and 
conversely in myaesthenia gravis autoantibody binds the nicotinic acetyl choline 
receptor preventing neuromuscular transmission (Vincent, Lily et al. 1999). 
1.6.3.2 Immune complex mediated autoimmune disease 
The tissue injuries caused in immune complex mediated autoimmune disease, where 
soluble self antigens are bound by autoantibody, are caused by the same mechanisms as 
type III hypersensitivity reactions. These immune complexes can fix complement and 
can be bound to phagocytic cells via complement and Fc receptors. Under normal 
conditions these complexes would be phagocytosed causing little tissue injury. 
However, when normal clearance mechanisms are overwhelmed these immune 
complexes become pathogenic, depositing in small blood vessels and inciting an 
aggressive inflammatory reaction. In SLE there is IgG production to ubiquitous nuclear 
self antigens which are present in all nucleated cells (Kotzin 1996). On cell death these 
nuclear components become extracellular and large amounts of antigen are available to 
complex with autoantibody and deposit in small bloods vessels causing complement and 
phagocyte activation with subsequent tissue injury. This tissue injury releases further 
nuclear components and thus a further supply of self antigens and so the cycle 
continues. 
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1.6.3.3 T cell mediated autoimmune disease 
Effector Th1 cells can bind their cognate self peptide:MHC complex on the surface of  
APCs to trigger activation. This is the same mechanism by which type IV or delayed-
type hypersensitivity reactions occur, the prototypical reaction being after the intra-
dermal injection of tuberculin (Facktor, Bernstein et al. 1973). Patients with previous 
exposure to the mycobacterium by infection or immunisation develop a localised T cell 
mediated inflammatory reaction within 24-72 hours, mediated by Th1 cells recognising 
the peptide:MHC class II complex on an APC and releasing inflammatory cytokines to 
establish a localised inflammatory reaction. 
Activated, autoreactive Th1 cells cause local inflammation by activating macrophages 
and by direct damage to tissue cells. Firstly, chemokines released from the activated 
Th1 cell attract macrophages to the site of antigen deposition. Secondly, the release of 
IFN-γ induces expression of vascular adhesion molecules and activates macrophages to 
release inflammatory mediators. Activated macrophages can also act as APCs further 
amplifying the immune response.  TNF-α and TNF-β increase expression of adhesion 
molecules on local blood vessels and increase permeability allowing inflammatory and 
plasma cells to enter the site. Production of IL-3 and GM-CSF stimulates further 
monocyte production in the bone marrow. Cumulatively these mechanisms allow 
infiltration of activated lymphocytes and macrophages into the tissue where the self 
peptide is present and cause tissue injury and cell death. Similar reactions can be caused 
by CD8+ T cells depending upon the pathway by which the antigen is processed. T cells 
are also required to sustain all autoantibody mediated responses 
AIDs mediated by autoreactive T cells include diabetes mellitus, multiple sclerosis 
(Zamvil, Nelson et al. 1985) and SLE (Peng, Madaio et al. 1996). In type 1 diabetes 
mellitus, insulin peptides produced by β pancreatic islet cells are recognised by 
autoreactive CD8+ lymphocytes and once activated these T cells cause β cell death and 
reduced insulin production (Haskins and Wegmann 1996). 
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1.7 Tubulointerstitial kidney injury and fibrosis 
1.7.1 Introduction 
Chronic kidney disease (CKD) is an increasingly significant public health problem in 
the western world and affects approximately 10% of the adult population (Coresh, 
Selvin et al. 2007). Even in its mildest forms it impacts on morbidity and mortality and 
can also progress to renal failure, requiring dialysis or transplantation, which represents 
a huge health and socio-economic burden (Go, Chertow et al. 2004). 
Irrespective of the cause, progressive nephron loss with leukocyte infiltration into the 
tubulointerstitium (TI) and fibrosis is a consistent finding in CKD (Harris and Neilson 
2006). Studies have shown that, even in primary glomerular diseases, it is the degree of 
TI injury rather than the severity of glomerular involvement which determines renal 
outcome (Nath 1992; Bohle, Strutz et al. 1994). The relationship between TI 
inflammation and fibrosis is less well established however, the role and function of 
leukocytes in the pathogenesis of renal injury is becoming increasingly clear (Tapmeier, 
Fearn et al. 2010). Here I outline the current understanding of lymphocyte and 
macrophage function in the development of tubulointerstitial damage. 
1.7.2 The response to kidney injury 
The recognised model of fibrogenesis suggests that after an initial injury the kidney 
would try to repair damage and recover function. Although this repair process is 
initially beneficial in limiting injury and dampening down the inflammatory process, it 
is also pathogenic due to the production of profibrotic mediators causing a fibrotic scar 
to develop. Formation of this permanent scar disrupts the normal architecture of the TI 
and can propagate further injury, especially if the injury is either repeated or persistent 
as occurs in many causes of CKD. 
The initial damage which mediates this injury can result from various stimuli, including 
autoimmune disease, infection, toxins and mechanical injury. However, both 
immunologically and non-immunologically mediated damage results in the infiltration 
of leukocytes into the TI. The interaction between these leukocytes and non-
immunological factors is complex and illustrated in the transplanted kidney where a 
major cause of late transplant failure is caused by tubular atrophy and interstitial 
fibrosis. In the transplanted kidney recognition of alloantigen by the immune system is 
an obvious driving force for ongoing injury and fibrosis but a number of other non-
allogenic factors contribute including the use of calcineurin inhibitors, ischaemia-
 48 
reperfusion, proteinuria, hyperlipidaemia and recurrent infection. Non-allogenic factors 
also contribute to renal injury in native kidney disease however, in the absence of an 
alloantigen driven response, the role and function of infiltrating leukocytes is less clear. 
These initial injuries, regardless of aetiology, initiate tubular epithelial cell (TEC) 
activation and the production of molecules which propagate renal damage, facilitate 
interstitial inflammation and contribute to fibrosis. Chemokines released by TECs result 
in chemotactic gradients that attract inflammatory cells to the site of injury. This 
infiltrating leukocyte population is comprised of macrophages and lymphocytes which 
are predominantly T cells (Muller, Markovic-Lipkovski et al. 1992; Strutz and Neilson 
1994).  
1.7.3 Role of T lymphocytes in tubulointerstitial injury and fibrosis 
In studies of human renal disease there is a correlation between lymphocytic infiltration 
into the TI and subsequent injury but causality is unproven. Two groups have 
demonstrated an association between the progression of IgA nephropathy and TI 
inflammation: In 2007 a Finnish group established that infiltration of CD3+ cells into 
the TI was independently associated with disease progression in all patients, both those 
with preserved renal function and those with renal impairment (Myllymaki, Honkanen 
et al. 2007). In 2008 another group retrospectively analysed a smaller population of 50 
patients and showed a significant association with dual positive GMP-17 / CD8 
cytotoxic T cells and progression towards renal failure in patients with normal or near 
normal GFR (van Es, de Heer et al. 2008). Furthermore as far back as 1975 TI 
inflammation was demonstrated in lupus nephritis; along with the universal presence of 
glomerular injury, 66% of biopsy specimens also had TI involvement (Brentjens, 
Sepulveda et al. 1975). Other groups demonstrated that the severity of interstitial 
inflammation in SLE correlated with the degree of renal insufficiency (Park, D'Agati et 
al. 1986; Alexopoulos, Seron et al. 1990).  
In general the lymphocytic infiltrate is predominantly T cells (CD4+ > CD8+) and there 
are fewer B cells (Strutz and Neilson 1994). T lymphocytes probably act synergistically 
with macrophages to propagate injury.  
In non-immunologically mediated renal disease, although lymphocyte infiltration occurs 
and appears to contribute to injury, it is unclear how lymphocytes become activated. As 
a consequence of the initial injury new antigenic epitopes may be displayed which are 
recognised by lymphocytes as foreign and trigger an immune response (Truong, 
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Farhood et al. 1992). Alternatively, autoreactive T cells which are normally anergic 
could recognise their cognate antigen and become activated in the proinflammatory 
environment of the injured kidney, thereby breaking tolerance and resulting in immune 
mediated injury (Matzinger 2002). The third possible explanation would be that 
bystander naive T cells are activated in a non-classical manner by the proinflammatory 
environment of the injured kidney without the need for antigen recognition (Unutmaz, 
Pileri et al. 1994; Rodriguez-Iturbe, Pons et al. 2001; Bangs, McMichael et al. 2006; 
Pedersen 2007; Bangs, Baban et al. 2009). 
The exact phenotype of the T cell population may determine their contribution to 
fibrosis.  There is strong evidence, particularly from liver disease, that Th2 CD4+ T 
cells promote fibrosis whilst Th1 CD4+ T cells encourage resolution and less fibrosis 
(Wynn 2004). Evidence for this in renal disease is limited, although treatment with 
IFNγ, which favours a Th1 CD4 T cell response, reduced fibrosis in an animal model of 
TI disease (Oldroyd, Thomas et al. 1999). In the unilateral ureteric obstruction (UUO) 
model Tapmeier et al demonstrated the pivotal role of CD4+ T cells in promoting renal 
fibrosis (Tapmeier, Fearn et al. 2010). In addition it is increasingly recognised that 
certain lymphocyte populations, in particular regulatory T cells, have a part to play in 
regulating the immune response and protecting the kidney from fibrosis (Lee, Wang et 
al. 2008).  
In order to study the disease mechanisms involved in renal fibrosis a number of animal 
models of chronic kidney disease have been developed. In the case of UUO increased 
intra-renal pressure and stretch occurs, causing TEC injury (Chevalier 1999). In renal 
ischaemia-reperfusion injury the kidney becomes ischaemic, initiating cellular injury on 
reperfusion. In models of glomerular disease e.g. adriamycin nephropathy or the mouse 
model of Alport syndrome, proteinuria itself may be toxic to tubules with proteins in the 
filtrate initiating an inflammatory response. Lymphocytes have been manipulated in 
these models of CKD by using either depleting antibodies or lymphopenic animals e.g. 
recombination activation gene-1 (RAG-1) knockout mice or severe combined 
immunodeficient (SCID) mice. In the most part these studies have demonstrated that, in 
the absence of lymphocytes, fibrotic injury is ameliorated suggesting that T 
lymphocytes are playing a pathological role in promoting fibrosis.  
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1.7.3.1 Animal models of tubulointerstitial fibrosis 
1.7.3.1.1 Unilateral Ureteric Obstruction, chemokines and chronic TI injury 
The role of chemokines in the development of TI inflammatory infiltrates has been 
extensively described (Vielhauer, Eis et al. 2004). There is increased expression of 
chemokines CCL2/MCP-1 and CCL5/RANTES in the UUO kidney that correlates with 
the accumulation of macrophages and lymphocytes expressing the chemokine receptors 
CCR2 and CCR5 and also with fibrosis (Vielhauer, Anders et al. 2001). When 
chemokine receptor knockout animals (Eis, Luckow et al. 2004) and chemokine 
antagonists (Anders, Vielhauer et al. 2002) are used there is significantly less cellular 
infiltration into the TI compartment and less interstitial injury post obstruction. Drugs 
with lymphocyte specificity, including mycophenolate mofetil (MMF) and rapamycin, 
have been used in the UUO model. MMF, which blocks de-novo synthesis of purines by 
lymphocytes and confers lymphocyte specificity as an anti-proliferative agent, has been 
shown to reduce the TI inflammatory infiltrate in UUO animals and injury (Goncalves, 
Biato et al. 2004). Using rapamycin in UUO has also given similar results, with a 
reduction in TI injury (Wu, Wen et al. 2006). Therefore inhibition and genetic deletion 
of chemokine receptors and the use of immunosuppressive drugs in the UUO model 
have all demonstrated less mononuclear cell infiltration and a reduction in renal injury 
but do not distinguish between lymphocyte and macrophage function in promoting 
fibrosis.  
However, Tapmeier et al have specifically demonstrated CD4+ T cells are pivotal to the 
development of fibrosis following UUO (Tapmeier, Fearn et al. 2010) and that these 
lymphocytes persist despite reversal of obstruction (Tapmeier, Brown et al. 2008). 
Niedermeier et al demonstrated in UUO that activated CD4+ cells stimulate 
differentiation of haematopoietic monocytes into fibroblasts that produce collagen I 
(Niedermeier, Reich et al. 2009). This was only seen in the appropriate cytokine 
environment favoured by the presence of a calcineurin inhibitor and the cytokines TGF-
β and IL-13. 
In contrast Shappell et al demonstrated that lymphocytes were not required for 
progressive TI injury in SCID mice (Shappell, Gurpinar et al. 1998). These differences 
may be explained by the genetic background of the mice used (Puri, Shakaib et al. 
2010). 
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Dong et al looked at the specific phenotype of cells that were activated by DCs in the 
UUO model of renal injury (Dong, Bachman et al. 2008). In the presence of cytokine 
rich dendritic cells producing MCP-1, IL-6 and IFN-γ, IFN-γ producing CD4 Th1+ and 
CD8+ memory T cells, and CD4+Th17+ memory cells secreting IL-17 were thought to 
be responsible for renal injury.  
1.7.3.1.2 Ischaemia-reperfusion injury and chronic TI injury 
The role of lymphocytes both in the early and late stages after renal ischaemia-
reperfusion injury (IRI) has been evaluated. It has been shown that CD4+ T cells play 
an important role in promoting renal injury soon after IRI. A significant attenuation of 
renal injury post IRI was observed in CD4-/- mice and this injury was restored when 
CD4+ T cells are adoptively transferred into CD4-/- animals (Rabb, Daniels et al. 2000; 
Burne, Daniels et al. 2001; Yokota, Daniels et al. 2002). Both athymic mice and mice 
treated with T cell depleting antibodies were also protected from injury. The 
requirement for intact co-stimulation was also evident as CD4+CD28- T cell 
reconstitution did not restore renal injury to that seen in the WT animals (Takada, 
Chandraker et al. 1997). Interestingly RAG-1 knockout mice were not protected against 
IRI (Burne-Taney, Yokota-Ikeda et al. 2005). 
The regulatory CD4+CD25+FoxP3+ T cell population driven by the cytokine TGF-β 
have also been shown to reduce TI injury in IRI (Gandolfo, Jang et al. 2009; Kinsey, 
Sharma et al. 2009). They may act to limit immune cell activation by modulating the 
proinflammatory cytokine production of other T cells or macrophages, modify 
mononuclear cell phenotype or promote renal cell recovery (Jang, Kim et al. 2008). 
After a longer follow up period of 6 weeks, renal function remained worse in animals 
after IRI compared to control sham operated mice and there was associated histological 
injury with inflammatory infiltrate, tubular atrophy and TI fibrosis (Burne-Taney, 
Yokota et al. 2005). The inflammatory infiltrate comprised of phagocytic cells and 
CD4+ lymphocytes. These infiltrating lymphocytes displayed surface markers of both 
activated effector and memory cells (Ascon, Ascon et al. 2009). This supports the 
hypothesis that lymphocytes are playing a pathogenic role in promoting chronic injury, 
rather than simply trafficking through the kidney, with activation occurring either by 
antigen dependent or independent mechanisms. This also suggests there are long term 
consequences of renal disease progression despite a single episode of IRI. 
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The mechanism of lymphocyte activation in an alloantigen or exogenous antigen-
independent environment such as IRI may be explained by antigen-independent T cell 
activation due to high concentrations of cytokines and chemokines. RANTES is present 
in high levels in the IRI kidney even 6 weeks after injury (Ascon, Ascon et al. 2009). 
The activation of T cells by RANTES independent of antigen has been shown by Bacon 
et al (Bacon, Premack et al. 1995), as has T cell activation by other cytokines e.g. IL-6, 
IL-2 and TNF-α (Rodriguez-Iturbe, Pons et al. 2001; Bangs, McMichael et al. 2006; 
Pedersen 2007). The alternative and more traditional explanation for T cell activation 
would involve antigen recognition in the context of MHC with co-stimulation. In the 
settling of IRI (with no allo- or exogenous antigen) this latter explanation would suggest 
loss of tolerance to self antigen. This explanation is supported by two observations. 
Firstly, T cell deficient mice develop less injury when reconstituted with T cells with a 
limited T cell receptor repertoire compared to when reconstituted with normal T cells, 
suggesting a critical dependency on the TCR-antigen interaction (Satpute, Park et al. 
2009). Secondly, renal injury is seen in normal mice after the adoptive transfer of 
lymphocytes from IRI mice (Burne-Taney, Liu et al. 2006). This suggests memory T 
cells are being transferred that have lost tolerance to renal self antigen during IRI. These 
T cells recognise antigenic epitopes in normal mice provoking renal injury and 
proteinuria. The nature of the antigen in the IRI model has not been reported. 
1.7.3.1.3 Lymphocytes in secondary tubulointerstitial disease 
Adriamycin nephropathy (ADN) in mice has features of human focal segmental 
glomerulosclerosis and is characterised by proteinuria and ensuing TI damage. Studies 
of lymphocyte function in this model have highlighted the importance of sub-
populations of T cells. More severe glomerular and TI disease was seen after depletion 
of CD4+ T cells (Wang, Wang et al. 2001). In contrast, depletion of CD8+ T cells 
(Wang, Wang et al. 2001) resulted in significantly less injury than in the untreated 
animals. The increased injury seen with CD4+ T cell depletion could be due to the loss 
of a population of regulatory CD4+ T cells. Studies in lymphopenic SCID mice support 
this hypothesis. When ADN is induced in SCID mice they develop more severe disease 
than that seen in wild type Balb/c mice (Lee, Wang et al. 2006). Reconstituting SCID 
mice with polyclonal T regulatory (Tregs) cells (CD4+CD25+FoxP3+) significantly 
reduced interstitial injury to the level seen in wild type mice (Mahajan, Wang et al. 
2006; Wang, Zhang et al. 2006). Tregs can use multiple mechanisms to suppress 
immune responses and TGF-β appears to be critical in the control of injury. 
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Alport syndrome is due to a mutation in collagen IV, a major protein of the glomerular 
basement membrane. A mouse model exists which has many of the features of human 
disease, including progressive glomerular and TI injury. When the Alport mouse is 
crossed with a RAG-knockout mouse to create a double knockout, the severity of the 
glomerular disease is unaffected as this is due to the absence of collagen IV. However, 
the absence of lymphocytes significantly reduces the severity of the TI disease and 
prevents loss of renal function (Lebleu, Sugimoto et al. 2008). This clearly demonstrates 
the importance of lymphocyte function in secondary TI injury. Another group 
demonstrated improved survival of Alport mice after irradiation, which caused 
depletion of bone marrow derived cells, again suggesting these cells play a role in renal 
injury (Katayama, Kawano et al. 2008). These results differ from those in ADN 
suggesting either: different mechanisms of injury occur in differing diseases, the 
method and timing of lymphocyte depletion may be important or that the genetic 
background of the mice may alter the method of injury (Puri, Shakaib et al. 2010). 
Even in experimental models of hypertension, lymphocytes may be involved in renal 
injury. In rats with hypertension, lymphocyte proliferation has been demonstrated in 
response to Hsp70, an antigen whose expression is increased in the damaged kidney 
(Parra, Quiroz et al. 2008). Furthermore RAG-KO mice have a blunted response to 
induced hypertension and adoptive transfer of T cells, but not B cells, restores this 
(Guzik, Hoch et al. 2007). Therefore it has been proposed that in salt sensitive 
hypertension the intra-renal inflammation which occurs may be responsible for the 
subsequent renal injury. This in turn exacerbates the hypertension and accelerates the 
renal injury (Harrison, Vinh et al. 2010). The hypertensive models of renal injury are 
also ameliorated with MMF by blocking the inflammatory macrophage and lymphocyte 
infiltrate (Quiroz, Pons et al. 2001; Rodriguez-Iturbe, Pons et al. 2001). 
1.7.3.1.4 Lymphocytes, dendritic cells and renal injury 
A network of dendritic cells has been identified within the renal interstitium, close to 
the basolateral surface of the tubular epithelium and peritubular capillaries (Kaissling, 
Hegyi et al. 1996). The DCs are F4/80+ and CD11c+ and can be identified 
morphologically as a population distinct from macrophages (Kruger, Benke et al. 2004). 
Dendritic cells in their immature form are potent phagocytic cells with only weak T cell 
stimulatory capacity. However, a phenotypic shift can occur during inflammation with 
DCs maturing to develop potent T cell stimulatory capacity with upregulation of co-
stimulatory and MHC class II cell surface proteins (Mellman and Steinman 2001). A 
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number of groups have shown that DCs are able to present peptide and activate T cells 
in the context of non-immune mediated renal disease. 
DCs are able to sense and respond to substances reabsorbed from the tubular lumen and 
to changes within the interstitial compartment (Dong, Swaminathan et al. 2005). 
Inflammation induced by either local injury (IRI) or LPS administration induces DC 
trafficking to regional lymph nodes, where they have been shown to present filtered 
dextrans and exogenous proteins. This study also demonstrated the capacity for CD11c+ 
DC’s to transport and present native renal antigens (Tamm Horsfall protein) in draining 
lymph nodes. Subsequently Edgtton et al demonstrated that injected ovalbumin could be 
taken up by renal DCs that then migrated to regional lymph nodes inducing activation 
and proliferation of CD4+ T cells in OTII transgenic mice (Edgtton, Kausman et al. 
2008). These observations suggest a possible mechanism for a break in T cell tolerance 
to self antigen occurring when antigen is presented by DC in an inflammatory 
environment. This mechanism was confirmed by Macconi et al in 2009 when 
demonstrating that renal DC’s can process the ubiquitous protein albumin in the their 
proteosome and present antigenic fragments with class I MHC to CD8+ T cells, causing 
activation and the production of IFN-γ (Macconi, Chiabrando et al. 2009). 
DCs not only present antigen but may also provide signals that determine the nature of 
the T cell response. Using the UUO model Dong at al described the phenotype of 
lymphocytes that were activated by intra-renal DCs (Dong, Bachman et al. 2008). They 
demonstrated co-localisation of DCs and CD4+Th17+, CD4+Th1+ and CD8+ 
lymphocytes up to 72 hours after obstruction. After DC depletion, T cell infiltration 
remained but the character of this infiltrate differed: there were significantly fewer IL-
17+ and IFN-γ+ T cells. 
1.7.4 B cells in chronic tubulointerstitial injury 
Traditionally the number of B cells within the leukocyte infiltrate in TI disease was 
believed to be low, accounting for <20% of the infiltrate (Hooke, Gee et al. 1987). This 
has been demonstrated in human subjects with primary and secondary interstitial 
pathologies and in diseases which are both immunologically and traditionally non-
immunologically mediated for example lupus nephritis (Alexopoulos, Seron et al. 
1990), interstitial nephritis (Husby, Tung et al. 1981) and diabetic nephropathy (Hooke, 
Gee et al. 1987). However, more recently significant populations of CD20+ B cells have 
been reported in membranous nephropathy (Cohen, Calvaresi et al. 2005) and within 
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renal allografts (Kerjaschki, Regele et al. 2004), as well as in the setting of primary and 
secondary (IgA) interstitial disease (Heller, Lindenmeyer et al. 2007). Interestingly 
these B cell infiltrates are seen in three main patterns of distribution within the TI: 
diffusely spread throughout the TI, as small cellular aggregates and present within 
larger follicle-like structures, similar to those seen in secondary lymphoid structures 
(Drayton, Liao et al. 2006). T cells, macrophages and DCs co-localise in these follicular 
structures, which may act as a localised environment for antigen presentation and the 
development of immune responses.  
B cells can have a number of functions which include antigen presentation to T cells 
promoting their activation. Activated T cells can provide membrane bound (e.g. 
CD40L) and cytokine (e.g. IL-4) stimuli to activate B cells recognising linked peptide. 
These B cells can then synthesise cytokines, chemokines and antibody which may 
contribute to chronic interstitial injury. They may also contribute to the formation of 
neolymphangiogenesis which has been described in chronic TI disease (Kerjaschki, 
Regele et al. 2004). The presence of B cells in both primary and secondary interstitial 
renal disease suggests they may participate in the final common pathway which induces 
renal fibrosis. Little work has been performed in models of renal injury to determine the 
role of B cells in TI fibrosis however one published study suggested B cells may be 
protective in IRI (Burne-Taney, Yokota-Ikeda et al. 2005). In models of fibrosis in other 
tissues, the importance of B cells have been demonstrated e.g. carbon tetrachloride 
induced liver fibrosis (Novobrantseva, Majeau et al. 2005).  
1.7.5 Macrophage function in chronic renal injury 
Macrophages are functionally diverse and can synthesise several molecules which can 
contribute to renal injury. They can promote tissue fibrosis by the release of the 
fibrogenic growth factor TGF-β and matrix proteins as well as causing direct tissue 
injury with the release of potent inflammatory mediators for example TNF-α and 
reactive oxygen species. Once activated macrophages upregulate their expression of 
class II MHC and co-stimulatory molecules and can mediate injury via their ability to 
act as an APC. There is increasing evidence from proteinuric and non-proteinuric 
models of renal disease that macrophages play an important role in chronic renal injury. 
There is a clear association between the number of infiltrating macrophages in the TI 
and the severity of injury in both adriamycin nephropathy (Lee, Wang et al. 2006) and 
UUO (Diamond 1995). Several strategies have been used to confirm a pathogenic role 
for macrophages including macrophage depletion (Wang, Mahajan et al. 2005; Sung, Jo 
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et al. 2007), inhibition of chemotaxis (Watson, Zheng et al. 2009) and adoptive transfer 
of macrophages (Wang, Wang et al. 2008).  
However, it has also become clear that there are functionally distinct populations of 
macrophages which play different roles in inflammation and fibrosis (Mosser and 
Edwards 2008). In the carbon tetrachloride induced model of hepatic fibrosis 
macrophage depletion during the early initiation phase causes reduced levels of injury 
and fibrosis. In contrast later macrophage depletion causes the resolution of fibrosis to 
be delayed (Duffield, Forbes et al. 2005). The classically activated M1 phenotype, 
induced by IFN-γ, TNF-α and TLR agonists are highly inflammatory and induce tissue 
injury via their production of proinflammatory mediators e.g. TNF-α, IL-6, IL-12, IFN-
γ and nitric oxide and through activation of Th17 cells. The second population or 
‘alternatively activated macrophages’ (M2) are activated by anti-inflammatory 
cytokines e.g. IL-4, IL-13, IL-10 and TGF-β and by the phagocytosis of apoptotic 
bodies (Duffield, Ware et al. 2001). These M2 macrophages promote wound healing 
and a fibrotic environment with the liberation of TGF-β, along with immunoregulation 
by stimulating Tregs. Regulatory macrophages have also been described, activated by 
IL-10. 
The importance of macrophage phenotype can be seen in ADN. Transfer of 
macrophages with an M2 phenotype into SCID mice with ADN (induced by IL-4 and 
IL-13) reduces renal injury whereas stimulating macrophages with LPS to adopt an M1 
phenotype prior to transfer worsens injury (Wang, Wang et al. 2007). This work 
demonstrates the phenotype of infiltrating macrophages is a critical determinant of 
outcome and may explain the conflicting results regarding macrophage function in 
UUO. Macrophage infiltration is a prominent feature of UUO and several reports 
demonstrate they contribute to injury. However, other reports have failed to confirm this 
(Nishida and Hamaoka 2008) possibly because different macrophage populations have 
opposing effects.  In addition there may also be a regulatory population of macrophages 
which influence bystander macrophage function by production of IL-10. This has been 
demonstrated in obstructive uropathy and glomerulonephritis with genetically modified 
macrophages which express high levels of IL-10 (Yamagishi, Yokoo et al. 2001). 
1.7.6 NKT cells and native renal injury   
In the literature there is some work on the role of NKT cells in renal injury. In particular 
NKT cells are important in the pathogenesis of IRI (Ascon, Lopez-Briones et al. 2006; 
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Li, Huang et al. 2007). In Rabb’s work, after 3 and 24 hours of IRI increased numbers 
of CD3+NK1.1+ cells were seen in the ischaemic kidney compared to normal controls. 
The Okusa group were able to demonstrate a significant reduction in IRI when NKT 
cells were depleted; either their activation was inhibited or NKT deficient mice were 
used. This was associated with the reduction in IFN-γ producing neutrophils suggesting 
that NKT cells were involved in the early injury mediated by neutrophils. To date there 
is no literature on the role of NKT cells in chronic tubulointerstitial injury however, 
work from other organ systems suggest a profound immunomodulatory role (Wu, 
Gabriel et al. 2009). NKT cells produce copious amounts of pro and anti-inflammatory 
cytokines upon activation but overall may favour immune regulation and provide a link 
between innate and adaptive immunity.  
1.7.7 Development of fibrosis 
During TI fibrosis there is an increase in the number of activated fibroblasts in the 
kidney. The hallmarks of fibroblast activation include expression of α-smooth muscle 
actin, a contractile protein usually found in perivascular smooth muscle cells 
(myofibroblasts) and the production of excessive ECM components including collagen 
type I and III and fibronectin. The increase in the activated myofibroblast population 
within the TI has been shown to be derived from a number of sources. The predominant 
source may be activated resident renal fibroblasts (Picard, Baum et al. 2008) however, 
epithelial derived cells (Iwano, Plieth et al. 2002), bone marrow derived CD34+ 
fibrocytes (Bucala, Spiegel et al. 1994; Wada, Sakai et al. 2007) and pericytes (Lin, 
Kisseleva et al. 2008) also contribute.  
Tubular epithelial cells have been demonstrated to undergo epithelial-to-mesenchymal 
transition (EMT), driven by the inflammatory environment, resulting in loss of 
epithelial phenotype, migration through the tubular basement membrane and adoption 
of a myofibroblast phenotype (Robertson, Ali et al. 2004).  
Fibrocytes are circulating BM-derived cells which express markers of both leukocytes 
and mesenchymal cells (CD45 and CD34). They have been shown to differentiate into 
myofibroblasts with a high potential for collagen I synthesis and thus contribute to renal 
fibrosis. Fibrocytes circulate in low numbers in peripheral blood and like other 
infiltrating cells are directed to the site of tissue injury by chemokine/chemokine 
receptor interactions (Anders, Vielhauer et al. 2003; Wada, Sakai et al. 2007).  
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Recently much interest has been shown by Duffield’s group in the role of pericytes in 
TI fibrosis. They have shown by fate mapping that pericytes (and not cells which have 
undergone EMT) are responsible for the generation of myofibroblasts (Humphreys, Lin 
et al. 2010). Pericytes are usually adherent to endothelium but when detached after 
vascular injury they migrate into the interstitial space where they become 
myofibroblasts. Also, after pericyte detachment the capillaries become unstable causing 
microvascular damage by a switch in the secretion of VEGF isomers and subsequently 
renal ischaemia develops (Lin, Chang et al. 2011). This drives the activation of 
parenchymal cells that in turn recruit inflammatory cells such as macrophages and 
subsequently product TGF-β. 
Koester’s group have also lately shown that TGF-β dependent peritubular fibrosis and 
nephron degeneration may not involve EMT but tubular autophagy (Koesters, Kaissling 
et al. 2010). This is a novel method of tubular decomposition where the surrounding 
area becomes a dense fibrotic network derived from myofibroblasts which did not 
develop by EMT but from local fibroblasts or pericytes. 
It is clear that lymphocytes and macrophages can influence fibroblast accumulation and 
activation. Th2 T cell cytokines promote the differentiation of fibrocytes whereas Th1 
cytokines inhibit their differentiation (Shao, Suresh et al. 2008). In the absence of CD4+ 
T cell derived signals there is a reduction in the number of renal fibrocytes and collagen 
I deposition after UUO (Niedermeier, Reich et al. 2009). Lymphocyte and macrophage 
derived TGF-β can also promote EMT (Robertson, Ali et al. 2004). In renal 
transplantation Robertson et al demonstrated that activated CD8+ T cells were able to 
induce EMT and promote fibrotic injury. CD8+ T cells were induced to express the β7 
integrin by TGF-β, thus enabling these CD8+CD103+ T cells to bind E-cadherin on 
TECs and present TGF-β to the TEC thus inducing EMT.  
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1.8 Hypothesis and aims 
I hypothesise that T cells are recruited into the injured kidney because they are 
recognising and responding to autoantigens, representing a break in self tolerance. 
The aims of my thesis are two fold: 
1. To characterise the mononuclear infiltrate into the renal tubulointerstitium post 
injury, looking at the phenotype of the infiltrating cells and correlating this with 
levels of injury. 
2. Molecular analysis of the T cell receptor to try to determine whether there is 
clonal proliferation of T cells in UUO kidney that would suggest antigen 
dependent T cell activation and loss of immunological tolerance. 
 60 
Chapter 2. Materials and Methods 
 
2.1 General materials  
General chemicals were purchased from Sigma-Aldrich (Poole, UK). Histological 
stains, microscope slides and consumables were purchased from VWR (Lutterworth, 
UK), DakoCytomation (Glostrup, Denmark) and Signa-Aldrich (Poole, UK).  
RNA extraction from tissue and cells was carried out using the RNAeasy Mini Kit by 
Quiagen (Crawley, West Sussex, UK) and TRIzol reagent purchased from Invitogen 
Life technologies (Paisley, Scotland). Reagents for the formation of cDNA and standard 
PCR were purchased from Invitogen Life technologies (Paisley, Scotland) and Promega 
(Southampton, UK). The custom made oligonucleotide primers were purchased from 
Eurofins MWG Operon (Ebersberg, Germany). Consumables, Taq polymerase and the 
FAM probe for real time PCR were purchased from Applied Biosystems (Warrington, 
UK). The TOPO TA cloning kit for sequencing used to clone and transform cells was 
from Invitrogen (Paisley, Scotland). 
The collagenase used for kidney tissue digestion was from Sigma-Aldrich (Poole, UK) 
and DNAse-1 from Roche (Burgess Hill, West Sussex). 
2.1.1 Buffers  
 
Phosphate buffered saline 8g of NaCl, 0.2g of KCl, 1.44g of Na2HPO4, 0.24g of 
KH2PO4 in 1000ml d-H2O, pH adjusted to 7.4 
 
0.05% PBS-Tween  PBS containing 0.05% Tween 20 
 
TBE 10.8g Tris base, 5.5g boric acid, 0.93g EDTA in 1000ml 
d-H2O 
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2.2 Antibodies 
The primary antibodies used throughout the thesis for immunohistochemistry (Table 
2.1), imunofluorescence (Table 2.2) and flow cytometry (Table 2.3) are listed below. 
Primary antibodies were purchased from BD Pharmingen (Oxford, UK), Millipore 
(Watford, UK), Novocastra (Newcastle Upon Tyne, UK), Serotec (Oxford, UK) and 
Sigma-Aldrich (Poole, UK). Secondary antibodies (Table 2.4) were bought from BD 
Pharmingen and DakoCytomation (Glostrup, Denmark). Isotype control antibodies used 
in immunofluorescence and flow cytometry (Table 2.5) were purchased from BD 
Pharmingen. 
Table 2.1- Primary antibodies used in immunohistochemistry 
Antibody  Clone  Isotype Manufacturer Cat no 
Anti-mouse CD4 H129.19 Rat IgG2a BD Pharmingen 550278 
Anti-mouse CD8 53-6.7  Rat IgG2a BD Pharmingen 550281 
Anti-mouse F4/80  A3-1  Rat IgG2b Serotec  MCA497 
Anti-mouse α-SMA  1A4  Mouse IgG2a Sigma-Aldrich A2547 
Anti-mouse collagen I Polyclonal Rabbit  Millipore  AB765  
 
 
Table 2.2- Primary antibodies used in immunofluorescence  
Antibody   Conjugation Clone   Isotype Manufacturer 
Anti-mouse CD4  FITC   H129.19 Rat IgG2a BD Pharminge n 
Anti-mouse CD8a  FITC  53-6.7  Rat IgG2a BD Pharminge n 
Anti-mouse CD69  PE  H1.2F3 Hamster IgG1 BD Pharminge n 
Anti-mouse CD44  APC  IM7  Rat IgG2b BD Pharminge n 
Anti-human Ki67   Polyclonal Rabbit  Novocastra 
 
Table 2.3- Antibodies used in flow cytometry 
Antibody   Conjugation Clone   Isotype Manufacturer 
Anti-mouse CD45 APC-Cy7 30-F11  Rat IgG2b BD Pharmingen 
Anti-mouse CD4  FITC   H129.19 Rat IgG2a BD Pharminge n 
Anti-mouse CD8a PerCP  53-6.7  Rat IgG2a BD Pharminge n 
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Table 2.4- Secondary antibodies used in immunohistochemistry and fluorescence 
Antibody  Conjugation Application    Manufacturer 
Goat anti-rat  Biotin  IHC: CD4, CD8 and F4/80  BD Pharminogen 
Goat anti-mouse HRP  IHC: α-SMA    DakoCytomation 
Goat anti-rabbit HRP  IHC: Collagen I   DakoCytomation 
Swine anti-rabbit IgG TRITC  IF: Ki67    DakoCytomation 
 
Table 2.5- Isotype control antibodies used in immunofluorescence and flow 
cytometry   
Isotype  Conjugation  Clone  Manufacturer 
Rat IgG2b  APC-Cy7   A95-1  BD Pharminge n 
Rat IgG2a  FITC    R35-95  BD Pharmingen 
Rat IgG2a   PerCP    R35-95  BD Pharmingen 
Hamster IgG1  PE    G235-2356  BD Pharmingen 
Rat IgG2b  APC   A95-1  BD Pharmingen 
 
 
2.3 Animal experiments 
C57Bl/6 female mice between 8-10 weeks of age were used for all experiments and 
purchased from Charles Rivers (Watford, UK). My group had gained experience and 
successfully used female mice for UUO and therefore I chose this sex of mice to use. 
They were housed in the comparative biology centre with free access to food and water.  
2.4 Animal model of chronic kidney disease 
In order to investigate the role of lymphocytes in the development of renal fibrosis, the 
established animal model unilateral ureteric obstruction was used. Obstruction of the 
ureter has been shown to result in the development of fibrosis within the kidney. This 
process is similar the development of chronic renal damage seen in humans. All 
procedures were carried out according to the home office guidelines under home office 
licences.  
2.4.1 Unilateral Ureteric Obstruction 
UUO of the left kidney was performed. Anaesthesia was induced using 5% isoflurane 
gas in an induction chamber and mice were then given a subcutaneous injection of 
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500µl of buprenorphine (concentration 3µg/ml) as analgesia. Anaesthesia was then 
maintained using 2% isoflurane and 2l of oxygen via a mask. 
Following midline laparotomy, the bowel was reflected cranially to expose the 
retroperitoneal area. An operating microscope was used to aid identification of the left 
ureter which was separated from surrounding adipose tissue. Two 7/0 silk ligatures were 
placed around the upper third of the ureter approximately 0.5cm apart. The ureter was 
cut between the ligatures, the bowel reflected back into position and the abdomen closed 
in 2 layers using 4/0 vicryl sutures. Sham operated controls underwent similar surgical 
procedures but the left ureter was only manipulated. Animals were placed in a heated 
chamber during recovery. 
2.4.2 Sacrificing and tissue sampling 
Groups of four mice were sacrificed by cervical dislocation after 3, 7 and 10 days of 
obstruction or sham operation when renal tissue was required for histological 
examination. The group size of four animals was calculated using a power calculation 
tool. In retrospect this group size should have been larger to increase the possibility of 
attaining statistically significant results. Cardiac puncture, exsanguination and 
subsequent perfusion with 60ml of 0.9% saline was used as the preferred method of 
sacrifice when animals were required for TCR analysis after 7, 14 and 28 days of 
obstruction or sham operation. These later time points were chosen to assess TCR 
clonality rather than the earlier 3, 7 and 10 days used in the histological analyses. This 
was because I believed that a broader range of lengths of ureteric obstruction would 
allow demonstration of early limited T cell clonality but also the development of a 
larger number of T cell clones at later time points suggestive of epitope spreading. 
Obstructed and contralateral kidneys and the spleen were excised by blunt dissection. 
When tissue was required for histological examination the kidney was bisected cranio-
caudally. One half was embedded in OCT on cork boards and snap frozen in isopentane 
and then liquid nitrogen and stored at -80ºC. The remaining half was fixed in 4% 
formalin overnight at room temperature, processed and embedded in wax for 
histological analysis. When tissue was required for the subsequent extraction of RNA, 
as described later, the organs were dissected and fragments snap frozen in liquid 
nitrogen and stored at -80ºC for later use. 
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2.5 Histology and immunohistochemical assessment  
Lymphocyte and macrophage infiltration into the kidneys of UUO and normal mice 
were quantified and an assessment of renal injury and fibrosis was made. Subsequently, 
lymphocyte activation and proliferation was examined. 
2.5.1 Preparation of sections 
Both wax embedded and frozen sections were required for histological assessment. 
2.5.1.1 Preparation of wax embedded sections 
Formalin-fixed, wax embedded tissue was prepared and 2µm sections were cut using a 
sledge microtome (Microm HM 330, Heidelberg, Germany). Sections were floated on a 
20% ethanol water bath at 42ºC, collected on glass slides and left to dry at room 
temperature. Slides were then dried at 37ºC overnight or alternatively 65ºC for 1 hour. 
Sections were de-waxed prior to use by immersion in two changes of xylene and re-
hydrated through graded alcohols for approximately 1 minute each (100% and 95%) and 
then finally water.  
2.5.1.2 Preparation of frozen sections 
Frozen sections of 5µm were cut using a cryostat microtome (Leica CM1900, Nussloch, 
Germany), transferred to glass slides and left to air-dry overnight before staining. 
Alternatively these slides were stored in air-tight containers at -80ºC to use at a later 
date. When the stored sections were required, they were warmed to room temperature 
for 30 minutes prior to use.  
2.5.2 Assessment of renal injury after UUO using Periodic acid Schiff (PAS) 
staining on wax-embedded sections 
PAS staining was used to delineate tubular and glomerular basement membranes. PAS 
has specificity for carbohydrate residues and therefore stains the proteoglycans of these 
membranes. The de-waxed and re-hydrated tissue sections were incubated in 1% 
periodic acid for 6 minutes and then washed in distilled water. The slides were 
incubated with Schiff’s reagent for 10 minutes, washed in running tap water for 10 
minutes and counterstained with Mayer’s haematoxylin for 1 minute. Finally the 
sections were washed in running tap water for 5 minutes before they were dehydrated 
through graded alcohols (70% to 100%) to xylene and mounted with DPX. Histology 
was examined using a Leica DMR light microscope (Leica Lasertechnik GmbH, 
Heidelberg, Germany). 
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2.5.2.1 Analysis of PAS stained sections 
The volume of the interstitium in the renal cortex was used as an assessment of cortical 
interstitial expansion. Sections of 2 µm were cut and PAS stained. A 10 x 10 grid was 
superimposed on sections at x250 magnification, with 81 positive cross sections. Only 
the renal cortex was considered. The interstitium was defined as the area between 
cortical tubules and glomeruli excluding blood vessels. The number of cross sections 
which fell in the interstitium was expressed as a percentage of the total number of cross 
sections which fell within the renal cortex. This was termed the percentage interstitial 
expansion (% IE) and used to estimate the interstitial volume and therefore degree of 
renal injury. These assessments were carried out in a blinded manner on renal tissue at 
three time points: 3, 7 and 10 days post obstruction. Five high power fields (HPF) per 
animal were analysed. The mean percentage of interstitial expansion was calculated for 
each animal and then for the group of four animals as a whole at each time point. 
2.5.3 Immunohistochemistry 
2.5.3.1 CD4, CD8 and F4/80 staining of frozen sections 
Frozen sections were warmed to room temperature before being fixed in ice cold 
acetone at -20ºC for 5 minutes and left to air dry before being washed in 1x PBS. 
Sections were then incubated with 0.3% hydrogen peroxide (H2O2) in PBS for 10 
minutes to block endogenous peroxidase activity and again washed in PBS. Sections 
were incubated in streptavidin blocking agent for 15 minutes and then biotin blocking 
agent for 15 minutes (Vector Laboratories Ltd, California, USA) to block endogenous 
biotin, biotin receptors and streptavidin binding sites in the tissue. The slides were 
washed before incubation in anti-CD4 or anti-CD8 rat anti-mouse monoclonal 
antibodies in PBS at 1 in 20 dilution or anti-F4/80 rat anti-mouse monoclonal antibody 
in PBS at 1 in 50 dilution for 60 minutes. After washing, the sections were incubated 
with the biotinylated secondary antibody goat anti-rat polyclonal antibody in PBS at 1 
in 100 dilution for 30 minutes and then washed. The sections were incubated in 
Streptavidin-conjugated Horseradish peroxidase (Strep-HRP) for 30 minutes. After 
washing, the staining was visualised with diaminobenzidine (DAB) for 5 minutes or 
until the desired colour intensity was reached. After DAB detection they were washed in 
d-H2O for 5 minutes before counterstaining for 5 minutes in haematoxylin and ‘blued’ 
under running tap water for 5 minutes. The DAB waste was collected in a hazardous 
materials container for later appropriate disposal. Finally the slides were dehydrated 
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through graded alcohols (70% to 100%) to xylene and mounted with DPX before 
examination. Histology was then examined using a Leica DMR light microscope.  
2.5.3.1.1 Analysis of CD4, CD8 and F4/80 immunohistochemical staining 
The number of infiltrating cells into UUO and contralateral kidneys was quantified for 
four animals at 3, 7 and 10 days after ureteric obstruction. Five random non-overlapping 
HPFs in the renal cortex at x250 magnification were analysed for each kidney in a 
blinded manner. The total number of positively stained infiltrating cells was counted for 
each HPF and the mean number of cells per HPF calculated for each animal. Then the 
mean number of infiltrating cells per HPF was calculated for the group of four mice at 
each time point. Quantification was carried out twice and the mean score recorded. 
2.5.3.2 Alpha-SMA staining of wax embedded sections 
De-waxed and re-hydrated tissue sections were incubated in 0.3% H2O2 in PBS for 15 
minutes to block endogenous peroxidise activity, after which they were washed in 
0.05% PBS-Tween (PBST). Slides were then incubated with the primary antibody, 
monoclonal mouse anti α-SMA at 1 in 10,000 dilution in 1x PBS for 1 hour at room 
temperature, then washed in 0.05% PBST. Following this the Envision kit 
(DakoCytomation, Glostrup, Denmark) was used and the slides were incubated with a 
goat anti-mouse polymer conjugated with HRP for 30 minutes at room temperature, 
then washed in PBST. Slides were covered with DAB solution, made according to 
Envision kit instructions and placed in the dark for 5 to 10 minutes until a brown 
colouring has developed. After DAB detection they were washed in d-H2O for 5 
minutes before counterstaining for 5 minutes in haematoxylin and ‘blued’ under running 
tap water for 5 minutes. Finally the slides were dehydrated through graded alcohols 
(70% to 100%) to xylene and mounted with DPX before examination. Histology was 
examined using a Leica DMR light microscope. 
2.5.3.2.1 Analysis of α-SMA stained sections 
The degree of tubulointerstitial fibrosis, as determined by staining activated 
myofibroblasts with α-SMA was analysed using a point counting method, similar to that 
used to assess percentage interstitial expansion on PAS stained sections. A 10 x 10 grid 
was superimposed on sections at x250 magnification. The number of cross sections 
which fell on α-SMA stained tissue was expressed as a percentage of the total number 
of cross sections. These assessments were carried out on renal tissue from three time 
points: 3, 7 and 10 days post obstruction and five HPFs per animal were analysed in a 
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blinded manner. The mean percentage of α-SMA was calculated for each animal and 
then for the group of four animals as a whole at each time point.  
2.5.3.3 Collagen I staining of frozen sections 
Frozen sections were warmed to room temperature before being fixed in ice cold 
acetone at -20ºC for 5 minutes and then left to air dry before being washed in 1x PBS. 
Sections were then incubated with 0.3% H2O2 in PBS for 10 minutes to block 
endogenous peroxidase activity and again washed in 0.05% PBST. Sections were 
incubated in 20% goat serum for 1 hour at room temperature. Slides were then 
incubated with the primary antibody polyclonal rabbit anti-mouse collagen I at 1 in 200 
dilution in 20% goat serum for 1 hour at room temperature, then washed in PBST. 
Following this, slides were incubated with a polyclonal goat anti-rabbit HRP conjugated 
secondary antibody at 1 in 200 dilution for 1 hour at room temperature, then washed in 
PBST. Staining was visualised using DAB, incubated for 5 minutes in the dark or until 
the desired colour intensity was reached. After DAB detection they were washed in d-
H2O for 5 minutes before counterstaining for 5 minutes in haematoxylin and ‘blued’ 
under running tap water for 5 minutes. Finally the slides were dehydrated through 
graded alcohols (70% to 100%) to xylene and mounted with DPX before examination. 
Histology was examined using a Leica DMR light microscope. 
2.5.3.3.1 Analysis of collagen I stained sections 
In order to analyse the area of collagen I staining per section, Q-Win software was used 
to capture, process and analyse the sections using the pixel intensity grading function. 
The mean percentage area of collagen I staining in ten non-overlapping HPFs at x250 
magnification was calculated for each group of four animals at each of the three time 
points post obstruction in a blinded manner. 
2.5.4 Immunofluorescence  
UUO experiments were carried out on groups of four animals for 3, 7 and 10 days after 
which the animals were sacrificed and the organs harvested. Immunofluorescent 
staining of T lymphocytes was performed along with staining either for CD69 (a cell 
surface marker present on recently activated T cells), CD44 (a cell surface marker found 
on memory T cells) or Ki67 (the nuclear proliferation marker). Sections were assessed 
using a confocal laser scanning microscope and processed using Leica TCS-NT 
software. The numbers of single and dual positively stained cells were calculated using 
Photoshop software. Since the immunohistochemistry work demonstrated very little or 
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no cellular infiltration of lymphocytes into sham operated kidneys, the contralateral 
kidney of a UUO animal and normal kidneys, these tissues were not assessed by 
immunofluorescence. 
2.5.4.1 Dual staining of CD4+ or CD8+ cells with CD69 or CD44 
Frozen sections were warmed to room temperature before being fixed in ice cold 
acetone at -20ºC for 5 minutes and then left to air dry before being washed in 1x PBS. 
Slides were then incubated in 1% BSA in PBS for 1 hour at room temperature to block 
non-specific binding of the antibody. 200µl of diluted antibody in 1% BSA was applied 
to the sections in a humidified chamber for 1 hour at room temperature in the dark. All 
antibodies were applied individually and in appropriate combinations. The rat anti-
mouse CD4 and CD8 FITC linked monoclonal antibodies were used at 1 in 20 dilution. 
The hamster anti-mouse CD69 PE linked monoclonal antibody was diluted 1 in 10 and 
the rat anti-mouse CD44 APC linked monoclonal antibody was diluted to 1 in 20. After 
incubation they were washed in PBS. When DAPI was used to aid cell localisation, it 
was used at 1 in 3000 dilution in d-H2O applied to the sections for 5 minutes. Washed 
slides were mounted with a fluorescent mounting medium (DakoCryomation, Glostrup, 
Denmark) and placed in the dark at 4ºC.  
2.5.4.2 Dual staining of CD4 or CD8 cells with Ki67 
Sections were prepared as in 2.5.4.1. and incubated with 200µl of the diluted antibody 
in 1% BSA in PBS in a humidified chamber for 1 hour at room temperature. The rat 
anti-mouse CD4 and CD8 monoclonal antibodies were used at 1 in 20 dilution and 
primarily conjugated to the fluorochrome FITC. The rabbit anti-human polyclonal Ki67 
primary antibody was used at 1 in 1000 dilution. After washing in PBS, the sections 
were then incubated with the secondary antibody, a TRITC linked swine anti-rabbit 
polyclonal antibody diluted 1 in 20 in 1% BSA and further rat anti-mouse CD4 or CD8 
monoclonal antibodies were added at 1 in 20 dilution and incubated for 1 hour at room 
temperature in the dark. The sections were washed on PBS and if DAPI was used, 
incubated in a 1 in 3000 dilution solution in d-H2O for 5 minutes in the dark. The 
washed slides were then mounted with fluorescent mounting medium 
(DakoCryomation, Glostrup, Denmark) and placed in the dark at 4ºC. 
2.5.5 Confocal microscopy 
All slides were assessed using the Leica TCS-SP2UV confocal laser scanning 
microscope (Leica Lasertechnik GmbH, Heidelberg, Germany) running under Leica 
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TCS-NT software (version 2.0). Images were acquired through a x63 oil immersion 
objective lens with a numerical aperture of 1.2. An excitation beam laser from an argon 
ion laser of wavelength 480nm was used for the FITC and PE fluorochromes, a 
wavelength of 630nm for APC, 560nm for TRITC and 360nm for DAPI. Any light 
emitted was collected via a pinhole aperture in front of a photomultiplier tube as a 
photodetection device. Light was collected from one plane of focus only and any out of 
focus signal was excluded. The images were collected sequentially, frame by frame, and 
combined to produce the final image. In order to demonstrate co-localisation of stains 
on the same cell, the confocal software also assembled selected images in X-Z stacks 
and plotted pixel colour on cytofluorograms.  
2.5.5.1 Analysis of stained sections by immunofluorescence 
The number of single positive FITC stained CD4+ or CD8+ cells were quantified by 
examining between five and ten random non-overlapping HPFs at x63 magnification for 
each UUO kidney using Photoshop software in a blinded manner. Subsequently the 
number of dual positive cells stained with CD4 or CD8 and then either CD69 or Ki67 
were also counted on the above sections. The percentage of dual positive cells was 
calculated for each HPF and the mean percentage per HPF calculated for each animal. 
Then the mean percentage per HPF was calculated for each group of four mice.  
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2.6 RNA and DNA methodology 
DNA is transcribed into single stranded RNA in the nucleus under physiological 
conditions using RNA polymerase. RNA can take a number of forms, which are either 
protein-coding such as messanger RNA (mRNA) or are non-coding like ribosomal 
(rRNA) and transfer RNA (tRNA). The coding sequence of the mRNA determines the 
amino acid sequence of the protein which is produced in the ribosome with the help of 
tRNA and is generated after the non-coding intron sequences are spliced out. However, 
mRNA is unstable and easily degraded by ubiquotous RNAses. In order to measure the 
amount of mRNA or examine the mRNA sequences it can be amplified by PCR but in 
order to do this it must be extracted and reverse transcribed to DNA. 
2.6.1 Extraction of RNA and assessment of purity 
RNA was extracted from the whole tissue of UUO kidney and spleen, as well as from 
the sorted lymphocyte populations extracted from kidney tissue. Once RNA was 
extracted spectrophotometry and the separation of RNA fragments using agarose gel 
electrophoresis were used to determine the quality of this process. 
2.6.1.1 Extraction of RNA from tissue 
Kidney and spleen were harvested for the sacrificed animals at 7, 14 and 28 days post 
UUO and snap frozen in liquid nitrogen. Samples were then stored at -80˚C until 
required. Whole RNA was extracted using the RNeasy Mini Kit (Quiagen, West Sussex, 
UK) according to the manufacturer’s instructions. The kit used a selective silica-gel 
based membrane to bind RNA, followed by removal of contaminants with a series of 
buffers and centrifugation. 
Initially the frozen fragments of tissue were placed in 800µl of TRIzol reagent, 
containing guanidinium isothiocyanate and phenol, in a 1.5ml RNAse free tube without 
defrosting, to lyse the cells, denature the protein but maintain RNA integrity. The tissue 
was then homogenised using an RNAse free pestle to fragment the genomic DNA and 
the suspension centrifuged at 10,000 rpm for 10 minutes at 4ºC. The supernatant was 
then transferred to a phase lock gel separation tube and 160µl of chloroform was added 
and the solution mixed with vigorous shaking. The sample was left for 2-3 minutes 
before centrifuging at 10,000 rpm for 15 minutes at 4ºC.  This allowed separation of the 
upper, water soluble RNA layer from the lower, organic lipid layer containing DNA and 
protein fragments in chloroform and phenol. This upper aqueous layer was transferred 
into another RNAse free tube with an equal volume of 70% ethanol, in DEPC water. 
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The resulting mix was applied to the RNeasy spin column and centrifuged for 15 
seconds at 10,000 rpm. The flow through was then discarded. The contaminants were 
then removed by using a series of different wash buffers and centrifugation. RNA was 
then eluted from the wash column by the addition of 30µl of RNAse free water and 
centrifugation. The RNA samples were stored at -20ºC until they were processed into 
cDNA by reverse transcription. 
2.6.1.2 Extraction of RNA from cells 
Lymphocytes sorted by flow cytometry were collected into Quiagen lysis buffer 
containing β-mercaptoethanol (β-ME), as per the Quiagen RNeasy Mini Kit 
instructions, in order to irreversibly denature RNases. Within this lysis buffer were 
approximately 5x 10
5 mouse proximal tubular epithelial cells, which acted as a carrier to 
prevent the sorted cells adhering to the surface of the tube. The lysate was then passed 
five times though a blunt 20-gauge needle fitted to an RNAse-free syringe. One volume 
of 70% ethanol was added and mixed by pipetting. The resulting mix was applied to the 
RNeasy spin column and centrifuged for 15 seconds at 10,000 rpm. The flow through 
was then discarded. The contaminants were then removed by using a series of different 
wash buffers and centrifugation. RNA was eluted from the wash column by the addition 
of 30µl of RNAse free water and centrifugation. The RNA samples were stored at -20ºC 
until they were processed into cDNA by reverse transcription. 
2.6.1.3 Purity and quantification of extracted RNA 
The purity and quantity of RNA was estimated by spectrophotometry. UV light of 
different wavelengths was shone onto the RNA specimen and the amount of UV light 
absorbed at the different wavelengths was calculated. The purity of the RNA was 
calculated by measuring the ratio of UV light absorbance at 260 and 280nm. The 
estimated quantity of RNA was calculated by measuring the absorbance of RNA at 
260nm (one OD per cm path length being equivalent to approximately 40µg/ml of 
RNA).  
Nucleic acids, both RNA and DNA, have a maximum UV absorbance at a wavelength 
of 260nm however, proteins have little absorbance at this wavelength. The minimum 
absorbance for nucleic acids is at the lower wavelength of 215-230nm, where buffers 
such as Tris and proteins can absorb the UV light. At 270nm phenol absorbs UV 
strongly which may contaminate nucleic acid preparations and at 280nm aromatic 
amino acids absorb the UV light. At the higher wavelength of 320nm neither proteins 
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nor nucleic acids absorb. Therefore to estimate the purity of the nucleic acid the ratio of 
the absorbance at 260nm and 280nm was calculated: 
• A 260/A 280 ratio of 2.0 is characteristic of pure RNA 
• A 260/A 280 ratio of 1.8 is characteristic of pure DNA 
• A 260/A 280 ratio of 0.6 is characteristic of pure protein 
The RNA was also assessed for quality by separation into the various sized fragments 
by agarose gel electrophoresis. Gels were prepared with 1.2% agarose in 1x TBE. 
Ethidium bromide (0.5µg/ml of TBE) was added to the solution before pouring into a 
gel cast. Once the gel had set, 1x TBE running buffer was poured over the gel in the gel 
tank and the RNA samples prepared for loading into the wells. A mixture of 5µl of 
loading buffer and 3µl of RNAse free water was added to 2µl of RNA which was heated 
to 65ºC for 5 minutes to separate the strands of RNA and subsequently allowed to cool 
for 1 minute on ice prior to loading into the gel. The RNA ladder was prepared as 
above, substituting the RNA specimen for the ladder. Once the wells were loaded the 
gel was run at 90V for 40 minutes. The rRNA fragments of 4.8kb and 1.8kb, 
corresponding to ribosomal 28S and 18S RNA, should then be visualised, if RNA was 
intact, by fluorescence of the incorporated ethidium bromide using the alpha 
transilluminating system from AlphaInnotech (Sussex, UK) with the AlphaEase PC 
software.  
2.6.2 Reverse transcription 
cDNA synthesis was carried out from RNA using oligo (dt)15 primers, dNTPs and 
reverse transcriptase according to the method by Sambrook et al (1989). RNA has a 
poly-A tail sequence and so a complementary dT oligonucleotide was used as a primer 
for the reverse transcription. RNA samples were denatured by heating to 90ºC for 5 
minutes to favour the annealing of oligo dT primers to the poly-A tails of the mRNAs, 
and then transferred to ice to maintain the oligo dT primers in position. A 20µl reaction 
mixture was prepared by adding the following reagents, in order, to an RNAse free tube 
on ice: 
 
Reverse transcriptase buffer (5x)     4µl 
DTT (100mM)      2µl 
RNasin (40U/µl)       0.75µl 
dNTP mixture (5mM)      2µl 
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Oligo (dt)15 (0.5µg/µl)      0.32µl 
Total RNA (max 1µg/µl)      5µl 
RNAse free water (DEPC)      3.93µl 
M-MLV reverse transcriptase (200U/µl)    1µl 
 
The mixture was incubated at 37ºC for 40 minutes and then a further 1µl of Moloney-
murine leukaemic virus (M-MLV) reverse transcriptase was added and the mixture 
incubated for a further 40 minutes. The cDNA product was stored at -20ºC until it was 
required for PCR. 
2.6.3 Standard polymerase chain reaction 
In order to detect the presence of genetic message for TRVβ gene segments, standard 
PCR was carried out using primer sequences (Hu, Watson et al. 2008). Twenty two 
different TRVβ primers were designed to anneal to each of the twenty two individual 
TRVβ gene segments as the forward primer (Table 2.6). In contrast, the reverse primer 
used for all the PCR reactions investigating TRVβ gene segment expression was the 
same throughout and was designed to anneal to the TRC region of the β-chain (Table 
2.7). Primer sequences were verified using the international ImMunoGeneTics database 
(IMGT) and were all found to be within exons of the genomic sequence of the 
respective TRVβ and TRCβ gene segments. The theoretical PCR product length, in base 
pairs, was calculated for each set of the twenty two primer pairs assuming each TRVβ 
gene segment was joined to the TRDβ1 and TRJβ1 gene segments and there was no 
deletion of base pairs at the junctions between these segments. 
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Table 2.6- Twenty two TRVβ forward primer sequences and their characteristics 
Each primer sequence was designed to anneal to a specific TRVβ gene segment as listed 
below. The manufacturer’s melting temperature (Tm) is documented along with the 
optimum annealing temperature for the primer pair calculated using the Tm of the 
forward and reverse primers. The theoretical PCR product length was determined 
assuming that each TRVβ gene segment was joined to the TRDβ1 and TRJβ1 gene 
segments and that there was no deletion of base pairs at the junctions. 
TRVβ  Primer sequence Tm 
(°C) 
Anneal 
temp 
(°C) 
PCR 
product 
(bp) 
1 5’-  CAACATGAGCCAAGGCAGAAC -3’ 59.8 55.45 186 
2 5’-  TCACAGCTCTAAAGCCTGATGACT -3’ 61.0 56.00 198 
3 5’-  CACTGGAGGACTCAGCTGTGTACT -3’  64.4 58.00 186 
4 5’-  CAAGTCTGTAGAGCTGGAGGACTCT -3’ 64.6 58.00 192 
5 5’-  ATATATCTGCCGTGGATCCAGAA -3’ 58.9 55.00 201 
12-1 5’-  TGGAACTGGAGGACTCTGCTATGTA -3’ 63.0 57.05 187 
12-2 5’-  GAGCTAGAGGACTCTGCCGTGTA -3’ 64.2 57.65 185 
13-1 5’-  CTCCTGCTGGAATTGGCTTCT -3’ 59.8 55.45 204 
13-2 5’-  GCTACCCCCTCTCAGACATCA -3’ 61.8 56.45 189 
13-3 5’-  ATTCTGGAGTTGGCTTCCCTTT -3’ 58.4 54.75 201 
14 5’-  GCAAAGCAGGGCGACACA -3’ 58.2 54.65 189 
15 5’-  CCACTCTGAAGATTCAACCTACAGAA -3’ 61.6 56.35 210 
16 5’-  ACGCAACCCCAGGACTCA -3’ 58.2 54.65 190 
17 5’-  GGCTCTGCAGGCCTAGAGTATTCT -3’ 64.4 57.75 196 
19 5’-  CATCTGCCCAGAAGAACGAGAT -3’ 60.3 55.70 194 
20 5’- TGACAGTTTTAAATGCATATCTTGAAGAC-3’ 59.6 55.35 201 
23 5’-  CAGAACGTGCGAAGCAGAAGA -3’ 59.8 55.45 197 
24 5’-  GCTGCATCCTGGAAATCCTATC -3’ 60.3 55.70 213 
26 5’-  CAGTCCTCTGAGGCAGGAGACT -3’ 64.0 57.55 196 
29 5’-  AGCATTTCTCCCTGATTCTGGATT -3’ 59.3 55.20 216 
30 5’-  CAAGGCCTGGAGACAGCAGTAT -3’ 62.1 56.60 186 
31 5’-  CTAAGCACGGAGAAGCTGCTT -3’ 59.8 55.45 202 
 
Table 2.7- Universal reverse primer TRCβ 
The universal reverse primer annealed to the constant gene segment on the β-chain and 
its sequence is listed below along with manufacturer’s documented melting temperature 
(Tm). 
TRCβ  Primer sequence Tm (°C) 
 5’-  GGTAGCCTTTTGTTTGTTTGCAA -3’ 57.1 
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2.6.3.1 DNA amplification by standard PCR of reverse transcribed RNA from 
whole kidney or spleen 
The following 25µl PCR mix was used for each PCR reaction during the set-up of the 
experiments to ensure all 22 primer pairs annealed and allowed amplification of DNA: 
 
GoTaq Promega Taq MM x2 (PCR buffer, MgCl2 and dNTPs)  12.5µl 
Forward primer, TRVβx (25µM, final concentration 500nM) 0.25µl 
Reverse primer, TRCβ (25µM, final concentration 500nM)   0.25µl 
RNAse free water       11µl 
cDNA         1µl 
 
The cycling conditions for the PCR thermal cycler (GStorm, Gene Technologies, 
Braintree, UK) for each set of primer pairs were as follows: 
 
Stage 1: 94ºC for 5 minutes for 1 cycle 
Stage 2: 94ºC for 60s denaturation, 56ºC for 60s annealing and 72ºC for 60s 
extending for 35 cycles 
Stage 3: 72ºC for 5 mins for 1 cycle 
Stage 4: Cool to 4ºC 
 
2.6.3.2 DNA amplification by standard PCR for the cloning reactions 
In order to generate DNA for the cloning reactions, the following 50µl PCR mix was 
used for each reaction, using a high fidelity Taq master mix from Invitrogen: 
 
Invitrogen High Fidelity Taq MM (PCR buffer, MgCl2 and dNTPs)  45µl 
Forward primer, TRVβ3 (12.5µM, final concentration 250nM)  1µl 
Reverse primer, TRCβ (12.5µM, final concentration 250nM)  1µl 
cDNA (from the stock which was diluted 1:4)    3µl 
 
The cycling conditions were as follows: 
 
Stage 1: 94ºC for 5 mins for 1 cycle 
Stage 2: 94ºC for 60s, 56ºC for 60s, 72ºC for 60s for 30 cycles 
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Stage 3: 72ºC for 7 minutes final extension step for 1 cycle. This ensured DNA 
was fully extended and there was an A tail at the 3’ end of the PCR product to 
allow cloning. 
Stage 4: Cool to 4ºC 
 
When using cDNA which had been generated from sorted lymphocyte populations, 
stage 2 was performed for either 35 or 55 cycles. 
 
2.6.3.3 DNA amplification by standard PCR to ensure the appropriate sized 
plasmid insert was generated 
The following 25µl PCR mix was used for each PCR reaction using plasmid vector 
DNA extracted from bacteria, to ensure that an appropriate sized insert had been 
generated: 
 
GoTaq Promega Taq MM x2 (PCR buffer, MgCl2 and dNTPs)  12.5µl 
Forward primer, TRVβ3 (12.5µM, final concentration 500nM) 1µl 
Reverse primer, TRCβ (12.5µM, final concentration 500nM) 1µl 
cDNA (1:100 dilution of plasmid DNA)    0.5µl 
RNAse free water       10µl 
 
The cycling conditions were as follows: 
 
Stage 1: 94ºC for 5 mins for 1 cycle 
Stage 2: 94ºC for 60s, 56ºC for 60s, 72ºC for 60s for 25 cycles 
Stage 3: 72ºC for 7 mins for 1 cycle 
Stage 4: Cool to 4ºC 
 
2.6.3.4 Resolving the PCR products by agarose gel electrophoresis 
The products arising from PCR amplification were resolved by electrophoresis in 2% 
agarose to verify that an appropriate sized product had been generated, using a similar 
method to that described in section 2.6.1.3.  
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2.6.4 Real time polymerase chain reaction 
Quantitative or real time PCR can be used to quantify in relative or absolute terms the 
starting amount of product. Real time PCR measures fluorescent molecules which are 
generated with successive rounds of PCR. This technique was used to assess the relative 
use of the TCVβ gene segments in kidney and spleen. 
Alexander’s group compared the two principal techniques for real time PCR when 
measuring TRVβ repertoires: SYBR Green and fluorescent probes (Walters and 
Alexander 2004).  SYBR Green is a fluorescent dye which binds to all dsDNA in a PCR 
reaction. Alternatively fluorescent probes can be used where fluorescently labelled 
specific oligonucleotides are added to the PCR reaction. These can either fluoresce upon 
binding the target (single labelled probe) or when degraded by Taq Polymerase on 
amplification of the target (dual labelled probe). Alexander found that the fluorescent 
probe technique was more consistent across the range of TCR signal levels and more 
robust in the presence of contaminating non-TCR cDNA. Therefore we used the 
fluorescent probe Taqman technique to detect amplification of cDNA. The 6FAM (6-
carboxyfluorescein) reporter dye and minor grove binding protein non-fluorescent 
quencher (MGB NFQ) labelled probe annealed to the constant gene segment on the β 
chain (Applied Biosystems, Warrington, UK) (Table 2.8). 
FAM, a fluorescent reporter dye, was at the 5’ end of the Taqman probe and the 
quencher MGB at the 3’ end. When the reporter dye and quencher were in close 
proximity and the probe intact, no fluorescent signal was emitted as it was absorbed by 
the quencher. However, as the Taq Polymerase extended the probe was cleaved from 
the DNA strand so the reporter and quencher were separated (Figure 2.1). Therefore the 
dye fluoresced and was detected by the PCR machine (Applied Biosystems ABI Prism 
7000 Sequence Detection System, Warrington, UK) and the signal subsequently 
analysed using the ABI Prism 7000 SDS software. 
Table 2.8- Nucleotide sequence of the fluorescent probe used in real time PCR  
The sequence of the universal fluorescent probe which annealed to the constant gene 
segment on the β-chain of the TCR in all the real time PCR reactions is listed below. 
TRCβ Probe Probe sequence 
 5’- 6FAM  CTCCACCCAAGGTC  MGB NFQ -3’ 
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Figure 2.1- Summary of the mechanism of real time PCR using fluorescent probes 
The complementary probe annealed to single stranded DNA with the reporter and 
quencher in close proximity. When Taq Polymerase cleaved the probe the reported dye 
was released and detected by the PCR machine. Successive rounds of PCR generated 
proportionately higher levels of fluorescence. 
 
Probe: Reporter dye = FAM and Quencher = MBG 
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2.6.4.1 Optimising real time PCR reaction annealing temperature and primer and 
probe concentrations  
It was clear from standard PCR reactions that the primer pairs were able to replicate the 
template DNA but a fluorescent probe was required to quantify the relative expression 
of TRVβ gene segments by T lymphocytes in UUO kidney and spleen using real time 
PCR. The primer and probe concentrations along with their annealing temperature had 
to be optimised in order to generate fluorescently labelled PCR product that could be 
detected by real time PCR. 
Optimizing the annealing temperature of the real time PCR assay was important, as 
setting the annealing temperature too low may have lead to amplification of non-
specific PCR products. On the other hand, setting the annealing temperature too high 
would reduce the yield of a desired PCR product. The optimal annealing temperature for 
the assays was determined using the thermal gradient feature on the real time PCR 
machine, setting the temperature above and below the Tm of the primers. The allowed 
testing of a range of temperatures simultaneously, so the annealing temperature could be 
optimized in a single experiment. The optimal annealing temperature was found to be 
56.5ºC, at which there was the lowest Ct with no non-specific amplification. 
For varying primer and probe concentrations the reactions were run in triplicate and the 
Ct value for each reaction documented (Table 2.9). This optimisation was performed 
using the primer pair annealing to TRVβ1 and TRCβ.  
For a given amount of starting cDNA with the annealing temperature set at 56.5 ºC, 
detectable Ct values were found to be less than 40 cycles only when the probe 
concentration was set to greater than 300nM. Increasing concentrations of the probe 
made little change to the Ct value. Using a probe concentration of 300nM, increasing 
concentrations of the primer pair were used for a given amount of starting DNA, using 
an annealing temperature of 56.5ºC. There was no reduction in the Ct value when the 
final concentrations of the primers were increased beyond 600nM. 
Using the results of these optimisation experiments, the final concentration of probe 
used in the PCR reaction mixture was 300nM whilst the primers were used at 600nM, 
with an annealing temperature of 56.5 ºC. 
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Table 2.9- Optimising (a) probe and (b) primer concentration for real time PCR reactions using the TRVβ1 and TRCβ primer pair 
Using constant amounts of starting DNA and by setting the PCR reaction annealing temperature to 56.5 ºC, PCR product was not consistently detected 
below 40 cycles of PCR with probe concentrations <300nM. When the probe was used at 300nM, no reduction in Ct value was demonstrated by 
increasing the primer concentrations above 600nM. 
(a) Probe optimisation 
Probe concentration 
(nM) 
Ct v1 Ct v2 Ct v3 Mean Ct Primer concentration 
(nM) 
cDNA  
(ng) 
Annealing temp 
(ºC) 
50 Undet Undet Undet  200/200 50 56.5 
100 39.57 Undet 36.82  200/200 50 56.5 
200 Undet Undet 36.89  200/200 50 56.5 
250 Undet 38.86 35.75  200/200 50 56.5 
300 35.88 38.56 38.73 37.72 200/200 50 56.5 
300 31.14 31.04 31.23 31.14 600/600 50 56.5 
400 32.26 32.84 32.41 32.50 600/600 50 56.5 
500 30.64 32.64 32.29 31.86 600/600 50 56.5 
(b) Primer optimisation 
Primer concentration 
(nM) 
Ct v1 Ct v2 Ct v3 Mean Ct Probe concentration 
(nM) 
cDNA  
(ng) 
Annealing temp 
(ºC) 
50/50 36.13 34.96 37.52 36.20 300 50 56.5 
100/100 34.57 33.36 33.30 33.74 300 50 56.5 
200/200 34.04 33.20 34.20 33.81 300 50 56.5 
300/300 32.60 32.68 32.69 32.66 300 50 56.5 
600/600 32.71 33.00 32.46 32.72 300 50 56.5 
900/900 32.38 32.19 32.74 32.44 300 50 56.5 
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2.6.4.2 DNA amplification by real time PCR of reverse transcribed RNA from 
whole kidney or spleen 
To compare the relative expression of each TRVβ gene segment all twenty two different 
PCR reactions were run in triplicate simultaneously. The following 20µl PCR mix was 
used for each PCR reaction using the Applied Biosystems master mix which contained 
ROX as the reference dye: 
 
Applied Biosystems master mix  10µl 
Forward primer, TRVβx (5µM)   2.4µl 
Reverse primer, TRCβ (5µM)   2.4µl 
Taqman custom probe (5µM)   1.2µl     
cDNA      4µl    
 
The cycling conditions for the PCR thermal cycler (Applied Biosystems ABI Prism 
7000 Sequence Detection System, Warrington, UK) for each set of primer pairs were as 
follows: 
 
Stage 1: 50ºC for 2 mins for 1 cycle to reduce non-specific amplification  
Stage 2: 95ºC for 10 mins for 1 cycle    
Stage 3: 95ºC for 15s to denature and 56.5ºC for 60s to extend and anneal for 40 
cycles 
 
ABI Prism 7000 SDS software was used to generate the amplification plots and Ct 
values. 
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2.6.4.3 Calculating the Ct value of the PCR reaction 
The number of PCR cycles taken to generate a threshold fluorescent intensity is termed 
the Ct value. This threshold fluorescent intensity is set at the start of the linear portion 
of the ‘Log ∆fluorescence (Log ∆Rn) v cycle number’ amplification curve during the 
exponential phase of the PCR reaction (Figure 2.2). 
 
Figure 2.2- Amplification plot of Log ∆fluorescence v cycle number  
The number of PCR cycles required to generate a threshold fluorescent intensity is the 
Ct value for the PCR reaction. The change in fluorescence is determined by the PCR 
cycler as the ratio of the fluorescence from the reporter Taqman probe to the 
fluorescence from the passive reference dye ROX present in the master mix. 
 
 
2.6.4.4 Primer efficiencies 
If the amplification of product in a PCR reaction was 100% efficient then the amount of 
Taqman probe detected when the probe and quencher were cleaved by Taq Polymerase 
would double with each cycle of PCR. This would result in a linear relationship 
between the Ct value and log cDNA concentration for a given PCR reaction and the 
efficiency of that reaction would be 2. Amplification is not always this efficient. 
However, if the relative expressions of the twenty two TRVβ gene segments were to be 
compared then the individual PCR reactions needed to occur with comparable 
efficiency. This would then infer that any difference in the relative expression of one 
gene segment to another was due to the amount of starting product. 
In order to calculate the efficiency of the PCR reaction the following equation was used: 
Efficiency (E) = 10 (-1/slope) 
Threshold line 
 
Linear 
L
o
g
 ∆
R
n
  
Plateau 
Ct 
 
↓ 
 
Cycle number 
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Where the slope was calculated from the standard curve of Ct v Log cDNA 
concentration and when the slope was -3.3 +/-10% then E = 2 or 100% +/-10%. 
R² is statistical correlation which estimates the consistency of PCR amplification and 
determines how good one value is at predicting another. If R²=1 then you can accurately 
predict the value of x (DNA concentration) given the value of y (Ct).  
The efficiencies of each set of primer pairs were calculated by amplifying triplicate 
samples of 5 fold serial dilutions of pooled cDNA as per the method outlined in section 
2.6.4.2. and the mean Ct value calculated. These values were then plotted against log 
cDNA concentration and the slope calculated in order to determine the efficiency of 
each set of primer pairs and allow comparison between them (Figure 2.3). 
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Figure 2.3- Calculating primer efficiency for the TRVβ1 - TRCβ primer pair 
The PCR amplification plot was generated using triplicate 5-fold serial dilutions of 
cDNA at five concentrations (1-5) and had NTC PCR reactions (a). The mean Ct value 
was calculated for each cDNA concentration (ng/µl) (b) and a standard curve of mean 
Ct v Log cDNA concentration was generated. From this the efficiency of the PCR 
reaction was calculated (c), which was 97%. 
(a) 
 
(b)  
Log DNA 
Conc 
Ct v1  Ct v2  Ct v3 Mean Ct 
3.2553 26.37 26.30 26.24 26.30 
2.5563 29.88 29.74 29.59 29.74 
1.8573 31.84 31.80 31.77 31.80 
1.1584 33.47 34.32 34.78 34.19 
0.4594 36.53 35.3 36.1 35.98 
 
(c)  
0
5
10
15
20
25
30
35
40
0 0.5 1 1.5 2 2.5 3 3.5
Log DNA Concentration
C
t 
v
a
lu
e
 
1 2 3  4 5 
No cDNA 
 
 
R
2 
= 0.99 
E = 1.97 
 85 
2.6.4.5 Calculating the relative use of each TRVß gene segment in kidney or spleen  
The relative usage of each TRVß gene segment was calculated according to the 
following equation, which had been used by Pannetier’s group when they were 
comparing the frequency of TCR transcripts in humans with rheumatoid arthritis (Lim, 
Baron et al. 2002). 
 
Where Ct(x) was the fluorescent threshold cycle number measured for TRVßx 
This calculation was valid provided the efficiencies of all twenty two primer pairs were 
close to 100%.  Multiple commercial companies suggest an acceptable range for primer 
efficiency which allows for comparison of reactions is 100% +/- 10%. On review of the 
paper by Lim et al, their mean primer pair efficiency was 87% +/- 18%, which was less 
strict. 
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2.7 Cloning methodology for sequence analysis 
2.7.1 Standard PCR to generate PCR product for cloning 
The high fidelity Taq polymerase, Platinum PCR SuperMix High fidelity (Invitogen, 
Paisley, Scotland) was used for PCR as described in 2.6.3.2. This ensured high fidelity 
amplification of the DNA template and minimised the errors in nucleotide addition 
generated by the polymerase during creation of the complementary strand.  In order to 
achieve this, the mixture contained a Pyrococcus species GB-D thermostable 
polymerase which had proofreading ability by virtue of it’s 3’-5’ exonuclease activity, 
allowing the removal of mismatched base pairs to decrease the error rate. The mixture 
of the Taq DNA polymerase with a proofreading enzyme increased the fidelity of 
amplification approximately six times over that of a Taq DNA polymerase alone. This 
was important because errors generated in stand extension would ultimately lead to 
errors in the sequence read. 
Taq polymerase is also useful when there is a limited amount of starting material as it 
gives higher yields and also fewer extraneous bands due to non-specific amplification at 
lower temperatures, due to the hotstart technology. It also has nontemplate-dependent 
terminal transferase activity which adds a single deoxyadenosine (A) to the 3’ end of the 
PCR product during the final lengthened extension step. This made it possible to clone 
the PCR product into a linearised vector using the topoisomerase enzyme, which had a 
single overhanging 3’ deoxythymidine (T) (Figure 2.4).  
The pCR4-TOPO plasmid from Invitrogen (Paisley, Scotland) was used which 
contained a ccdB lethality gene, fused to the LacZα gene (Figure 2.5). The PCR product 
was inserted within this lethality gene to disrupt it. Therefore, if the vector re-
circularised without a PCR insert and was transformed into E. coli, this lethality gene 
remained intact and the bacteria died. However, if there was a PCR insert in the plasmid 
vector the lethality gene was disrupted and the bacteria lived ensuring that only bacteria 
transformed with a plasmid vector containing a PCR insert survived. The TOPO vector 
also contained a kanaymcin and ampicillin resistant gene and the bacteria were grown in 
media containing kanamycin, selecting only bacteria transformed with a recombinant 
vector to survive.  
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Figure 2.4- Generation of a T overhang on the linearised plasmid  
Topoisomerase I binds to dsDNA on the plasmid vector and cleaves the phosphodiester 
backbone after a 5’-CCCTT nucleotide sequence in one strand (Shuman 1994). The 
energy created by breaking the phosphodiester bond is conserved by the formation of a 
covalent bond between the 3’ phosphate of the cleaved strand and the tyrosol residue 
(Tyr-274) of topoisomerase I. This linearises the plasmid vector. However, the 
phosphor-tyrosol bond between the DNA and enzyme can be attacked by the 5’ 
hydroxyl (-OH) group of the original cleaved strand, reversing the reaction and 
releasing the topoisomerase enzyme, allowing the vector to re-circularise with the 
inserted PCR sequence. 
 
Figure 2.5- Map of the pCR4-TOPO plasmid 
The LacZα-ccdB lethality gene and antibiotic resistance genes are found within the 
pCR4-TOPO plasmid vector. 
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2.7.2 Cloning reaction 
The TOPO TA cloning kit for sequencing (Invitrogen, Paisley, Scotland) was used to 
clone and transform cells. The following cloning reaction mixture was used for each 
cloning reaction: 
 
PCR product      4µl 
Salt solution (1.2M NaCl, 0.06M MgCl2)   1µl 
TOPO vector       1 µl 
 
The reagents were mixed and incubated for 5 minutes at room temperature and the 
reaction placed on ice. 
 
2.7.3 Transformation of competent bacteria 
2µl of the TOPO cloning reaction was added to 1 vial of One Shot chemically 
competent E. coli, mixed and incubated on ice for 15 minutes. The E. coli were then 
heat shocked at 42°C for 30 seconds and transferred to ice. 250µl of SOC medium was 
added and the tube shaken horizontally at 200 rpm at 37°C for 1 hour in an orbital 
incubator. Aliquots of 50µl of the transformation reaction were spread onto pre-warmed 
LB agar plates containing kanamycin (50µg/ml) and incubated overnight at 37°C to 
grow individual colonies. 25-50 of these colonies were picked and individually grown 
overnight in LB, containing kanamycin (50µg/ml), at 37°C in the orbital incubator. 
2.7.4 Plasmid extraction from competent bacteria 
The PureLink quick plasmid miniprep kit (Invitrogen, Paisley, Scotland) was used to 
isolate plasmid DNA from E. coli as per the manufacturer’s instructions. Cells were 
lysed using an alkaline/SDS buffer. The lysate was applied to a silica membrane column 
that selectively bound plasmid DNA. Contaminants were removed using wash buffers 
and the plasmid DNA was eluted into TE buffer. A sample of the extracted plasmid 
DNA was then used in a PCR reaction, as detailed in section 2.6.3.3, and the products 
resolved by agarose electrophoresis. This was performed to check there was an 
appropriate sized PCR cloning product insert within the plasmid vector before the 
extracted plasmid DNA was sent for sequencing. 
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2.7.5 Cloning control reactions 
Control TOPO cloning reactions were performed to ensure the expected results were 
generated. This involved generating a control PCR product to use in the TOPO cloning 
reactions. Also the efficiency of transformation reactions was assessed using a pUC19 
plasmid. 
2.7.5.1 Control PCR product 
A 750bp control PCR product was generated using the method and reagents from the 
TOPO TA cloning kit (Invitrogen, Paisley, Scotland) and the product resolved by 
agarose gel electrophoresis as a discrete band of the appropriate size. 
2.7.5.2 Control TOPO cloning reaction 
Two cloning reactions were performed, as outlined in section 2.7.2, one using the 
control 750bp PCR product and the other substituting the DNA for an equivalent 
volume of DEPC water. E. coli were transformed and colonies grown using both 
separate cloning reaction products, as outlined in section 2.7.3. Aliquots of both 25µl 
and 50µl of each transformation reaction were plated. Few colonies grew when vector 
only was cloned due to the intact ccbD lethality gene. In contrast, colonies grew when 
the control PCR product was used in the cloning reaction and there was an incremental 
increase in the number of colonies grown when more transformed reaction mix was 
plated. Colonies were then picked and grown overnight in LB with kanamycin and the 
plasmid DNA extracted, as outlined in section 2.7.4. The final PCR reaction using the 
plasmid DNA confirmed a 750bp product using agarose gel electrophoresis. 
Other control studies were carried out with each set of cloning reactions to ensure: 
• no growth after overnight incubation of a LB agar plate with kanamycin, 
demonstrating that the plates were not contaminated 
• no growth on an LB agar plate with kanamycin, when unmanipulated E. coli 
were plated out because they were not resistant to kanamycin 
• multiple confluent colonies grown on a LB agar plate without antibiotic added 
when unmanipulated E. coli were plated, demonstrating the bacteria could 
proliferate 
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2.7.5.3 Transformation efficiency 
In order to determine how well the transformation reactions were working the 
transformation efficiency of the reaction was calculated using the following equation: 
 
Transformation efficiency  =  Total number of cells growing on the agar plate 
               
Amount of DNA spread on the agar plate in µg 
 
50µl of One Shot competent E.coli were chemically transformed using the standard 
method, with a circular plasmid pUC19 which was equivalent to 10pg DNA. This 
plasmid DNA had not been cloned with a PCR product and contained an ampicillin 
resistance gene. One fifth of the transformation reaction was transferred onto a LB agar 
plate with ampicillin (100µg/ml) and after overnight incubation 60 colony forming units 
(cfu) developed. Therefore 30 x 106 cfu/µg DNA were grown, when the transformation 
efficiency was expected to be ~1 x 109 cfu/µg DNA. Therefore the efficiency of the 
reaction was 3%. 
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2.8 Sequencing 
The automated sequencing service from the commercial company Macrogen (Seoul, 
Korea) was used to determine the nucleotide sequence of the PCR product in each 
plasmid vector. Macrogen use a dye-terminator method to determine nucleotide 
sequence, by labelling each of the four dideoxynucleotide chain terminators with 
different fluorescent dyes which have different wavelengths of fluorescence and 
emission (Sanger, Nicklen et al. 1977). They terminate DNA strand elongation because 
they lack the 3'-OH group required for the formation of a phosphodiester bond between 
two nucleotides, thus resulting in DNA fragments of varying length The sequencing 
reactions were conducted under BigDyeTM terminator cycling conditions and run using 
the Applied Biosystems automatic sequencer. Each nucleotide sequence read out from 
Macrogen for an individual sample of the plasmid DNA included the DNA sequence 
trace chromatogram (Figure 2.6). The limitations of this dye-terminator method include 
dye effects due to differences in the incorporation of the dye-labelled chain terminators 
into the DNA fragment, resulting in unequal peak heights and shapes in the electronic 
DNA sequence trace chromatogram after capillary electrophoresis. 
 
Figure 2.6- Chromatogram of the sequence generated from colony 1 of the 
D14A9K CD4+ sorted cells 
An example of a DNA sequence trace chromatogram, which accompanied each 
nucleotide sequence for each sample of plasmid DNA, is illustrated here. 
 
 
2.8.1 Sequencing analysis 
The locations of each of the primer pairs and which TRJβ gene was used were first 
identified in each of the sequences. Subsequently the multiple sequences were aligned 
using the EMBL-EBI website (www.ebi.ac.uk/Tools/clustalw2/index). The Translate 
tool from the Expasy website (http://www.expasy.ch/tools/) was used for conversion of 
nucleotide to amino acid sequences. 
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2.9 Lymphocyte extraction and sorting from kidney and spleen tissue 
2.9.1 Digestion of renal tissue 
Mice were sacrificed, exsanguinated and perfused with 50ml of 0.9% saline until their 
organs became visibly pale. The UUO kidney was dissected and divided into 2 halves. 
One half was left whole and snap frozen in liquid isopentone and stored at -80°C along 
with the spleen. The other half was dissected into 1mm3 sections and placed in DMEM 
(Invitrogen, Paisley, Scotland) on ice. 1.6mg/ml of collagenase (Sigma-Aldrich, Poole, 
UK) and 200µg/ml of DNase-1 (Roche, Burgess Hill, West Sussex) was added to the 
DMEM tissue suspension and incubated at 37°C for 40 minutes with agitation. The 
suspension was centrifuged (Heraeus Labofuge 400R, Thermofisher Scientific, 
Langenselbold, Germany) at 500g for 5 minutes to form a pellet. The cells were washed 
three times with DMEM and re-suspended in 10ml of DMEM and further digested by 
the addition of 200µg/ml of DNase-1 for 15 minutes at 37°C with agitation. The digest 
was again washed and re-suspended in FACS buffer (1% BSA) and the suspension left 
to settle for 20 minutes. The upper two thirds were removed for analysis and contained 
the low density cells of interest. The cells were counted using a haemocytometer and the 
ratio of live:dead cells estimated with the addition of trypan blue. The cells were then 
re-suspended in 1% heat inactivated mouse serum to block non-specific binding. The 
risk of separating immune cells from the kidney by this methodology is that the cell 
population may not be representative of the whole T lymphocyte pool within the UUO 
kidney. The very lymphocytes I am interested in, embedded within dense fibrous tissue, 
may be more difficult to extract. Alternatively the activated T lymphocyte population 
may be more liable to damage or die by this extraction procedure. This would introduce 
bias to the cell population retrieved and not be representative of the total kidney 
lymphocyte pool. 
2.9.2 Flow cytometry and cell sorting 
Primary fluorochrome labelled antibodies to CD45, CD4 and CD8 were added directly 
to the cell suspension at 0.8µg / 10
6
cells and incubated at 4°C in the dark for 30 minutes 
in FACS tubes. Tubes were centrifuged at 350g for 5 minutes to obtain a pellet. Cells 
were washed three times with FACS solution and re-suspended in 200µl of FACS 
solution.  
The intensity of the fluorescent staining on the cells was detected using the LSRII 
flowcytometer (Becton Dickinson, Oxford, UK) and the cells sorted into CD4+ and 
CD8+ populations using the FACSDIVA (Becton Dickinson, Oxford, UK). Cells were 
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sorted directly into plastic eppendorfs containing 1ml lysis buffer with 10µl β- 
mercaptoethanol (Quiagen RNA extraction kit). The lysis buffer also contained ~105 
PTEC acting as carrier cells. These were used to discourage RNA from the sorted cells 
binding to the side of the tube and so improve RNA yield. RNA extraction was 
performed immediately using the standard Quiagen RNA extraction kit as illustrated in 
section 2.6.1.2. The data was analysed using the FACSDIVA software (Becton 
Dickinson, Oxford, UK). 
2.10 Statistics 
Statistics were performed using the statistical analysis function in the Prism Graph Pad 
program. P values were calculated to compare the means of two samples with equal 
variance using the student t test. ANOVA was used when making comparisons of >2 
variables, when the variances of the samples were equal. The Bonferroni adjustment 
was made for multiple comparisons. P values using the Chi squared test were used to 
assess whether paired observations on two variables, expressed on a contingency table, 
were independent of each other. P values of less than 0.05 were regarded as significant. 
Correlation coefficients (r) were calculated to determine whether there was a 
relationship between two factors; –1 demonstrated a perfect negative correlation, 0 no 
correlation and +1 a perfect positive correlation. 
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Chapter 3. The composition and phenotype of the cellular infiltrate 
post UUO injury and its correlation with renal injury and fibrosis 
 
3.1 Introduction 
Irrespective of the aetiology of chronic renal disease there are cellular infiltrates in the 
tubulointerstitial compartment and evidence of tubulointerstitial fibrosis, which is the 
morphological hallmark of chronic progressive renal disease (Harris and Neilson 2006). 
The rate of decline in glomerular filtration rate (GFR) strongly correlates with the extent 
of this tubulointerstitial damage (Nath 1992; Strutz and Neilson 1994). 
An animal model which demonstrates many features of progressive renal disease seen in 
the clinical setting is unilateral ureteric obstruction. Within 1-2 weeks of ligation of the 
ureter there is consistent time-dependent leukocyte influx into the tubulointerstitial 
compartment and fibrosis (Schreiner, Harris et al. 1988). This has made UUO a popular 
rodent model for the study of renal fibrosis. I used this model to investigate the role of 
the inflammatory infiltrate in progressive renal disease. 
The inflammatory cell recruitment into the tubulointerstitium seen both in the clinical 
setting and in the UUO model of kidney disease is believed to be facilitated by the up-
regulation of chemokines and adhesion molecules (Vielhauer, Eis et al. 2004). 
Conversely if obstruction is released at an early time point in the UUO model, the 
amount of inflammatory infiltrate can be reversed and declines (Cochrane, Kett et al. 
2005; Tapmeier, Brown et al. 2008). 
My initial aim was to evaluate the time course of the inflammatory cell influx into the 
tubulointerstitium and to correlate this with the subsequent injury that developed. 
Correlating the presence of this inflammatory infiltrate with progressive renal injury 
does not determine that this infiltrate is playing a causal role. 
On completion of lymphocyte development in the thymus, lymphocytes enter the blood 
stream and lymphoid organs as naive T cells. They are unable to participate in adaptive 
immune responses with effector function until they encounter their specific antigen with 
MHC and co-stimulation. Lymphocytes then proliferate and differentiate into effector 
cells which contribute to the removal of that antigen. Activated lymphocytes display 
specific cell surface antigens and nuclear markers of proliferation, which are not present 
when they are in their naive state. My hypothesis is that lymphocytes are playing an 
 95 
active role in promoting tubulointerstitial injury in UUO. Therefore I aimed to 
determine whether this tubulointerstitial lymphocytic infiltrate, post UUO, was 
comprised of activated and proliferating T cells which could play an active role in 
promoting tubulointerstitial injury. 
3.2 Establishing the model of UUO 
UUO was performed on 8-10 week old female C57Bl/6 mice, with a parallel group of 
sham operated animals, and were sacrificed at 3, 7 and 10 days post obstruction. No 
animals died before the end of the experiment. Both the obstructed UUO kidney and the 
unobstructed contralateral kidney were analysed. At day 3 post obstruction, the 
harvested UUO kidney was not macroscopically different to a normal kidney or the 
contralateral kidney. By day 10, the obstructed kidney was macroscopically pale and 
hydronephrotic with a markedly thinned cortex (Figure 3.1). The day 7 obstructed 
kidneys were abnormal however the changes not as marked as that seen at the later time 
point. 
Figure 3.1- Macroscopic appearances of the obstructed kidney at day 10 post UUO 
A digital photograph of a mouse that had undergone a laparotomy and ligation of the 
left ureter ten days earlier. The obstructed left kidney was enlarged (arrow) due to 
hydronephrosis. Following removal and decompression of this kidney, marked 
reduction in the cortical thickness was demonstrated.             
                
 
 96 
3.3 Characterising the mononuclear cell infiltrate and tubulointerstitial injury 
following UUO 
In order to investigate the composition of the inflammatory cell infiltrate in the 
development of tubulointerstitial fibrosis, UUO was performed in groups of four 
C57Bl/6 mice. The animals were sacrificed at three time points: 3, 7 and 10 days post 
UUO, in parallel with sham operated animals. UUO kidneys, contralateral kidneys and 
renal tissue from sham operated animals were processed from the sacrificed animals. 
Immunohistochemical staining was carried out to identify the phenotype of the 
infiltrating cells and to assess the degree of injury. 
3.3.1 Histological analysis of the cellular infiltration 
Histological analysis of infiltrating mononuclear cells into day 3, 7 and 10 UUO kidney 
was performed by immunohistochemistry on frozen sections in a blinded manner 
(Figure 3.2). From the published literature that looked at cellular infiltration into UUO 
kidney, the predominant cell types were T lymphocytes and macrophages (Schreiner, 
Harris et al. 1988), therefore monoclonal antibodies to CD4, CD8 and F4/80 antigens 
were used. The F4/80 antigen is expressed on tissue macrophages and has been the 
predominant antibody used in the literature to detect macrophages in mice (Khazen, 
M'Bika J et al. 2005; van den Berg and Kraal 2005). Histological examination also 
demonstrated tubulitis (Figure 3.3). 
A progressive increase in the mean number of CD4+ T cells infiltrating UUO kidney 
between 3, 7 and 10 days post obstruction was demonstrated but this did not reach 
statistical significance (p=0.065). A similar pattern of increasing F4/80+ cell infiltration 
with prolonged UUO was also seen and this increase in the mean number of cells 
between 3, 7 and 10 days post obstruction was statistically significant (p=0.016), 
although the number plateaued between day 7 and 10. The mean number of CD8+ T 
cells peaked after 7 days of obstruction and there were less CD8+ T cells seen at 10 
days. The mean number of CD8+ T cells infiltrating the day 7 UUO kidney was 
significantly more than the number seen after 3 days of obstruction (p=0.011). Overall, 
the mean number of CD4+ cells predominated over the number of CD8+ cells in 
obstructed kidney, with a CD4:CD8 ratio of 2.5:1 and 6:1 at days 7 and 10 respectively 
(Figure 3.4).  
Comparison was then made between the cellular infiltration seen in UUO kidney with 
that of sham operated kidney, the contralateral kidney from a UUO mouse and normal 
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kidney. These controls did not show any histological difference in cellular infiltration, 
where very few of the three cell types were detected (Figure 3.5). After three days of 
UUO there was minimal infiltration of all three cells types into the obstructed kidney 
and no significant difference between the mean number of infiltrating CD4+, CD8+ and 
F4/80+ cells compared to the controls (p>0.05). In comparison, after 10 days of UUO 
there was a significant increase in the mean number of infiltrating CD4+, CD8+ and 
F4/80+ cells in the day 10 UUO kidney compared to histologically normal kidneys 
(p<0.05).  
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Figure 3.2- Immunohistochemical staining for T cell and macrophage infiltration 
into the tubulointerstitium of UUO kidney at 3, 7 and 10 days post UUO 
A Streptavidin-Horseradish peroxidise immunohistochemical staining technique was 
used on frozen sections of obstructed kidney at 3, 7 and 10 days post UUO to detect 
infiltrating T lymphocytes and macrophages (arrow). The number of infiltrating CD4+, 
CD8+ and F4/80+ cells increased with time post UUO. Magnification x250. 
      CD4+           CD8+                         F4/80+ 
(a) Day 3 UUO 
    
(b) Day 7 UUO 
   
(c) Day 10 UUO 
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Figure 3.3- Immunohistochemical staining for CD4+ T cells in the 
tubulointerstitium of UUO kidney 10 days post obstruction demonstrating tubulitis 
A Streptavidin-Horseradish peroxidise immunohistochemical staining technique was 
used on a frozen section of day 10 UUO kidney. This demonstrates CD4+ T cells 
(arrow) which have breached the tubular basement membrane, to cause tubulitis. 
Magnification x250. 
 
 
 
 
 
 
 
 
 
 
 
 
 100 
Figure 3.4- Mononuclear infiltrate into the UUO kidney at time points post UUO 
The number of infiltrating cells was quantified by analysing five random non-
overlapping HPF at x250 magnification for each UUO kidney. The total number of 
positively stained infiltrating cells was counted for each HPF and the mean number of 
cells per HPF calculated for each animal. Then the mean number of infiltrating cells per 
HPF was calculated for the group of four mice at each time point. 
There was a significant change in the mean number of infiltrating F4/80+ cells 
(*p=0.016) and CD8+ T cells (**p=0.0008) between 3, 7 and 10 days post UUO. 
Although the mean number of infiltrating CD4+ T cells increased with progressive 
length of obstruction, this was not statistically significant (***p=0.065). There were 
very few infiltrating CD4+, CD8+ and F4/80+ cells in the normal, sham operated and 
contralateral UUO kidney sections analysed (data not shown). 
Each group consisted of four mice with error bars depicting the standard error of the 
mean. 
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Figure 3.5- Immunohistochemical staining for T cell and macrophage infiltration 
into the tubulointerstitium of normal and contralateral UUO kidney and spleen    
A Streptavidin-Horseradish peroxidise immunohistochemical staining technique was 
used on frozen sections of the contralateral kidney in a UUO animal and normal kidney 
and spleen to detect infiltrating T lymphocytes and macrophages. The contralateral 
UUO kidney and normal kidney looked identical and few cellular infiltrates were 
demonstrated. Identical findings were seen in sham operated kidney (data not shown). 
Positive staining for CD4+ and CD8+ T cells and F4/80+ macrophages was found in 
normal spleen, which was used as the positive control. Magnification x250. 
                 CD4+           CD8+                         F4/80+ 
(a) Contralateral kidney 
   
(b)Normal kidney                                                                                         
    
(c) Normal spleen 
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3.3.2 Histological analysis of the tubulointerstitial injury 
3.3.2.1 Characterising tubulointerstitial injury with Periodic acid Schiff staining 
The degree of tubulointerstitial injury can be assessed histologically in a number of 
ways. Initially Periodic acid Schiff (PAS) staining was performed on formalin-fixed, 
wax-embedded sections. Normal kidneys had a tightly packed tubulointerstitial space 
with back-to-back tubules and tall, tubular epithelial cells (Figure 3.6(a)). This was 
similar to the histology seen in both the contralateral kidney of UUO mice (Figure 
3.6(b)) and the kidney of sham operated controls (not shown). 
The tubulointerstitial injury demonstrated in day 3, 7 and 10 UUO kidney samples were 
compared (Figure 3.6(c)). In day 3 UUO kidney there was some tubulointerstitial 
expansion and tubular separation, as well as evidence of tubular epithelial cell 
flattening. More marked histological changes were seen in kidney after 7 and 10 days of 
obstruction, with noticeable loss of normal renal architecture, expansion of the 
tubulointerstitial compartment and separation of the tubules. Tubular epithelial cells lost 
height and became flattened and there was tubular dilatation. In some sections there was 
such severe injury to the tubulointerstitial compartment with prolonged obstruction that 
recognisable renal architecture was lost. No glomerular changes were apparent in UUO 
kidney confirming this to be a tubulointerstitial disease.  
The percentage of cortical cross section occupied by interstitium (as a measure of 
interstitial expansion) was significantly greater in the obstructed compared to the 
contralateral kidney at day 3 (p=0.0487), 7 (p=0.0024) and 10 (p=0.0001) post 
obstruction (Figure 3.7). Similar significant increases in interstitial expansion were seen 
when comparing UUO and normal kidney at day 10 (p<0.0001) (data not shown).  
Furthermore, interstitial expansion increased significantly with increasing duration of 
obstruction in the UUO kidney (p=0.0003). There was also a positive correlation 
between the number of CD4+ cells and interstitial expansion post UUO (Figure 3.8). 
These histological changes were similar to those seen in clinical biopsy specimens of 
patients with advanced chronic kidney disease. 
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Figure 3.6- PAS staining of normal kidney, contralateral kidney from a UUO 
animal and UUO kidney at day 3, 7 and 10 post obstruction 
PAS stained, formalin fixed and wax embedded sections of normal kidney (a), day 10 
contralateral kidney (b) and UUO kidney at the three time points post UUO (c) were 
used to assess renal injury. The contralateral kidney in figure (b) showed histologically 
normal renal architecture, as seen in figure (a). Figure (c) demonstrates progressive loss 
of normal renal architecture, with increasing expansion of the interstitial space at 
successive times after obstruction. There is also loss of tubular epithelial cell height and 
tubular dilatation (arrow). Magnification x250. 
(a) Normal kidney                  (b) Contralateral UUO kidney   
  
(c) Day 3 UUO     Day 7 UUO                              Day 10 UUO 
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Figure 3.7- Comparison of the percentage of interstitial expansion in the UUO and 
contralateral kidneys at 3, 7 and 10 days post obstruction 
The degree of tubular injury as assessed by PAS staining and percentage interstitial 
expansion was compared at three time points post UUO. To examine the degree of 
tubulointerstitial expansion a point counting method was used as outlined in Chapter 2. 
A 10 x 10 grid was superimposed over each of five HPFs per animal, with eighty one 
positive intersections. The number of positive intersections which lay outside the tubule 
and in the interstitial space were counted and used to calculate the percentage of 
interstitial expansion. The mean percentage of interstitial expansion was calculated for 
each animal and then for the group of four animals as a whole at each time point. 
There was a significant difference between the mean percentage of interstitial expansion 
between the UUO and contralateral kidney at 3 (*p=0.0487), 7 (**p=0.0024) and 10 
(***p=0.0001) days post obstruction. There was also a significant increase in interstitial 
expansion in the UUO kidney between 3, 7 and 10 days post obstruction (p=0.0003). 
Each group consisted of four animals with error bars depicting the standard error of the 
mean. 
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Figure 3.8- Infiltration of (a) CD4+, (b) CD8+ and (c) F4/80+ mononuclear cells 
correlated with interstitial expansion at 3, 7 and 10 days post UUO  
The degree of tubular injury as assessed by PAS staining and percentage of interstitial 
expansion was correlated with the number and type of infiltrating mononuclear cells. 
There was a positive correlation between number of CD4+ cells and interstitial 
expansion with increasing length of renal obstruction (r=0.98) (a). The correlation 
coefficients for CD8+ and F4/80+ cells with IE were 0.59 and 0.89 respectively (b + c). 
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0
2
4
6
8
10
12
14
3 7 10
Day post UUO
C
e
ll
 c
o
u
n
t
0
10
20
30
40
50
%
 i
n
te
r
st
it
ia
l 
e
x
p
a
n
si
o
n
CD4
IE
(b) CD8+ 
0
2
4
6
8
10
12
14
3 7 10
Day post UUO
C
e
ll
 c
o
u
n
t
0
10
20
30
40
50
%
 i
n
te
r
st
it
ia
l 
e
x
p
a
n
si
o
n
CD8
IE
 
(c) F4/80+ 
0
2
4
6
8
10
12
14
3 7 10
Day post UUO
C
e
ll
 c
o
u
n
t
0
10
20
30
40
50
%
 i
n
te
r
st
it
ia
l 
e
x
p
a
n
si
o
n
F4/80
IE
 
 106 
3.3.2.2 Tubulointerstitial injury and markers of fibrosis 
Interstitial expansion as demonstrated by PAS staining in UUO kidney is presumed to 
represent the development of fibrosis and has been demonstrated in previous studies 
using the UUO model (Tapmeier, Brown et al. 2008). However, this expansion may 
represent oedema rather than fibrosis and so to characterise interstitial expansion further 
obstructed kidney was stained immunohistochemically for alpha-smooth muscle actin 
(α-SMA) and collagen I. 
The key factor in renal fibrosis is the accumulation and proliferation of fibroblasts 
within the interstitium that are stimulated to produce large amounts of extracellular 
matrix. The hallmark features of fibroblast activation include expression of α-smooth 
muscle actin, a contractile protein usually found in perivascular smooth muscle cells, 
and the production of excessive extracellular matrix components including collagen 
type I and III and fibronectin. The origin of the expanded activated myofibroblast 
population within the interstitial compartment is controversial, as outlined in Chapter 1, 
and has been shown to be derived from a number of sources. As a consequence staining 
for α-SMA and collagen I are more specific methods of assessing renal fibrotic injury 
than calculating interstitial expansion. 
Histological analysis for α-SMA and collagen I in UUO kidney 3 days after obstruction 
revealed low levels of positive staining (Figures 3.9(a) and 3.10(a)). In comparison 
there was a significant increase in staining in the UUO kidney for both markers of 
fibrosis between 3, 7 and 10 days of obstruction (p<0.0001 for α-SMA and p=0.0003 
for collagen I). In sham operated kidney (not shown), contralateral kidney from a UUO 
animal (Figure 3.9(b)) and normal kidney (Figure 3.9(c) and 3.11(a)) there was little 
staining for the two markers of fibrotic injury. There was even significantly less α-SMA 
staining in the contralateral kidney of a day 3 UUO animal compared to the obstructed 
kidney (p=0.0407) (Figure 3.12) and less collagen I staining in normal kidney compared 
to day 3 UUO kidney (p=0.0425) (Figure 3.13). This data reflected the results seen with 
PAS stained sections when the percentage of interstitial expansion was used as a 
surrogate marker for fibrosis (Figure 3.7).  
Overall, a clear relationship between the two markers of fibrosis, α-SMA and collagen I, 
the percentage of interstitial expansion and mononuclear cell infiltration has been 
demonstrated. 
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Figure 3.9- α-SMA staining of day 3, 7 and 10 UUO kidney, normal kidney and the 
contralateral kidney from a UUO mouse 
Immunohistochemical staining of α-SMA was carried out on formalin fixed, wax 
embedded sections of UUO kidney from three time points post UUO (a), a day 7 UUO 
contralateral kidney (b) and a normal kidney (c). Figure (a) shows a progressive 
increase in the α-SMA staining within the expanded interstitium (brown staining). The 
architecture seen in the contralateral kidney (b) is similar to that in the histologically 
normal kidney (c) and demonstrates minimal α-SMA staining. The blood vessel in the 
section of normal kidney (c) has a smooth muscle wall and stains positively for α-SMA 
and therefore acts as a positive control. Magnification x250.  
(a) Day 3 UUO kidney                      Day 7 UUO kidney 
  
Day 10 UUO kidney 
 
 
(b) Day 7 contralateral UUO kidney        (c) Positive control: kidney vasculature   
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Figure 3.10- Collagen I staining of frozen tissue using pixel intensity grading to 
assess the percentage area of collagen I staining in UUO kidneys  
Immunohistochemical staining for collagen I on frozen sections of UUO kidney was 
performed at 3, 7 and 10 days after ureteric obstruction (column (a)). Q-Win software 
was used to analyse the mean percentage area of collagen I staining (column (b)), 
delineated by the blue area. With increasing length of ureteric obstruction there was loss 
of the normal renal architecture and a progressive increase in collagen I staining along 
with expansion of the interstitial space. Magnification x250. 
(a) Collagen I staining                       (b) Percentage area of staining 
Day 3 post UUO 
   
Day 7 post UUO 
  
Day 10 post UUO 
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Figure 3.11- Collagen I staining of frozen kidney and liver tissue and using the 
pixel intensity grading to assess percentage area of collagen I staining  
Frozen sections of normal kidney and liver were stained for collagen I using a 
horseradish peroxidise conjugated secondary antibody (a). Q-Win software determined 
the mean percentage area of collagen I staining using the pixel intensity grading 
function (b). Normal kidney acted as a negative control with little collagen I staining 
and normal liver a positive control because it is present in the portal fields and fibrous 
septa. Using the same method on UUO kidney without adding the collagen I primary 
antibody, there was no positive staining (c). This demonstrated that the secondary 
antibody and DAB bind specifically. Magnification x250. 
(a) Collagen I staining                              (b) Percentage area of staining 
Normal kidney 
  
Normal Liver (positive control) 
    
 
 (c) No primary antibody: UUO kidney 
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Figure 3.12- α-SMA staining of obstructed and contralateral kidney at three time 
points after ureteric obstruction 
The degree of tubulointerstitial fibrosis, as determined by α-SMA staining of activated 
fibroblasts, was analysed using the point counting method illustrated in Chapter 2 and 
similar to that used to assess the percentage of interstitial expansion in PAS stained 
sections. 
There was a significant difference between α-SMA staining in the obstructed compared 
to the contralateral kidneys in the UUO animals at all three time points (*p=0.0407, 
**p<0.0001 and ***p=0.0001). There was also a significant increase in the α-SMA 
staining of obstructed UUO kidney between 3, 7 and 10 days (p<0.0001). 
Each group consisted of four mice with error bars depicting the standard error of the 
mean. 
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Figure 3.13- Collagen I staining of obstructed kidney 3, 7 and 10 days after UUO 
The degree of tubulointerstitial fibrosis, as determined by staining the extracellular 
matrix protein collagen I, was assessed for normal and UUO kidney at 3, 7 and 10 days 
post obstruction. The percentage of the interstitial space stained by collagen I, as 
determined by the Q-win pixel intensity function, was calculated for ten non-
overlapping HPF per mouse and the mean percentage was determined for each mouse. 
Finally the mean percentage of collagen I staining was calculated for the group of four 
mice at each time point. 
The increase in Collagen I staining between normal kidney and obstructed kidney was 
seen as early as three days after obstruction, where a significant increase was detected 
(*p=0.0425). There were then significant increases in collagen I deposition in UUO 
kidney tissue between 3, 7 and 10 days post obstruction (p=0.0003). 
Each group consisted of four mice with error bars depicting the standard error of the 
mean. 
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3.4 Assessing the phenotype of the infiltrating T lymphocytes  
After demonstrating that the cellular infiltrate into the tubulointerstitium post UUO 
correlated with progressive injury and markers of fibrosis, an assessment was made to 
determine whether the infiltration could be actively contributing to progressive renal 
injury. In order to do this infiltrating T lymphocytes were examined for markers of 
activation and proliferation, suggesting they had effector functions. If the infiltrating T 
cells did not demonstrate evidence of activation or proliferation it would imply they 
were naive cells which had not yet recognised their cognate antigen and suggested they 
were trafficking through the injured tissue in response to the inflammatory chemokine 
gradient but not actively participating in the injury. 
My hypothesis was that lymphocytes were playing an active role in promoting 
tubulointerstitial injury in UUO and contributing to the development of fibrosis. 
3.4.1 Characteristics of activated T lymphocytes 
In order to assess whether T cells within the UUO kidney were activated, well 
recognised surface markers of effector and memory T cell phenotype were used: CD69 
and CD44. Using primary fluorochrome labelled antibodies to CD69 or CD44, 
immunofluorescent staining was performed on frozen sections of UUO kidney at 3, 7 
and 10 days post obstruction, using groups of four mice at each time point. The sections 
were also dual stained with a FITC linked antibody to either CD4 or CD8. They were 
then assessed using the confocal laser scanning microscope and processed using Leica 
TCS-NT software. The images were then analysed using Photoshop software to 
determine the percentage of dual positive cells, which represented the activated T cell 
population as explained in Chapter 2. Since previous work demonstrated very little or 
no lymphocyte infiltration into sham operated kidney, the contralateral kidney of a 
UUO animal and normal kidney, these tissues were not assessed. 
3.4.1.1 Activated CD69+ T cells in UUO kidney 
CD69 is one of the earliest cell surface antigens expressed by T cells following 
activation (Cosulich, Rubartelli et al. 1987). Once expressed, CD69 acts as a co-
stimulatory molecule for T cell activation.  Importantly, the expression of CD69 after 
lymphocyte activation is transient, lasting only for a matter of hours, and therefore the 
subsequent lack of CD69 staining does not imply that lymphocytes were not activated 
(Santis, Lopez-Cabrera et al. 1995). A PE labelled antibody to the CD69 antigen was 
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used which was excited at a wavelength of 488nm and emitted light once activated at 
578nm (Figure 3.14).  
Consistent with the immunohistochemical findings presented in Figure 3.4, 
immunofluoresent staining demonstrated increasing numbers of CD4+ and CD8+ 
cellular infiltrates at successive time points post obstruction and CD4+ T cells 
predominated in number over CD8+ cells at all three time points. When these 
lymphocytes were further examined for dual staining with CD69, a group of CD4+ and 
CD8+ cells were shown to stain positively for CD69 at all three time points post UUO. 
This suggested that a proportion of the total T cell infiltrate had been recently activated 
(Figures 3.15 and 3.16).  
There was an increase in the percentage of dual stained CD4+ cells between 3 and 7 
days of obstruction, and a subsequent fall in dual staining by day 10 . In the day 7 UUO 
kidney the mean percentage of dual stained CD4+ T cells, implying recent activation, 
was approximately 44%. There was a sequential significant increase in the percentage 
of dual stained CD8+ cells between 3, 7 and 10 days (p=0.0001), with approximately 
55% of all CD8+ cells being dual stained after 10 days of UUO. Interestingly the 
percentage of recently activated CD4+ T cells was significantly greater that the 
percentage of CD8+ cells 3 days after UUO (p=0.0023) but conversely after 10 days of 
obstruction there were significantly more recently activated CD8+ than CD4+ T cells 
(p=0.0178) (Figure 3.17). 
In order to demonstrate co-localisation of FITC and PE staining on an individual cell 
the confocal software assembled the image in an X-Z stack (Figure 3.18) and plotted the 
pixel colour of the region of interest on a cytofluorogram (Figure 3.19). It was not 
possible to perform these two analyses on each dual positive cell that was counted and 
so a random selection was examined in this way. In all the samples reviewed this 
confirmed that dual positivity was due to dual staining of the same cell, rather then two 
single positive cells stacked on top of one another. 
Isotype control antibodies labelled with FITC and PE confirmed there was no 
confounding non-specific antibody binding (Figure 3.20). Tubular epithelial cells 
demonstrated auto-fluorescence on non-stained sections. This was minimal and 
therefore no counter-stain was required however, it was useful for orientation within the 
section. 
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Both the FITC and PE fluorochromes were excited by the same blue argon laser at a 
wavelength of 488nm. The FITC labelled image was detected at around 520nm, whilst 
the PE labelled was detected at around 578nm. As illustrated in Figure 3.14, there was a 
possible area of crossover of emission between the two detection channels. It was 
important to minimise this to ensure only CD69 single positive cells were detected in 
the red 578mn channel and not also in the 520nm green channel and vice versa for FITC 
labelled cells. To guard against this the laser intensity and gain were adjusted and the 
detection range for a given fluorochrome was narrow. In order to review this, single 
staining of tissue sections was always performed and examined as a control. 
Furthermore the aim was to analyse sections that contained both single positive FITC 
and PE cells and dual positive cells to ensure the fluorochrome was detected in the 
correct channel. To maintain standardisation the detection wavelengths were constant 
throughout all the experiments.  
Figure 3.14- Fluorescence spectrum of the fluorochromes FITC and PE 
Both fluorochromes were excited by the same laser at 488nm, however the FITC 
labelled images were detected at around 520nm and the PE labelled images at around 
578nm. The two fluorescent spectrums do overlap and therefore there was a possible 
area of crossover of emission between the two detection channels. 
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Figure 3.15- Immunofluorescent dual staining of FITC labelled CD4+ cells and PE 
labelled CD69+ cells in the interstitium of the UUO kidney at three time points 
Dual staining with monoclonal antibodies conjugated to fluorochromes was carried out 
on UUO kidney. FITC was conjugated to the CD4 antibody (green cells) and PE to the 
CD69 antibody (red cells).  Dual stained cells were yellow (arrow). The number of 
infiltrating CD4+ cells increased with time post UUO and the percentage of dual 
positive cells peaked at day 7. At all time points single positive CD4 cells were seen and 
represented naive CD4+ cells (or previously activated CD4+ cells) whilst single positive 
CD69 cells were activated CD4- T cells (activated CD8+ cells). Magnification x63. 
             CD4FITC        CD69PE          CD4FITC + CD69PE 
Day 3  
   
Day 7  
   
Day10  
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Figure 3.16- Immunofluorescent dual staining of FITC labelled CD8+ cells and PE 
labelled CD69+ cells in the interstitium of the day 3, 7 and 10 UUO kidney  
Dual staining was performed on UUO kidney with monoclonal antibodies conjugated to 
fluorochromes. FITC was conjugated to the CD8 antibody (green cells) and PE to the 
CD69 antibody (red cells).  Dual stained cells were yellow (arrow). The number of 
infiltrating CD8+ cells increased with time post UUO and the percentage of dual 
positive cells peaked at day 10. At all time points single positive CD8 cells seen 
represented naive CD8+ cells (or previously activated CD8+ cells) whilst single positive 
CD69 cells were activated CD8- T cells (activated CD4+ cells). Magnification x63. 
                 CD8FITC       CD69PE           CD8FITC + CD69PE 
Day 3  
   
Day 7  
   
Day 10  
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Figure 3.17- Percentage of CD69+ T lymphocytes infiltrating UUO at 3, 7 and 10 
days after obstruction 
The number of single and dual positive CD4+ and CD8+ cells were quantified by 
examining between five and ten random non-overlapping HPFs at x63 magnification for 
each UUO kidney. The percentage of dual positive cells was calculated for each HPF 
and the mean percentage per HPF calculated for each mouse. Subsequently the mean 
percentage per HPF was calculated for the group of four mice at each time point.  
At all three time points CD4+ and CD8+ T cells were dual stained with CD69. The peak 
percentage of dual positive CD4+ T cells was found at day 7, when approximately 44% 
of CD4+ T cells were dual staining. In contrast there was a significant sequential 
increase in the percentage of dual stained CD8+ cells between day 3, 7 and 10 
(***p=0.0001), with approximately 55% of the population being dual stained at 10 days 
following UUO. The percentage of recently activated CD4+ T cells was significantly 
greater that the percentage of CD8+ cells at day 3 (*p=0.0023) and by day 10 there was 
a significantly higher proportion of recently activated CD8+ cells compared to 
CD69+CD4+ cells (**p=0.0178). 
Each group consisted of four animals with error bars depicting the standard error of the 
mean. 
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Figure 3.18- Immunofluorescent staining of FITC labelled CD8+ and PE labelled 
CD69+ cells in a region of interest in UUO kidney with an X-Z stack of that region  
Immunofluorescent staining was performed with FITC conjugated to the CD8 antibody 
(green cells) and PE to the CD69 antibody (red cells). Dual stained cells were yellow. 
To determine whether the dual staining was due to two single positive FITC+ and PE+ 
cells lying in the same X-Z plane, or whether the two cell surface fluorochromes co-
localised to the same cell, the confocal software assembled the image in the X-Z plane 
at the region of interest (ROI), the X axis shown in (a) and (b). FITC and PE staining 
was present at the same distance along the Z axis and overlapped on the merged image, 
illustrating the image was generated from a single activated CD8+ cell (c).  
(a) ROI: CD8FITC            (b) ROI: CD8FITC + CD69PE 
  
(c) X-Z stack of above ROI 
CD8FITC 
 
CD69PE 
 
Merge 
 
X axis 
Z axis 
Z axis 
Z axis 
X axis 
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Figure 3.19- Immunofluorescent dual staining of FITC labelled CD8+ cells and PE 
labelled CD69+ cells in a day 7 UUO kidney with a cytofluorogram of the ROI 
Immunofluorescent staining was performed using a FITC conjugated CD8 antibody 
(green cells) and PE conjugated CD69 antibody (red cells). When the two pictures were 
merged, dual staining produced yellow cells (a). The cytofluorogram is a graphical 
representation of the staining of each pixel in the ROI, on a plot of FITC (x axis) v PE 
(y axis) (b). As illustrated the predominant population of points lie equidistant between 
the X and Y axes, demonstrating that the majority of pixels were dual stained and co-
localised. Scale as shown. 
(a) ROI:CD8FITC                   ROI:CD69PE                  ROI:CD8FITC+ CD69PE                   
    
 
(b) Cytofluorogram 
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Figure 3.20- Immunofluorescent staining with FITC and PE labelled isotype 
control antibodies on day 7 UUO kidney and a section with no primary antibody  
Immunofluorescent staining was performed with FITC and PE labelled isotype controls 
to look for non-specific antibody binding ((a) and (b)). This demonstrated minimal 
background staining of the renal tubular epithelial cells and blood vessel walls. No 
infiltrating cells were stained showing that the monoclonal antibodies used to detect 
CD4+, CD8+ and CD69+ cells were specific. An unstained UUO kidney section was 
assessed using the 488nm excitation laser to examine for auto-fluorescence (c). The 
renal tubular epithelial cells did demonstrate minimal auto-fluorescence, which was 
useful for orientation within the section and therefore no counter-stain was required. 
Magnification x63. 
(a) FITC isotype control         (b) PE isotype control             (c) No primary 
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3.4.1.2 CD44+ memory T cells 
CD44 is a type I transmembrane glycoprotein expressed on the surface of numerous cell 
types including leukocytes, fibroblasts, epithelial and endothelial cells. It is a major 
receptor for the ubiquitous glycosaminoglycan component of extracellular matrix, 
hyaluronic acid, when in an activated state but has also been shown to be a receptor for 
other ligands (Lesley and Hyman 1992). T cell expression of CD44 differs according to 
the cell’s stage of differentiation and activation status. At early stages in lymphocyte 
development precursors in the thymus express high levels of CD44 but later during 
thymocyte development CD44 expression is down-regulated. Naive T cells in secondary 
lymphoid structures continue to be CD44 low. After T cell activation there is a rapid 
increase in CD44 cell surface expression, conversion of CD44 to its active form and 
hyaluronic acid binding. Memory T cells are typically CD44 high.  
It is believed that CD44 contributes to the regulation of T cell migration in two ways. 
Firstly, CD44 is important in helping T cell precursors to migrate into the thymus and 
therefore has a role in T cell development (Wu, Kincade et al. 1993). Secondly, CD44 
mediates the extravasation of mature activated T cells into areas of inflammation 
(DeGrendele, Estess et al. 1997). On other cell types CD44–hyaluronic interactions 
have been shown to mediate cell adhesion and migration (Lesley, Hyman et al. 1993).  
An APC labelled antibody to the CD44 antigen was used which was excited at a 
wavelength of 630nm and emitted light at 660nm. Since CD44 is expressed by many 
cells, CD44 staining was seen widely within the renal tissue. However, differentiation 
between naive lymphocytes which had low levels of CD44 expression and memory 
lymphocytes which had high CD44 expression was possible because the cells were dual 
labelled with antibodies to either CD4 or CD8.  
Ten days following UUO, populations of both CD4+ and CD8+ lymphocytes were 
found to be CD44+ (Figure 3.21) suggesting a population of activated lymphocytes with 
a memory phenotype. There was also a large number of cells which were only CD44+ 
and represented the numerous other cell types which display CD44. 
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Figure 3.21- Immunofluorescent dual staining of FITC labelled CD4+ or CD8+ 
cells and APC labelled CD44+ cells in the interstitium of day 10 UUO kidney  
Dual staining with monoclonal antibodies conjugated to fluorochromes was carried out 
on UUO kidney tissue at 10 days following obstruction. FITC was conjugated to the 
CD4 (a) and CD8 (b) antibodies (green cells) and APC to the CD44 antibody (blue 
cells).  When the two pictures were merged, dual stained cells became pale blue in 
colour. There were large amounts of lymphocyte negative CD44+ cell staining. 
However, there were populations of CD4+ and CD8+ lymphocytes which were CD44+, 
suggesting they were activated and had a memory phenotype (arrow). Magnification 
x63. 
(a) CD4FITC      CD44APC           CD4FITC + CD44APC 
Day 10 UUO kidney 
   
 
(b) CD8FITC      CD44APC          CD8FITC + CD44APC 
Day 10 UUO kidney 
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3.4.1.3 Proliferating Ki67+ T cells 
Ki67 is a nuclear antigen expressed on all proliferating cells during late G1, S, G2 and M 
phases of the cell cycle and is absent from resting cells in G0. Immunofluorescent 
staining was performed with a TRITC labelled antibody to the Ki67 nuclear antigen, 
which was excited at a wavelength of 560nm and emitted light at 578nm. 
This technique demonstrated there were very few CD4+ and CD8+ proliferating cells at 
day 3 following UUO however, by 7 and 10 days proliferating lymphocytes were seen 
(Figures 3.22 and 3.23). Adding a further nuclear stain, DAPI, allowed improved 
localisation of the cells within the tissue architecture, especially the Ki67 negative cells 
(Figure 3.24). At all time points some of the Ki67+ cells identified were CD4- and 
CD8- when serial sections were reviewed. A number of these proliferating cells co-
localised to tubular epithelial cells, identified by their auto-fluorescence (Figure 3.25). 
Alternative explanations for these cells may be an unconventional population of 
proliferating double negative T cells, of the type described by Rabb et al in normal 
mouse kidney (Ascon, Ascon et al. 2008), or a proliferating population of macrophages. 
At day 10 following UUO the mean percentage of proliferating CD4+ cells were 33% 
and dual positive CD8+ cells 22%, which was not significantly different (p=0.3611) 
(Figure 3.26).  
As explained for the fluorochromes FITC and PE, there was a risk of detecting emission 
from one fluorochrome in the detection channel of the other fluorochrome due to 
overlapping of the two emission spectra. This was also the case for the two 
fluorochromes used here, FITC and TRITC therefore similar precautions were taken to 
minimise this as explained earlier.  
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Figure 3.22- Immunofluorescent dual staining of FITC labelled CD4+ and TRITC 
labelled Ki67+ cells in the interstitium of the UUO kidney at three time points  
Dual staining with monoclonal antibodies conjugated to fluorochromes was carried out 
on UUO kidney tissue at 3, 7 and 10 days following obstruction. FITC was conjugated 
to the CD4 antibody (green cells) and TRITC to the Ki67 antibody (red nuclear 
staining).  Dual labelled cells were seen at all three time points post obstruction, 
demonstrating CD4+ lymphocyte proliferation (arrow). Magnification x63. 
 CD4FITC                               Ki67TRITC                     CD4FITC + Ki67TRITC   
Day 3 
   
Day 7  
   
Day 10  
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Figure 3.23- Immunofluorescent dual staining of FITC labelled CD8+ and TRITC 
labelled Ki67+ cells in the interstitium of day 3, 7 and 10 UUO kidney 
Dual staining with monoclonal antibodies conjugated to fluorochromes was performed 
on UUO kidney tissue. FITC was conjugated to the CD8 antibody (green cells) and 
TRITC to the Ki67 antibody (red nuclear staining).  The number of infiltrating CD8+ 
cells increased with time post obstruction however, were fewer in number that the 
CD4+ population. Dual labelled cells were seen at all three time points post UUO, 
demonstrating CD8+ cell proliferation (arrow). Magnification x63.   
 CD8FITC                             Ki67TRITC                       CD8FITC + Ki67TRITC 
Day 3  
   
Day 7  
   
Day 10  
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Figure 3.24- Immunofluorescent triple staining of FITC labelled CD4+ cells, 
TRITC labelled Ki67+ cells and DAPI in UUO kidney at 7 days post obstruction 
Immunofluoresent staining of a day 7 UUO kidney using FITC labelled CD4 (green 
cells) and TRITC labelled Ki67 (red nuclear staining) antibodies, with DAPI (blue 
nuclear staining). Proliferating and non-proliferating CD4+ cells were demonstrated 
along with proliferating CD4- cells. DAPI staining provided better localisation of the 
non-proliferating CD4+ cells. Magnification x63. 
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Figure 3.25- Immunofluorescent staining with a TRITC labelled antibody to Ki67 
demonstrating proliferating tubular epithelial cells in the day 10 UUO kidney  
Immunofluorescent staining with the nuclear Ki67 antigen conjugated to the TRITC 
fluorochrome was carried out alone. Auto-fluorescence allowed localisation of the 
tubular epithelial cells, some of which were Ki67 positive and therefore proliferating 
(arrow). Magnification x63. 
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Figure 3.26- Number of proliferating CD4+ and CD8+ T cells at 10 days post UUO  
The number of single and dual positive CD4+ and CD8+ cells was quantified by 
analysing between five and ten random non-overlapping HPFs of day 10 UUO kidney, 
for a group of four mice. The total numbers of single and dual positive cells were 
counted for each HPF and the mean number per HPF calculated for each mouse. 
Subsequently the mean number per HPF was calculated for the group of four mice. 
There was a non-significant difference in the mean percentage of proliferating CD4+ 
and CD8+ cells at 10 days post obstruction, where 33% of the CD4+ cells and 22% of 
the CD8+ cells were Ki67+ (p=0.3611). 
Each group consisted of four mice with error bars depicting the standard error of the 
mean. 
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3.5 Discussion 
The role of the inflammatory infiltrate into the tubulointerstitium after a non-
immunologically mediated injury like UUO is unknown and therefore this chapter set 
out to determine whether T lymphocytes may be playing a role in propagating 
progressive renal injury. Work using the UUO model by Shappell et al demonstrated 
that in severe combined immunodeficient mice there was no difference in injury seen 
after UUO compared to that induced in wild-type mice also subjected to the same 
method of injury (Shappell, Gurpinar et al. 1998). SCID mice have no mature T and B 
cells due to a variety of gene defects which impair the joining of coding sequences 
during VDJ recombination and prevent the production of the TCR and immunoglobulin. 
This work suggested that lymphocytic infiltrate was not required for progressive tubular 
injury and development of fibrosis in the UUO model. They speculated that the 
prominent macrophage infiltrate into the tubulointerstitium after UUO, independent of 
lymphocytes, may contribute to the progressive renal injury seen. Alternatively they 
suggested neither mononuclear cell type were involved and that ‘fibrogenic factors’, 
produced by damaged tubular epithelial cells, may induce fibrosis.  
Work by other groups, including my own, produced contradictory findings to those of 
Shappell. Harris et al irradiated rats which then underwent ureteric obstruction (Harris, 
Schreiner et al. 1989). They demonstrated that irradiation abolished leukocyte 
infiltration post obstruction and improved post obstruction renal function compared to 
non-irradiated rats. Obstruction was only maintained for 24 hours, so better post-
obstruction renal function after irradiation was unlikely to be caused by the 
development of less renal fibrosis but due to less acute inflammation causing acute 
tubular injury. Infiltration of both lymphocytes and macrophages was abolished in this 
model and so the cell type contributing to renal dysfunction was unclear.  
However, my own group carried out work on recombinant arrangement gene-I knock 
out mice which underwent 14 days of UUO and found significantly less renal injury in 
the RAG-I KO mice than in wild-type UUO controls (Tapmeier, Fearn et al. 2010). 
Furthermore, by reconstituting these knockout mice with lymphocytes, injury was seen 
at the same level as that in the wild-type mice which had undergone UUO. In a further 
experiment RAG-1 KO mice reconstituted with CD4+ T cells, but not CD8+ 
lymphocytes, had significantly greater tubulointerstitial injury than RAG-1 KO mice 
injected with PBS after renal obstruction. This suggested that lymphocytes do play a 
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role in the progressive fibrotic injury of UUO and CD4+ cells may be the predominant 
T lymphocyte subclass. 
There is also evidence from the work on the mouse UUO model by Niedermeier et al 
demonstrating that the differentiation and development of fibrocytes (haematopoietic 
cells which produce collagen I and contribute to fibrosis) are critically dependent upon 
CD4+ T cells (Niedermeier, Reich et al. 2009). Importantly the context in which T cells 
develop determines whether fibrocyte development is supported or inhibited. In vivo 
depletion of CD4+ cells, either by using T cell deficient SCID mice or antibodies, 
resulted in less CD4+ cells and less fibrocytes in the UUO kidney. There was also a 
positive correlation between the number of infiltrating fibrocytes and the degree of renal 
fibrosis in the obstructed kidney and they demonstrated that the cytokine environment 
in which the T cells developed was important. In vitro the presence of calcineurin 
inhibitors, activated CD4+ T cells allowed fibrocyte differentiation. This was 
hypothesised to be because of soluble pro-fibrotic factors e.g. TGF-β that were 
generated and a decrease in anti-fibrocyte factors e.g. IL-2, TNF and IFN-γ mediated by 
the calcineurin inhibitor. 
Together the results from the groups led by Harris, Tapmeier and Niedermeier directly 
contradict those from the work in SCID mice by Shappell, demonstrating T cell 
involvement is pivotal to injury. These differences may have been due to the different 
strains of mouse used or their genetic backgrounds (Puri, Shakaib et al. 2010). 
Since the above literature suggested that T lymphocytes play a critical role in promoting 
renal damage by the non-immunologically mediated injury of ureteric obstruction, my 
initial task was to determine whether there was a definite T cell infiltrate post 
obstruction and to characterise the phenotype of this infiltrate. This would allow me to 
determine whether these lymphocytes were capable of performing effector functions 
which could include promoting renal fibrosis. 
My initial work carried out on UUO mice demonstrated a progressive increase in the 
number of mononuclear cells into the tubulointerstitium with increasing time after the 
non-immunologically mediated obstructive injury. The T cell infiltrate consisted of 
more CD4+ than CD8+ cells at each of the three time points, along with macrophages. 
The numbers of infiltrating cells post UUO were significantly greater than in the 
contralateral kidney of a UUO animal or in the kidney of an unmanipulated animal. The 
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progressive cell infiltration correlated with fibrotic renal injury, suggesting a causal 
relationship. 
The next series of experiments established the T lymphocyte infiltrate was not a naive T 
cell population but that populations of both CD4+ and CD8+ T cells demonstrated an 
activated effector phenotype with CD69 positivity. A population of both CD4+ and 
CD8+ T cells in the UUO kidney were also shown to be proliferating, as demonstrated 
by staining for the nuclear proliferation marker Ki67. This effector T cell population 
was found especially at the later time points following 7 and 10 days of obstruction and 
certain T lymphocytes were shown to have a memory phenotype. Chapman et al 
demonstrated that recruitment of primed T cells into a site of infection is antigen 
independent. However, for T cells to carry out effector functions they must recognise 
antigen and be activated and proliferating (Chapman, Castrucci et al. 2005). My work 
showed that infiltrating T cells had effector function and therefore if conventional 
immunological mechanisms were to hold true the effector T cells must have recognised 
antigen. They would also be theoretically capable of contributing to the fibrotic renal 
injury seen in these animals. 
If naive T cells were activated by UUO injury then the process of T cell activation and 
proliferation should take some days to develop and generate significant numbers of cells 
within the renal tubulointerstitial space. This would be consistent with my findings of 
increasing numbers of activated cells between 3 and 7 days. Time is required for the 
numerous processes needed for classical T cell activation to occur: 
• Naive T cells must be attracted to the area of inflammation by a chemokine 
gradient established by the UUO injury and circulate between the tissue and 
draining lymph node 
• Dendritic cells or other APCs must be activated to become professional APCs, 
with a loss of their phagocytic properties and increase in co-stimulatory 
molecules on their surface (Dong, Swaminathan et al. 2005) 
• Dendritic cell must process antigen and present it with MHC on the DC cell 
surface 
• T cells must then recognise the peptide-MHC complex on the DC cell surface 
and with co-stimulation become activated 
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• Activated T cells must then traffic back into the injured kidney from the draining 
lymph node to carry out their effector functions, which may involve contributing 
to renal injury 
It would have been interesting to look at earlier time points, before 3 days of 
obstruction. This would have allowed me to confirm that the development of a 
population of activated T cells within the UUO interstitium takes days rather than hours 
to develop. Certainly my experiments demonstrated very few mononuclear cells in the 
tubulointerstitium after 3 days of obstruction and this would suggest that the 
development of the effector population takes days to achieve. If significant numbers of 
activated T cells were found at much earlier time points, possibly even within hours of 
obstruction, this would suggest that they were not activated de novo by traditional 
immunological methods. One possible explanation for the presence of activated 
lymphocytes within hours of injury could be that a naive population of T cells was 
activated independent of antigen, which has been described (Rodriguez-Iturbe, Pons et 
al. 2001).  
An alternative explanation for the presence of activated T cells before 3 days of renal 
obstruction could be that they were lymphocytes which were activated elsewhere in the 
body in response to an unassociated foreign antigen. Subsequently these activated 
lymphocytes were attracted to the area of obstructive injury by the chemokine gradient 
developed by renal cells in response to the increased pressure and ischaemia generated 
post ureteric obstruction. One possible source would be an activated lymphocyte 
population residing within the gut, which had been activated by recognition of gut 
pathogens. If this was the explanation then the infiltrating population would 
demonstrate an activated effector phenotype from the outset rather than the population 
progressively developing effector functions, as I have shown. 
Resident renal α:β T cells are present within normal kidney (Ascon, Ascon et al. 2008) 
and Dong et al described a resident population of memory cells within normal kidney 
prior to UUO injury (Dong, Bachman et al. 2008). If these memory cells were re-
exposed to their cognate antigen during UUO injury, they would be more rapidly 
activated than a population of naive T cells presented with antigen for the first time 
however, even this process would take some hours/days. 
Interestingly, from the three time points I investigated post obstruction the peak time at 
which CD4+ and CD8+ cells became activated differed. There was a significantly 
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higher percentage of activated CD4+ cells at the earlier time points but significantly 
higher percentage of activated CD8+ cells at the latest time point of day 10 (p<0.05). In 
order for naive CD8+ T cells to become armed effector cells they require more co-
stimulation that CD4+ T cells. This requirement can be met by either dendritic cells, 
activated CD4+ T cells or a combination of both. Mature dendritic cells have the highest 
co-stimulatory capacity of all APCs and are able to activate CD8+ T cells directly. 
However, some CD8+ cells still require the presence of effector CD4+ T cells during 
the priming of the naive CD8+ cell, which helps to activate the APC to produce higher 
levels of co-stimulatory activity. Once CD4+ cells are activated, the CD40 ligand on the 
T cell binds CD40 on the APC. This in turn induces further B7 expression on the APC 
and more co-stimulation, allowing CD8+ cell activation and production of IL-2. This 
occurs only when both the naive CD8+ cell and the activated CD4+ cell recognise 
related antigens on the surface of the APC. Assuming the lymphocytic infiltrate in UUO 
contributes to renal injury, then my data would be consistent with a mechanism by 
which naive CD4+ and CD8+ cells are activated in response to antigen exposure but 
that CD8+ T cell take longer to be activated due to the need for activated CD4+ T cell 
help.  
My work suggests that as a consequence of the non-immunologically mediated 
obstructive injury to the kidney, T cells are capable of infiltrating obstructed kidney and 
demonstrate a phenotype which would be capable of initiating and promoting renal 
fibrotic injury. The postulated mechanisms by which activated T lymphocytes may 
propagate destructive renal fibrosis after UUO have been discussed, along with 
suggestions regarding which sub-groups of CD4+ lymphocyte may be involved. There 
was also a strong correlation between the progressive increase in macrophage number 
with increasing time of ureteric obstruction and destructive injury. As previously 
discussed macrophages have the potential to synthesise molecules which could 
contribute to renal injury and I postulate are most likely to work with and along side 
lymphocytes to cause fibrosis in the obstructed kidney. B cells and neutrophil 
infiltration was not assessed as previous literature had not found significant cellular 
infiltration by these cell types after UUO (Schreiner, Harris et al. 1988). 
There are a number of technical issues that merit discussion from this chapter including 
the use of the monoclonal antibodies to F4/80 antigens to characterise macrophages and 
CD44 antigens to identify memory lymphocytes, along with the methods by which renal 
injury was assessed. The most widely used marker for macrophage identification in 
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mice in the literature is the cell surface antigen F4/80. However, there have been reports 
of the F4/80 antigen being present on a subpopulation of dendritic cells and so the 
infiltrating F4/80+ cells in the obstructed kidney in my experiments may not have been 
only macrophages but also dendritic cells (Kruger, Benke et al. 2004; Dong, Bachman 
et al. 2008). The morphology of F4/80+ cells has been used by some groups to further 
determine the cell type.  Many investigators have also demonstrated a significant 
resident F4/80+ population in normal murine kidney tissue. The lack of staining in the 
control normal, contralateral and sham kidneys I reviewed was likely to reflect issues 
with the F4/80 antibody concentrations or the tissue fixation methods used. The role and 
function of the F4/80 antigen on the macrophage is unknown but may play a role in 
adaptive immunity and tolerance induction and has been characterized as a member of 
the epidermal growth factor (EGF)-transmembrane 7 (TM7) family (van den Berg and 
Kraal 2005). 
In order to assess whether the infiltrating T cells demonstrated a memory phenotype, 
immunofluorescent staining with an antibody specific for the CD44 antigen was 
performed. CD44 is expressed on the surface of many cells types and therefore staining 
for CD44 antigen was seen widely within renal tissue. I was able to distinguish CD44+ 
lymphocytes from other cell types by the dual labelling technique I used. However, 
there is a spectrum of CD44 expression by T cells termed low, intermediate and high 
which was more difficult to distinguish by the immunofluorescent staining techniques I 
used, than when using an antibody to CD44 in flow cytometry. By immunofluorescence 
I should have been able to differentiate between naive lymphocytes which were CD44 
low and memory lymphocytes which had high CD44 expression. I was less confident 
that I was able to distinguish between activated cells that were intermediately 
expressing effector and highly expressing memory CD44 lymphocytes. On balance, this 
distinction was not critical since the aim of this work, which I successfully showed, was 
to demonstrate the presence of a population of activated lymphocytes which had the 
potential to contribute to the fibrotic tissue injury seen in UUO. 
In assessing renal injury both percentage interstitial expansion and immunochemical 
staining for α-SMA and collagen I were used. Initially interstitial expansion alone was 
used as a marker for renal injury but expansion may have been due to interstitial 
oedema caused by injury rather than the interstitial space being expanded by activated 
fibroblasts or extracellular matrix. Subsequently α-SMA staining and collagen I 
deposition correlated with the areas of interstitial expansion. Furthermore, with 
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increasing time after obstructive injury more fibroblasts were activated and fibrotic 
interstitial matrix deposited, signifying progressive fibrotic renal damage, which 
correlated with progressive lymphocyte infiltration. 
In this chapter I have demonstrated that activated and proliferating T cells were present 
within the mononuclear cell infiltrate following ureteric obstruction which could 
potentially play an active role in promoting the fibrotic injury seen in UUO kidney. 
 136 
Chapter 4. Repertoire of T cell receptor Vbeta gene segment usage in 
the normal and UUO kidney 
 
4.1. Introduction 
In both archetypal autoimmune diseases in humans and experimentally induced 
autoimmune diseases in animals, T cell clones have been demonstrated that have the 
same T cell receptor and therefore recognise the same antigenic epitope. In order to 
investigate this in the UUO model, the functional gene segments which combine to 
form the TCR were analysed in the population of infiltrating T cells. 
In the late 1980’s analysis of the TCR variable region in autoimmunity led to the ‘V 
region hypothesis’ that suggested recognition of a single epitope of an autoantigen 
resulted in the clonal expansion of a population of auto-reactive T cells which caused 
disease (Urban, Kumar et al. 1988; Kumar, Kono et al. 1989). Much of this work was 
carried out in the experimental allergic encephalitis model but subsequent work in both 
animals and humans suggested that the T cell repertoire was not as tightly restricted as 
was initially suggested and multiple populations of T cells developed in response to a 
number of antigenic epitopes. Work on immunologically mediated renal diseases such 
as systemic lupus erythematosus (Massengill, Goodenow et al. 1998) and Sjogrens 
(Murata, Kita et al. 1995) demonstrated a restricted repertoire of TRVβ gene segments 
expressed by infiltrating renal T cells compared to peripheral lymphocytes. Also 
oligoclonality was demonstrated by sequence analysis of the VDJ region, supporting the 
‘V region hypothesis’.  
The murine model of anti-tubular basement membrane disease, which produces a T cell 
mediated interstitial nephritis, is induced by inoculation of renal tubular antigen in 
Freud’s adjuvant. When Heeger’s group used this model of AID they initially 
demonstrated TRVβ restriction in the T cell population and common amino acids when 
sequencing across the CDR3 region (Heeger, Smoyer et al. 1994; Heeger, Smoyer et al. 
1996). This suggested that a restricted TRVβ repertoire of T cells was activated after 
recognition of the immunodominant epitope contained within the target antigen. 
However, they also found that with more advanced disease a heterogeneous population 
of T cells developed with a diverse TRVβ repertoire and CDR3 sequences. This 
suggested that after initial clonal T cell immune responses to a specific target antigen, a 
more heterogeneous T cell response developed with ongoing injury, where T cells 
recognised multiple antigenic epitopes by a process termed epitope spreading. 
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In this chapter I examine the T cell response during the first month of UUO injury. 
Using PCR I will determine whether there is over expression of a particular TRVβ gene 
segment in the UUO kidney compared to the spleen. If selective expansion of one 
TRVβ gene segment is demonstrated this would provide support for the hypothesis that 
antigen-dependent T cell activation may be occurring in the UUO model with the loss 
of immunological tolerance. However, over expression of a TRVβ gene segment in the 
UUO kidney would not be definitive proof for clonal proliferation since the other two 
gene segments and junctional diversity within the β-chain are unknown. It is also 
unlikely that one single clone of T cells would develop in response to UUO because of 
the phenomenon of epitope spreading however, by looking early in the disease process I 
postulate there would be restricted T cell responses to fewer antigenic epitopes.  
Unmanipulated kidney and spleen in control mice and the contralateral kidney in a 
UUO mouse were also examined to determine the expression of the TRVβ gene 
segments. This allowed comparison to the normal T cell repertoire in mice. 
4.2. The β-chain of the mouse T cell receptor 
As outlined in Chapter 1, the β-chain of the TCR consists of a constant and variable 
region. The variable region consists of the V, D and J gene segments. In the mouse there 
are twenty two functional TRVβ gene segments however, just one is used by any T cell 
to create combinational diversity. More than twenty two TRVβ gene segments are 
recognised but the other sequences are non-functional and either pseudogenes or open 
reading frame sequences (orfs). The gene segments are numbered as outlined in Table 
4.1 that compares the corresponding IMGT and Arden nomenclature classifications 
(Arden, Clark et al. 1995; Giudicelli, Chaume et al. 2005). 
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Table 4.1- IMGT and Arden classifications of the functional and non-functional 
TRVβ gene segments in the mouse 
The correlation between the nomenclature of the IMGT and Arden classifications for 
TCR β-chain sequences in the mouse are illustrated below for functional and non-
functional gene segments. Two gene segments in the IMGT classification were not 
recognised by Arden’s group. 
 
Functional genes Pseudogenes Orfs 
IMGT = Arden IMGT = Arden IMGT = Arden 
1 2.1 6 26.1 21 19.1 
2 4.1 7 * 22 22.1 
3 16.1 8 28.1   
4 10.1 9 24.1   
5 1.1 10 25.1   
12.1 5.2 11 29.1   
12.2 5.1 12.3 5.3   
13.1 8.3 18 23.1   
13.2 8.2 25 21.1   
13.3 8.1 28 31.1   
14 13.1     
15 12.1     
16 11.1     
17 9.1     
19 6.1     
20 *     
23 20.1     
24 17.1     
26 3.1     
29 7.1     
30 18.1     
31 14.1     
* Not recognised 
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4.3. Lymphocytes in the UUO kidney 
To investigate the possibility of clonal proliferation of T cells within the UUO animal I 
looked at the relative expression of the twenty two TRVβ gene segments in the UUO 
kidney compared to spleen. If I could demonstrate relatively greater expression of a 
particular TRVβ gene segment in the kidney of that animal, this could suggest a clonal 
population of T cells had developed in the kidney expressing that particular TRVβ. This 
would allow me to explore the hypothesis that T cells were recruited into injured kidney 
because they recognised and responded to auto-antigen, representing a break in self-
tolerance. Animals at different time points post UUO and controls were sacrificed and 
their organs perfused. The kidney and spleens were harvested and snap frozen prior to 
RNA extraction. 
 
4.4. PCR optimisation 
PCR was used to assess the relative expression of each TRVβ gene segment. In each 
reaction one of the twenty two forward primers was used, each of which annealed to one 
of the twenty two TRVβ gene segments on the antisense strand of DNA, with the same 
reverse primer annealing to the constant region on the sense strand of DNA. The 
conditions were optimised for standard and real time PCR to ensure accuracy of the 
results and exclude differences in PCR efficiency between different primer pairs. 
 
4.4.1. RNA purity and integrity 
Total RNA was extracted from mouse kidney and spleen tissue. The purity and integrity 
of all extracted RNA samples were tested by UV spectrophotometry and 
electrophoresis. These tests were carried out to ensure the RNA was not contaminated 
by genomic DNA or protein and had not degraded. 
Figure 4.1(a) illustrates an assessment of RNA purity for one sample using the UV 
spectrophotometer, where an A260/A280 ratio of 2.0 is characteristic of pure RNA. 
Running total RNA on an agarose gel stained with ethidium bromide demonstrated two 
sharp, clear ribosomal RNA bands at 28S (4.8kb) and 18S (1.8kb) confirming integrity 
(Figure 4.1(b)). The mRNA appears as a smear from 6kb to 0.5kb and generally makes 
up only between 1-5% of the total cellular RNA. Each RNA sample was assessed in this 
way and if the A260/A280 ratio was <1.8 the sample was not used. 
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Figure 4.1- Assessment of RNA purity and integrity  
An UV spectrophotometer trace is seen in panel (a) for a sample of extracted RNA, 
where the calculated A260/A280 ratio for the sample was 2.07, demonstrating pure RNA 
which was not contaminated by genomic DNA or protein. The agarose gel (b) shows the 
RNA sample could be separated into two sharp, clear ribosomal RNA bands 28S 
(4.8kb) and 18S (1.8kb) so there was no evidence of RNA degradation. 
 
(a) Spectrophotometer trace    (b) Agarose gel 
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4.4.2. Polymerase chain reaction 
The primer sequences used throughout this thesis to assess the TRVβ gene segment 
repertoire had previously been validated in experimental cardiac allograft recipients in 
mice (Hu, Watson et al. 2008). 
 
4.4.2.1. Determining the presence of the primer sequences within the TRVβ gene 
segments and the lengths of the PCR products generated 
Using the ImMunoGeneTics database (http://imgt.cines.fr/) the presence of the 
appropriate primer annealing sequences were confirmed in each of the twenty two 
functional TRVβ gene segments and TRCβ gene. The sequences for the functional 
TRDβ and TRJβ gene segments were also reviewed. 
To establish the relative and approximate lengths of the PCR products generated by the 
twenty two TRVβ primer pairs, the same TRDβ1 and TRJβ1-2 gene segments were 
used in each theoretical sequence to allow comparison (Figure 4.2). The lengths of the 
twenty two PCR products varied between 185 and 216bp. These theoretical PCR 
product lengths do not take into account junctional diversity which is unique to each 
TCR. In practice when real TCR β-chain sequences were reviewed which had junctional 
diversity, a shorter PCR product was generated than when complete gene segments 
were combined theoretically. 
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Figure 4.2- Hypothetical section of a single strand of DNA from a TCR β-chain 
demonstrating the gene segments involved and annealing sites for the PCR primers  
The figure illustrates a hypothetical TCR β-chain, where the TRVβ3 gene segment 
combines with the complete TRDβ1 (highlighted blue), TRJβ1-2 (highlighted green) 
and Cβ gene segments to create a nucleotide sequence without junctional diversity. The 
forward primers used for the PCR reactions annealed to a sequence on one of the twenty 
two TRVβ gene segments on the antisense strand and the reverse primer to a sequence 
on the sense DNA strand within the constant gene segment, which was the same for all 
the PCR reactions. For this sequence the locations of the primer annealing sites in either 
this or the complimentary strand of DNA are highlighted in bold type. The complete 
TRVβ3 and TRCβ gene segments are not shown. The length of PCR product generated 
from this reaction would be 186bp. 
 
5’ 
[-TRVβ3 primer site on antisense strand-]            
------------TRVβ3 gene segment-------------------------------------------][-TRDβ1-                 
CACTGGAGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTTAGCGGGACA 
 
------------][---------------------------------- TRJβ1-2--------------------------------------- 
GGGGGCCAAACTCCGACTACACCTTCGGCTCAGGGACCAGGCTTTTGGTA 
 
-------][--------------------------------------- TRCβ1----------------------------------------- 
ATAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCC 
 
                                        [-TRCβ primer site on this sense chain-] 
------------------------------------------------------------------------------- 
ATCAAAAGCAGAGATTGCAAACAAACAAAAGGCTACC                               3’ 
 
TRVβ3 primer 5’- CACTGGAGGACTCAGCTGTGTACT -3’ 
TRCβ primer  5’- GGTAGCCTTTTGTTTGTTTGCAA -3’ 
 
 
 
 
 
 
 
 
 143 
4.4.2.2. Standard PCR with TRVβ primers 
Standard PCR reactions were carried out using the twenty two specific Vβ primer pairs 
under identical conditions using reverse transcribed RNA and the PCR products were 
separated by agarose gel electrophoresis. This demonstrated standard PCR was able to 
amplify product of an appropriate size (approximately 200bp) (Figure 4.3 (a)). A 
GAPDH primer pair was used for comparison which generated product of the 
appropriate size (453bp). Control PCR reactions were performed with no template DNA 
to provide evidence of no contamination (Figure 4.3(b)). 
 
Figure 4.3- PCR products separated by agarose gel electrophoresis generated using 
the twenty two TRVβ primers pairs (a) with and (b) without reverse transcribed 
RNA from whole spleen 
Standard PCR reactions were carried out using each of the twenty two pairs of TRVβ 
primers on reverse transcribed RNA from whole spleen tissue (a) and the products 
separated by agarose gel electrophoresis, demonstrating a product of the appropriate 
size for all reactions. The gel in (b) demonstrates that no PCR products of the predicted 
size were generated when no cDNA was added to the reactions and excluded 
contamination. 
 
(a) 
 
(b) 
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4.4.2.3. Real time PCR optimisation of primer and probe concentrations                  
It was clear from the standard PCR reactions that the primer pairs were able to amplify 
the template DNA. However a FAM labelled probe was also now required for Taqman 
real time PCR. Therefore the primer and probe concentrations along with the annealing 
temperature had to be optimised. For varying primer and probe concentrations the 
reactions were run in triplicate and the Ct value for each reaction derived. This 
optimisation was performed using the primer pair which specifically annealed to 
TRVβ1 and TRCβ. 
For a given amount of starting cDNA with the annealing temperature set at 56.5 ºC, Ct 
values were calculable only when the probe concentration was set to ≥ 300nM. With 
increasing concentrations of probe beyond 300nM there was little change in the Ct 
value (Table 2.9 (a)), so a probe concentration of 300nM was used. Increasing 
concentrations of the primer pair were used for a given amount of starting DNA and 
fixed annealing temperature, with 300nM of probe. There was no change in the Ct value 
when the final primer concentrations were increased beyond 600nM (Table 2.9 (b)). 
From the results of these optimisation experiments all real time PCR experiments were 
preformed with a probe concentration of 300nM, primer concentration of 600nM and 
the annealing temperature was set to 56.5 ºC. 
4.4.3. Efficiency calculations 
If all the primer pairs had comparably high amplification efficiencies then any 
differences in the number of cycles required to generate a given fluorescent intensity (Ct 
value) must be related to the amount of starting template DNA. This would then allow 
calculation of the relative expression of each TRVβ gene segment in UUO kidney and 
spleen.  
The amplification efficiencies for all twenty two TRVβ primer pairs were calculated to 
ensure they were comparable and highly efficient. This was performed using real time 
PCR using the method shown in section 2.6.4. The results of these methodological 
experiments are pivotal to all the subsequent work in this thesis so two examples from 
the twenty two efficiency reactions are illustrated here for the TRVβ3-TRCβ and 
TRVβ12.2-TRCβ primer pairs. To calculate the primer efficiencies, PCR reactions were 
run in triplicate with 5-fold serial dilutions in the template DNA. If a PCR reaction was 
100% efficient then after completing one cycle of PCR the amount of template DNA 
would double and the calculated efficiency for that reaction would be 2. 
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4.4.3.1. Calculating the efficiency of the TRVβ3 and TRCβ primer pair 
Using the primer pairs TRVβ3 and TRCβ under standard conditions the slope of the Ct 
v Log [DNA] graph was calculated to be -3.42 +/- 0.09 (Figure 4.4). The efficiency of 
the PCR reaction generated from the slope was 1.96 or 96% with an R² value of 0.99. 
 
Figure 4.4- Efficiency calculation for the TRVβ3–TRCβ primer pair using the Ct 
slope method 
The line of best fit for the scatter plot of Ct v Log [DNA] was determined by linear 
regression analysis. This was used to calculate the efficiency of the TRVβ3 and TRCβ 
primer pair, which was 96%.  
 
(a) Mean Ct value calculated using five triplicate cDNA concentrations 
TRVβ3            
Log DNA 
Concentration 
Ct v1 Ct v2 Ct v3 Mean 
Ct    
3.2553 26.17 26 25.97 26.05    
2.5563 29.18 28.89 29.5 29.19    
1.8573 30.19 31.91 31.98 31.36  slope -3.42 
1.1584 33.59 34.2 33.2 33.66  1/slope -0.29 
0.4594 35.93 35.97 35.37 35.76  R
2
 0.99 
0 0 0 0 0  E 1.96 
 
(b) Standard curve of mean Ct v Log cDNA concentration (ng/µl) from which the slope 
of the curve and the efficiency of the reaction was calculated 
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4.4.3.2. Calculating the efficiency of the TRVβ12.2 and TRCβ primer pair 
Using the primer pairs TRVβ12.2 and TRCβ under standard conditions the slope of the 
Ct v Log [DNA] graph was calculated to be -3.50 +/- 0.06 (Figure 4.5). The efficiency 
of the PCR reaction generated from the slope was 1.93 or 93% with an R² value of 1.00. 
 
Figure 4.5- Efficiency calculation for the TRVβ12.2–TRCβ primer pair 
The line of best fit for the scatter plot of Ct v Log [DNA] was determined by linear 
regression analysis. This was used to calculate the efficiency of the TRVβ12.2 and 
TRCβ primer pair, which was 93%.  
 
(a) Mean Ct value calculated using five triplicate cDNA concentrations 
TRVβ12.2        
Log DNA 
Concentration 
Ct v1 Ct v2 Ct v3 Mean 
Ct    
3.2553 29.61 30.07 29.25 29.64    
2.5563 32.7 32.16 32.95 32.60    
1.8573  34.7 34.89 34.80  slope -3.50 
1.1584 37.43 37.49 37.11 37.34  1/slope -0.29 
0.4594 39.12 39.-5 39.9 39.51  R
2
 1.00 
0 0 0 0 0  E 1.93 
 
(b) Standard curve of mean Ct v Log cDNA concentration (ng/µl) from which the slope 
of the curve and the efficiency of the reaction was calculated 
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4.4.3.3. Summary of primer efficiencies 
For the twenty two primer pairs the median primer efficiency was equal to 1.94 or 94%. 
The range of efficiencies was 1.87 - 2.07 or 87% – 107%. The median R² value was 
0.99, with a range of 0.93 – 1.00 (Table 4.2). Both these median parameters fall within 
the accepted range for primer efficiency as quoted by multiple commercial technology 
companies including Stratagene and Applied Biosystems. They suggest the slope of the 
Ct v Log [DNA] plot should be -3.3 +/- 10%, generating an efficiency of 100% +/- 
10%. Almost all the efficiencies of the 22 primers pairs fell within this acceptable range. 
 
Table 4.2- Comparison of all twenty two TRVβ primer pair efficiencies 
Efficiencies and R² values for the TRVβ primer pairs calculated from Ct v Log [DNA]. 
TRVβ primer Slope Efficiency (%) R2 
1 -3.41 97 0.99 
2 -3.24 104 0.99 
3 -3.42 96 0.99 
4 -3.27 102 0.98 
5 -3.51 93 0.99 
12.1 -3.46 95 0.93 
12.2 -3.50 93 1.00 
13.1 -3.60 90 0.97 
13.2 -3.25 103 1.00 
13.3 -3.27 102 0.98 
14 -3.48 94 0.99 
15 -3.16 107 0.98 
16 -3.42 96 0.99 
17 -3.57 91 0.98 
19 -3.69 87 1.00 
20 -3.24 103 0.99 
23 -3.50 93 0.99 
24 -3.60 89 1.00 
26 -3.47 94 1.00 
29 -3.43 96 1.00 
30 -3.68 87 0.99 
31 -3.54 92 0.98 
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4.5. Relative expression of TRVβ gene segments by lymphocytes in kidney and 
spleen of normal and UUO animals 
Unmanipulated mice and mice at 7, 14 and 28 days post UUO, were sacrificed and their 
kidneys perfused to eliminate peripheral blood lymphocyte contamination. Extracted 
RNA was reverse transcribed and real time PCR was carried out on DNA from either 
normal, UUO or the contralateral UUO kidney and the spleen of each animal 
individually. All twenty two primer pairs were run in triplicate with the template DNA, 
along with a non-template control wells for each primer pair. All 88 PCR reactions for 
the tissue of interest from one animal were run simultaneously. If there was 
amplification of DNA in the absence of template suggesting contamination the 
experiment was repeated. The only control for pipetting error was that each PCR 
reaction was run in triplicate. 
The Ct value of each PCR reaction was determined and the relative expression of each 
of the twenty two TRVβ gene segments was calculated for that DNA sample. This 
allowed me to determine the percentage of the total T cell population expressing each 
individual TRVβ gene segment in that tissue (Lim, Baron et al. 2002). No house-
keeping gene was required for standardisation because the same quantity of template 
DNA was added to each reaction in a single experiment and comparisons were made 
between the relative expressions of the TRVβ gene segments within the one tissue. 
Over expression of a particular TRVβ gene segment in the kidney compared to the 
spleen would suggest a clonal population of T cells had developed in the kidney due to 
UUO injury. 
4.5.1 Relative expression of TRVβ gene segments by lymphocytes in kidney and 
spleen of normal animals 
TRVβ gene segment usage in the kidney and spleen of three normal mice was 
determined. The pattern of TRVβ gene segment expression was similar in all three 
normal animals, reflected by the narrow SEM (Figure 4.6). For most TRVβ gene 
segments the proportion of T cells expressing that gene segment was consistently high 
or low e.g. TRVβ23, 24 and 30 were always expressed at a low level in comparison to 
TRVβ3 and 13.2. 
However, there were differences in the expression of some TRVβ gene segments 
between the kidney and spleen. This was most obvious in all three animals for 
TRVβ13.2, where the expression of this gene segment in the kidney was up to three 
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times that in the spleen. TRVβ29 was also consistently over expressed in the kidney: 
this was most marked in animal 2 where the proportion of cells expressing TRVβ29 was 
three times that seen in the spleen. The gene segment TRVβ1 was over expressed in the 
kidney tissue of animals 1 and 3. 
Of note, the Ct values for PCR reactions using normal kidney were higher than seen in 
the UUO kidney reflecting lower concentrations of TCR mRNA. This was expected: as 
demonstrated in Chapter 3 there were significantly more T cells infiltrating UUO 
kidney than normal controls. However, since the total amount of T cell-derived cDNA 
used in the PCR reactions could not be standardised between different animals, 
estimates of the actual differences in T cell number between UUO and normal animals 
and between kidney and spleen of the same animal could not be made. 
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Figure 4.6- Relative expression of TRVβ gene segments in the kidney and spleen of 
three normal mice 
The bar charts in (a), (b) and (c) graphically represent the percentage of T cells in the 
kidney and spleen of three normal mice which express each TRVβ gene segment.  
The chart in (d) illustrates the mean percentage (+/- SEM) TRVβ gene segment 
expression for the three normal mice. The profiles of TRVβ gene segment expression 
were very similar between the animals as reflected by the narrow SEM. Certain TRVβs 
were consistently expressed at low levels in both the kidney and spleen e.g. TRVβ23, 24 
and 30 and others at higher levels e.g. TRVβ3 and 13.2. There was the over expression 
of the TRVβ13.2, 29 and 1 in normal kidney compared to spleen. 
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(c) Animal 3 
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(d) Mean (+/- SEM) relative expression of the TRVβ gene segments in the kidney 
and spleen of three normal animals 
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4.5.2 Relative expression of TRVβ gene segments by lymphocytes in the UUO 
kidney and spleen of ten UUO mice 
TRVβ expression was assessed in UUO kidney and spleen from a total of ten UUO 
animals at 7 (n=3), 14 (n=5) and 28 (n=2) days post obstruction (Figures 4.7, 4.8 and 
4.9). The number of animals used per group was small, especially at day 7 and 28, and 
should have been bigger to maximise the chances of achieving statistically significant 
results. Comparison was made between the percentage expression of the individual 
TRVβ gene segments in the kidney and spleen for each animal. The profile of TRVβ 
gene segment expression by T cells was similar between most of the mice especially at 
day 7 and 14 after obstruction. There was often a predominant TRVβ gene segment 
which was expressed by a larger percentage of T cells in the UUO kidney compared to 
the spleen and this was frequently the TRVβ3 gene segment (n=7/10). By day 28 the 
pattern of TRVβ gene segment expression was more homogenous, with no single TRVβ 
segment predominating as at the earlier time points. Certain TRVβ gene segments were 
consistently only expressed by a very small proportion of T cells in all UUO animals 
and at all time points e.g.TRVβ23 and 24. 
Looking specifically at the day 7 animals: the predominant gene segment over 
expressed in the UUO kidney of two mice was TRVβ13.3 (Figure 4.7 (a) and (b)) whilst 
in the other mouse it was the TRVβ13.1 gene segment (Figure 4.7 (c)). Animal 2 also 
had relative over expression of the TRVβ3 gene segment in the UUO kidney. The 
percentage expression of the TRVβ13.2 and 29 gene segments were similar in the UUO 
kidney and spleen of all three day 7 mice. 
Of the five mice that were obstructed for 14 days, four demonstrated over expression of 
the TRVβ3 gene segment in the UUO kidney, which was particularly pronounced in 
animals 3 and 6 (Figure 4.8). The proportion of the total T cell population in the kidney 
which expressed the TRVβ3 gene segment was between 1.3 and 2.2 times that seen in 
the comparator spleen: in animal 6, 10.2% of the splenic T cell population expressed 
TRVβ3, compared to 22.0% of the UUO kidney T cell population. Other TRVβ gene 
segments were over expressed in the UUO kidney of day 14 mice however, none were 
as pronounced as the proportion of T cells expressing the TRVβ3 segment in animal 6. 
Other examples include over expression of TRVβ26 in animal 2 and TRVβ13.2 in four 
of the animals. No day 14 UUO kidney demonstrated over expression of the TRVβ1 
gene segment. 
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In comparison, the TRVβ profiles generated from mice obstructed for 28 days were 
more homogeneous (Figure 4.9). No single TRVβ gene segment accounted for >13% of 
the total T cell pool in that kidney: this was different to that seen in the day 7 and 14 
UUO kidneys where certain TRVβ segments accounted for up to 22% of the total T cell 
population. There was some over expression of the TRVβ3 gene segment in the both 
UUO kidneys but this was less pronounced than at earlier time points.   
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Figure 4.7- Relative expression of TRVβ gene segments in the kidney and spleen of 
three day 7 UUO mice   
The relative expression of the TRVβ gene segments in the UUO kidney and spleen were 
determined for three day 7 UUO mice.  
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Figure 4.8- Relative expression of TRVβ gene segments in the kidney and spleen of 
five day 14 UUO mice  
The percentage expression of TRVβ gene segments were evaluated in the UUO kidney 
and spleen of five mice which had 14 days of left ureteric obstruction. In all but animal 
2 there was over expression of the TRVβ3 gene segment in the UUO kidney.  
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(c) Animal 6 
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(d) Animal 7 
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Figure 4.9- Relative expression of TRVβ gene segments in the kidney and spleen of 
two day 28 UUO mice 
TRVβ gene segment expression was compared in the UUO kidney and spleen of two 
animals which had undergone 28 days of UUO. Once again there was over expression 
of TRVβ3 in the kidney of both animals however this was less then seen in the day 14 
animals. No one TRVβ segment accounting for >13% of the total T cell pool in the 
kidney, which was different to the pattern seen in the day 7 and 14 UUO mice. 
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4.5.3 Relative expression of TRVβ gene segments by lymphocytes in the kidney and 
spleen of a sham operated day 7 animal 
One animal had a sham UUO operation during which a laparotomy incision was made 
and the left ureter was identified and manipulated but not tied. The mouse was housed 
in identical conditions to the UUO mice and sacrificed after 7 days. On harvesting the 
sham operated left kidney there was no evidence of obstruction and the kidney was 
histologically normal. 
Figure 4.10 graphically represents the real time data for this animal. The TRVβ gene 
segment expression profile was very similar to the profile in Figure 4.6 (d) which 
demonstrated the mean percentage TRVβ gene segment expression for three normal 
mice. This suggested that sham manipulation of the mouse made little difference to the 
renal T cell population. Consist with the findings from Chapter 3, Ct values were high, 
suggesting there were few TRVβ expressing cells in the sham kidney compared to the 
UUO kidney. Again similar to the findings in the normal kidney, the TRVβ13.2 and 29 
gene segments were over expressed in the sham operated kidney.  
 
Figure 4.10- Relative expression of TRVβ gene segments in the kidney and spleen 
of a sham operated day 7 UUO mouse  
The expression of the TRVβ gene segments by cells in the kidney and spleen of the 
sham operated UUO mouse were compared. The profile was similar to that of normal 
mice (Figure 4.6 (d)), with the percentage expression of TRVβ13.2 predominating in the 
kidney.  
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4.5.4 Mean relative expression of TRVβ gene segments by the lymphocytes in the 
kidney and spleen of all normal and UUO animals 
The percentage expression of some TRVβ gene segments in the normal and UUO mice 
were similar. Certain gene segments were expressed at very low levels in both organs of 
both groups of mice, such as TRVβ23, 24 and 30. In comparison specific TRVβ gene 
segments where over expressed in kidney such as TRVβ3 in UUO animals and 1, 13.2 
and 29 in normal kidneys. A variety of other TRVβ gene segments were also over 
expressed in the UUO kidney but not as consistently or to the extent demonstrated by 
TRVβ3.  
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4.6. Discussion 
From these experiments I have demonstrated an alteration in the TRVβ expression 
pattern of certain TRVβ gene segments in the UUO kidney compared to the spleen, in 
particular in the use of TRVβ3. Such a difference was not demonstrated in the TRVβ3 T 
cell expression in normal mice suggesting that the results in UUO animals represent the 
affect of disease rather than artefact. This supports the hypothesis that antigen-
dependent T cell activation may be occurring in the UUO model with the loss of 
immunological tolerance. Over expression of TRVβ3 at the earlier time points post 
UUO would be compatible with the early proliferation of a homogeneous population of 
T cells as shown in some AIDs. This would support the hypothesis that restricted T cell 
populations are responding to a limited number of auto-antigenic epitopes. Subsequent 
normalisation of the T cell repertoire at a later time point is in keeping with the 
phenomenon of epitope spreading also demonstrated in AIDs.  
If antigen-dependent T cell activation had occurred in the UUO model of renal disease 
we must consider the theoretical mechanisms by which loss of tolerance could occur. 
Theoretically peripheral tolerance could be evaded by a number of mechanisms in UUO 
where there is a change in the interaction between a self antigen:MHC complex and 
TCR. Firstly, the generation of a mature population of APCs which display high levels 
of co-stimulatory signals could allow some autoreactive T cells to avoid peripheral 
tolerance. The mechanical injury caused by obstructive uropathy produces DAMP 
molecules which activate TLRs on APCs. This then stimulates APCs in two ways: to 
produce proinflammatory cytokines that trigger further leukocyte recruitment and 
secondly to cause upregulation of co-stimulatory molecules on the surface of the APC, 
such as the B7 family of surface molecules. This generates mature APCs with high 
levels of co-stimulatory and MHC molecules on their surface. Therefore T cells that 
were not deleted in the thymus by negative selection due to a weak self peptide:MHC 
interaction could be now be activated by the strong second co-stimulatory signal 
generated by inflammation. There are examples in human diseases where inflammation 
precipitates AID flares including SLE and MS relapses which can be triggered by 
infection. Injury from sunlight precipitating a SLE flare may occur by a similar 
mechanism. 
Secondly, self antigens usually only present at immune privileged sites and sheltered 
from normal immune surveillance may be exposed by UUO injury. Subsequently T 
cells that were not negatively selected in the thymus may be exposed to these antigens 
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for the first time, recognise them as foreign and allow T cell activation to occur. This 
has been shown in the human disease sympathetic opthalmitis (Avichezer, Grajewski et 
al. 2003). 
Thirdly, post translational modification of self antigens may occur in response to cell 
stress caused by the increased pressure and stretch of UUO. This can cause amino acid 
modifications with the addition of groups or conversion of others (Anderton 2004; 
Pedersen 2007). The addition of new groups to the protein may occur by 
phosphorylation or glycation. Amino acid conversions may occur spontaneously or 
enzymatically to bring about changes which include deamination or citrullination. Such 
modifications can increase the binding affinity of the self peptide:MHC complex to the 
TCR. Therefore T cells that were not negatively selected in the thymus because of a 
weak self peptide:MHC interaction with a TCR can now bind the TCR more strongly 
and cause T cell activation, pending the second co-stimulatory signal. This mechanism 
of post translational modification is not necessarily about generating a new antigen 
which is recognised as foreign, but about increasing self peptide:MHC binding affinity 
to T cells, that have survived negative thymic selection. However, neoantigen 
generation may be another mechanism by which T cell activation can occur, where the 
neoantigen generated as a consequence of injury is recognised by the T cell as foreign. 
This has been proposed as a possible mechanism for Dressler’s syndrome, where there 
is an autoimmune response against myocardial neoantigens after myocardial injury. 
These reactions are usually transient and the neoantigens are subsequently removed but 
if the clearance mechanisms are impaired then clinical AID can result.  
In the UUO model all three mechanisms may be active. Acute cell injury caused by 
obstruction could precipitate the upregulation of co-stimulatory molecules on APCs 
allowing self antigens, which wouldn’t usually illicit a T cell response in a non-
inflammatory environment, to do so. Also modification to self antigens by UUO injury 
could increase their affinity to their TCR. With ongoing obstruction further antigen 
modifications or neoantigen production would develop which overwhelmed clearance 
mechanisms resulting in an ongoing chronic inflammatory reaction. Another possibility 
would be the release of sequestered antigens caused by UUO injury to which tolerance 
had not developed. 
There are examples in the literature where loss of tolerance to self antigen has been 
shown in models of renal injury which are not characteristically thought to be 
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immunologically mediated. As far back as the 1990s, Gillum’s group demonstrated a 
change in the tubular cytoskeletal and cell membrane protein profiles in a model of 
renal ischemic injury associated with pronounced interstitial inflammation (Truong, 
Farhood et al. 1992). The atrophic tubules demonstrated neoexpression of the 
cytoskeletal element vimentin, which is normally only expressed by immature renal 
tubular cells, and subtypes of keratin not usually expressed by renal tubules. The 
glycoprotein profile of the tubular cells also changed with marked decrease or absolute 
loss of some glycoproteins. This suggests ischaemia may initiate a cell mediated 
immune reaction caused by alteration in the antigenic profile of tubular cells and 
formation of neoantigens, which are recognised by T cells not negatively selected in the 
thymus. Rabb’s group, using the renal ischaemia-reperfusion injury model, 
demonstrated that when renal lymphocytes were adoptively transferred from animals 
which had undergone IRI into control animals, renal injury occurred (Burne-Taney, Liu 
et al. 2006). This suggests that adoptively transferred memory T cells, which have lost 
tolerance to self antigen in the inflammatory environment of IRI, are able to recognise 
self antigenic epitopes in the control mouse provoking proteinuria.  
Other groups have looked more specifically at possible self antigens that may be 
involved. These antigens may be lipid, protein or carbohydrate residues that are 
expressed exclusively in the normal kidney and to which central tolerance had not 
developed (Fang, Ballet et al. 2009). Alternatively, they could be an antigen which is 
only expressed in damaged kidney, such as the heat shock protein 70, which has been 
suggested as a candidate antigen for T cell mediated injury in hypertensive kidney 
disease (Parra, Quiroz et al. 2008). In response to the proinflammatory stimulus LPS, 
Dong et al’s group demonstrated dendritic cells in regional lymph nodes that were 
positively stained for Tamm Horsfall Protein and were able to activate T cells (Dong, 
Swaminathan et al. 2005). This work suggests a break in T cell tolerance could occur to 
the self antigen Tamm Horsfall Protein when presented by dendritic cells in an 
inflammatory environment. Benigni’s group developed this work in their model of renal 
injury, showing that dendritic cells could process the self protein albumin in the 
dendritic cell proteosome and present antigenic fragments with class I MHC to CD8+ T 
cells in the draining renal LNs, causing T cell activation and the production of IFN-γ 
(Macconi, Chiabrando et al. 2009). Work on the reversal-UUO model demonstrates a 
persistent T cell inflammatory infiltrate ten weeks after re-implantation of the ureter 
despite there being an improvement in renal function (Tapmeier, Brown et al. 2008). 
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This suggests an expanded T cell population develops during the inflammatory period 
of ureteric obstruction which recognises self antigen and which persists despite reversal 
since there is ongoing recognition of self antigen. 
An obvious alternative tissue to examine would be the contralateral kidney in the UUO 
model. If lymphocytes were activated after they had lost tolerance to an unmodified self 
antigen, subsequent evidence of renal injury in the contralateral kidney may have been 
demonstrated. However, if T cells were recognising a modified self antigen or new 
antigen then contralateral renal injury would not be expected. Injury to the contralateral 
kidney may be confounded by hyperfiltration injury in that kidney due to reduced 
nephron mass after the UUO kidney is no longer functional. 
As illustrated by these examples, there is an expanding body of evidence to suggest that 
models of renal injury which are not initially immunologically mediated, such as IRI 
and the hypertensive and proteinuric models of renal disease, can result in the activation 
of a T cell population due to loss of tolerance to self antigens. In other organs similar 
examples of loss of tolerance to self antigen have been reported. One example is from 
Rose’s group who demonstrated the presence of specific antibodies and CD8+ T cells to 
the self antigen vimentin after cardiac transplantation (Barber, Whitelegg et al. 2004). 
This suggests that T cells, which were not deleted during negative selection in the 
thymus, remained immunologically silent under non-inflammatory conditions. 
However, in the inflammatory environment of transplantation, there is upregulation of 
MHC and co-stimulatory molecules on the APC providing the second co-stimulatory 
signal. The self peptide:MHC complex on the APC, although weakly bound to the TCR, 
could then cause T cell activation due to a strong second signal. 
Another explanation for loss of peripheral tolerance to self may be due to dysregulation 
of the regulatory T cell population. It is possible that Tregs lose their suppressive 
abilities during renal injury thereby permitting the expansion of autoreactive T cell 
populations.  The inflammatory environment which develops as a consequence of renal 
injury, which is rich in IL-6, may skew the T cell population away from T cells with 
regulatory function towards a Th17 phenotype, which promotes injury. 
An alternative explanation for the presence of activated T cells in the UUO kidney 
would be that lymphocytes were activated elsewhere in the body in response to a non-
renal antigen and were subsequently attracted to the area of obstructive injury by the 
chemokine gradient developed by renal cells in response to ureteric obstruction. One 
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possible source would be an activated lymphocyte population residing within the gut, 
which had been activated by recognition of gut pathogens. If this was the explanation 
then the infiltrating population would demonstrate an activated effector phenotype from 
the outset rather than the population progressively developing effector functions. 
Does expansion in expression of the TRVβ3 gene segment by the T cell population in 
the kidney really suggest clonal proliferation? The only way to explore this is by 
sequencing the TCRs of these T cells (see Chapter 5). However, there are other possible 
explanations for the expansion of particular TRVβ gene segments in UUO injury which 
include superantigens and T cells activated in response to non-renal antigens. 
Superantigens are able to cause T cell activation independent of antigen/CDR3 
interactions. They bind to MHC on the APC and to specific regions on the β-chain of 
the TCR, encoded by the TRVβ gene segment, to trigger T cell activation. One such 
superantigen is coded for by the mouse mammary virus, a retrovirus able to integrate its 
viral genome into that of the host mouse. In the presence of superantigen a clonal 
proliferation of T cells using a specific TRVβ chain could be generated. Although the 
same TRVβ gene segment would be expressed by these T cells, the complete CDR3 
region would not be identical due to differing Dβ and Jβ gene segments. If a T cell 
clone using a specific TRVβ gene segment had been generated by superantigen 
stimulation in UUO, a similarly large population of these T cells would be seen in both 
kidney and spleen and therefore superantigens cannot explain the differences between 
kidney and spleen TRVβ expression within an individual mouse. The second possible 
explanation for the expansion of T cells using a particular TRVβ gene segment may be 
because a restricted T cell population has developed in response to a foreign antigen 
elsewhere. A monoclonal population of T cells developed in response to a gut pathogen 
could be attracted along a chemokine gradient generated by inflammation within the 
UUO kidney. However, the consistent finding of excess TRVβ3 gene segment 
expression by T cells in the kidney of multiple UUO mice makes this less likely. 
Therefore it remains to be seen in Chapter 5 whether the over expression of TRVβ3 in 
the UUO kidney represents a clone of T cells. 
The TRVβ expression profiles seen in the three normal and one sham mouse were very 
similar. This finding is consistent with other groups who have demonstrated correlation 
in the expression pattern of TRVβ gene segments between unrelated individuals 
(Melenhorst, Lay et al. 2008) but there was variability in expression of the different 
TRVβ gene segments. These biases or variability’s in expression of gene segments have 
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been shown to occur at two stages: either during pre-thymic selection of TCR 
development or during thymic selection. Pre-thymic selection biases could occur when 
TRVβ, TRDβ and TRJβ gene segments combine to produce the pre-TCR or at the stage 
when it combines with the pTα chain to form a mature TCR. Genetic factors intrinsic to 
the TRVβ locus may be important such as accessibility of a particular TRVβ locus, 
proximity of the TRVβ gene segment to the TRDβ and TRJβ gene segments and the 
efficiency by which a particular β-chain can pair with an α-chain (Melenhorst, Lay et al. 
2008). Others have suggested that inherent developmental genetic biases shape the 
repertoire prior to thymic selection (Wilson, Marechal et al. 2001). Biases in the TRVβ 
repertoire could also occur at the point of thymic T cell selection due to MHC 
interactions. The main TCR filtering process in the thymus positively selects for T cells 
which bind self antigen and self-MHC with low avidity, so it follows that the TRVβ 
repertoire is selected by MHC. Also particular TRVβ chains that recognise 
superantigens with Class II MHC can be negatively selected for in the thymus due to 
high affinity binding to the TCR, again affecting the mature TRVβ repertoire seen 
outside the thymus (Fairchild, Knight et al. 1991). 
In normal and sham animals I demonstrated higher levels of expression of certain TRVβ 
gene segments in kidney compared to spleen, in particular the TRVβ13.2 and 29 
segments. This was consistently seen all four animals and there are a number of 
explanations for this. One possibility is that it is artefact related to PCR. However, I 
made every effort to exclude sample contamination with a number of control checks. I 
always performed all PCR reactions with non-template control wells and discarded the 
entire experiment if template was detected in these wells. All PCR products were stored 
in a different laboratory to the location of the PCR reagents and all equipment was 
exposed to UV light to prevent DNA contamination: so this is an unlikely explanation 
for the over expression of TRVB13.2 and 29. Another explanation would be that 
circulating lymphocytes remained in the tissues despite perfusion with saline however, 
this technique has been an accepted strategy used by other groups performing similar 
experiments to eliminate circulating lymphocytes (Heeger, Smoyer et al. 1996). Since 
the total number of T cells within normal kidney is far fewer than in spleen or UUO 
kidney, a circulating clone of T cells e.g. developed in response to an infection would 
make more impact on the TRVβ gene segment expression profile in the normal kidney. 
However, it would seem unlikely that mice stored in a clean environment at different 
times would develop the same infection and that an identical population of T cells 
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would not also expand in the spleen. On balance this seems an inadequate explanation 
for expansion of TRVβ13.2 and 29 in the normal kidney. 
I think the most likely explanation for the over expression of TRVβ13.2 and 29 are 
clones of T cells within the normal and sham kidney. The TRVβ13.2 and 29 gene 
segments as classified by IMGT are the same as the TRVβ8.2 and 7.1 gene segments as 
classified by Arden. Type I NKT cells display a semi-invariant TCR which is most 
frequently made up from TRVβ8.2, 7 and 2 gene segments (Arden classification). When 
translated into the IMGT nomenclature, this corresponds to the TRVβ13.2, 29 and 1 
gene segments, respectively. It seems likely that I have demonstrated NKT cells in all 
four normal or sham kidneys expressing TRVβ13.2 (IMGT)/ 8.2 (Arden) and TRVβ29 
IMGT/ 7.1 (Arden). Also in two out of three normal kidneys TRVβ1 (IMGT) was over 
expressed which is consistent with this also being a population of NKT cells. It is 
important to note that not all NKT cells have such a limited TRVβ repertoire as 
suggested for type I NKT cells. 
Rabb’s group investigated the possibility of a resident population of conventional or 
unconventional T lymphocytes in healthy mice kidneys and found that 23% +/- 4% of 
the CD3+ lymphocytes were double negative (DN) (Ascon, Ascon et al. 2008). They 
also found a small NKT population, as determined by CD4+NK1.1+CD1d restricted 
cells, accounting for 12% of the total CD3+ population. They examined the TRVβ 
profile of these lymphocytes in the normal kidney by flow cytometry using antibodies to 
the TRVβ proteins and discovered an increased percentage of CD4+ lymphocytes 
expressing the TRVβ2, 7, 8.1 and 8.2 chains (TRVβ1, 29, 13.3 and 13.2 respectively as 
classified by IMGT). They also found CD8+ cells in the normal kidney which over-
expressed the TRVβ8.3 and 9 chains (TRVβ13.1 and 17 respectively, as classified by 
IMGT). The CD3+ DN population over expressed TRVβ2, 3, 5.5/5.2, 7, 8.3, 8.1/8.2 and 
13 (TRVβ1, 26, */12.1, 29, 13.1, 13.3/13.2 and 14 respectively as classified by IMGT, 
where * indicates not recognised). These findings by Ascon et al are consistent with and 
support my findings and suggest there are resident populations of NKT cells in normal 
mice kidneys. 
With UUO injury, there was no consistent increase in the proportion of the T cell 
population expressing either TRVβ13.2, 29 or 1 gene segments in the UUO kidney 
when compared to the expansion seen in the normal and sham kidneys. However, in the 
literature there are examples of NKT cells playing a role in early renal injury, with 
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evidence that NK and NKT cells are important in the pathogenesis of IRI (Ascon, 
Lopez-Briones et al. 2006; Li, Huang et al. 2007), but there is no literature on NKT 
cells, chronic TI injury and fibrosis. In the IRI work by Rabb, after injury increasing 
numbers of CD3+NK1.1+ and CD3-NK1.1+ cells were seen within the kidney after 3 
hours and this correlated with an increase in serum creatinine. By 24 hours there were 
also increased numbers of CD4+NK1.1+ cells in the ischemic kidney compared to 
normal controls. NKT cells can be CD4+ and display the surface markers CD69 and 
CD44 therefore, despite no evidence of NKT cell involvement by other groups in 
chronic injury, there is a possibility that the activated T cells demonstrated in Chapter 3 
may be NKT cells rather than traditional T cells. The role of NKT cells in normal 
kidney and disease is unclear but these cells are thought to have an immunomodulatory 
role (Wu, Gabriel et al. 2009). NKT cells produce copious amounts of pro and anti-
inflammatory cytokines upon activation but may overall favour immune regulation and 
contribute to and link both innate and adaptive immunity. The groups of cytokines 
produced by NKT cells may determine the phenotype of the effector lymphocyte 
population produced and help to facilitate lymphocyte and macrophage responses.  
From a technical viewpoint a number of specific decisions were made about the 
methods used. Taqman fluorescent probes rather than SYBR green were used for 
quantitative real time PCR, after reviewing published work comparing the two methods 
(Walters and Alexander 2004). The fluorescent probe method was found to be more 
consistent across a range of TCR signal levels and robust in the presence of 
contaminating non-TCR cDNA. Since the absolute numbers of T cells within the 
normal kidney were low compared to the large numbers present in the spleen, it was 
important that the PCR technique used were reliable across this range.  
The second technical point involves primer efficiencies. Two main comparisons were 
made: the first between kidney and spleen using the same primer pair and second 
between differences in the expression of the twenty two TRVβ gene segments using 
different primer pairs within the same animal. Consistent and highly efficient primers 
pairs were required to compare the expression of the different TRVβ gene segments 
within a single animal, since small differences in the efficiencies of the pairs may have 
skewed the TRVβ gene segment profiles. The most efficient primer pair, TRVβ15-
TRCβ, may have over represented the proportion of T cells expressing the TRVβ15 
gene segment. Conversely, the least efficient primer pair, TRVβ19-TRCβ, may have 
underestimated the T cell expression of this gene segment. The efficiency of the 
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TRVβ3-TRCβ primer pair, when TRVβ3 was consistently one of the most highly 
expressed gene segments in the UUO kidney, was 1.96, when the median primer 
efficiency was 1.94 and the range 1.87 – 2.07. The efficiency of the TRVβ3 primer pair 
was not at the extremes of the range and so primer efficiency was unlikely to have 
accounted for the increase in TRVβ3 expression by T cells in the UUO kidney, it is 
more likely that this truly represented the T cell population of the UUO kidney.  
Finally, one criticism for the approach taken in this chapter was that we only examined 
TRVβ gene segment expression within UUO kidney using real time PCR and thus 
transcribed TRVβ gene segments. This may not accurately represent TCR protein 
expression on the surface of T cells within UUO kidney. One approach would have 
been to use commercially available fluorochrome labelled antibodies to known TRVβ 
chain proteins and determine the relative protein expressions of the different TRVβ 
chains by flow cytometry. Other groups, including the work done by Heeger’s group, 
showed similarity between the TRVβ protein expression by flow cytometry and TRVβ 
at the transcript level by real time PCR. This justifies the real time PCR method used as 
it has been shown to provide a reasonable approximation to the TRVβ protein 
expression in vivo. 
In summary, the data from this chapter supports the hypothesis of antigen-dependent T 
cell activation in the UUO model of renal injury, with a loss of immunological 
tolerance. The next step was to sequence cells from UUO kidney where there was over 
expression of the TRVβ3 gene segment compared to the spleen, to determine whether 
this represented a clonal population of T cells. 
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Chapter 5. Evidence of T cell clonality in normal and diseased kidney 
 
5.1 Introduction  
In order to determine if antigen-dependent T cell activation occurs in UUO injury, I 
assessed whether T cell clones, with an identical CDR3 region, were present in 
obstructed kidney. 
The work using real time PCR from Chapter 4 demonstrated that in seven of the ten 
obstructed animals there was over expression of TRVβ3 by T cells within UUO kidney 
compared to spleen. The expansion of this T cell population expressing TRVβ3 might 
suggest that a clone of T cells had developed in the UUO kidney which expressed the 
same CDR3 region. To determine whether this was the case, the Dβ and Jβ gene 
segments and intervening nucleotides expressed by these T cells were sequenced.  
From the literature, groups have used a variety of methods in attempts to infer or prove 
the clonality of a population of T cells. Spectrotyping can be used to determine the 
length of the CDR3 nucleotide sequence: if a T cell population had identical CDR3 
length, it would infer (but not prove) clonality of that population since the individual 
nucleotides may be different (Lim, Baron et al. 2002). To definitively determine 
whether the CDR3 region of a T cell population is identical, sequencing the region of 
interest is necessary.  
In this chapter I present the results of T cell receptor sequencing performed on the 
kidney and spleen of UUO mice to establish whether a dominant sequence was present 
suggesting antigen-dependent T cell activation. I also sequenced the CDR3 region in 
lymphocytes from normal kidney and spleen to establish whether similar sequences 
were present without manipulation. 
5.2 Cloning of CDR3 TCR sequences 
Cloning techniques were used to allow the subsequent sequencing of the TCRs present 
in kidney and splenic tissues. Five UUO mice were examined in this way: one mouse 
sacrificed after 7 days of obstruction (D7 Animal 2 (A2)), three mice after 14 days (D14 
Animals 3 (A3), 6 (A6) and 9(A9)) and one after 28 days (D28 Animal 2 (A2)). In all of 
these mice the TRVβ3 gene segment was over expressed by T cells in the UUO kidney 
compared to the spleen, suggesting an expanded T cell population using TRVβ3 in their 
CDR3 region. 
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Standard PCR using a Taq polymerase with proof reading capability to prevent errors in 
amplification and the TRVβ3-TRCβ primer pair were used to amplify the reverse 
transcribed mRNA extracted from kidney or splenic tissue of UUO mice. This amplified 
the Dβ and Jβ gene segments for each TCR along with the intervening nucleotides 
which provide β-chain TCR diversity. 
The PCR products were then inserted into a plasmid vector and bacteria were 
transformed. A number of individual colonies, between 25 and 50, were selected, 
expanded and plasmid DNA extracted and plasmid insert sequenced. We assumed that 
each individual colony represented an individual T cell found in the kidney or spleen of 
that animal and the plasmid insert included the CDR3 β-chain region for that specific T 
cell. Comparison of the sequences generated from the different colonies determined 
whether there were identical CDR3 sequences within an individual UUO kidney and 
spleen and whether there were similarities between mice. Similar experiments were also 
performed on kidney and splenic tissue from three normal mice. 
5.2.1 Determining the success of the cloning reactions  
In order to determine whether the cloning reactions were successful before the plasmid 
inserts were sent away for sequencing, the extracted plasmid DNA from each of the 
chosen colonies underwent standard PCR with the TRVβ3-TRCβ primer pair and the 
PCR product assessed by agarose gel electrophoresis (Figure 5.1). This demonstrated 
that the initial PCR amplification and cloning reactions had been successful, and that 
the plasmids contained the TRVβ3 and TRCβ gene segments of interest in a nucleotide 
sequence of an appropriate size around 200bp.  There was no amplification of product 
in the non-template control lane demonstrating no contamination of reagents with DNA. 
For each of the five UUO and three normal mice examined, 25-50 colonies were chosen 
which had been generated from kidney tissue and 25-50 colonies from spleen. After 
extracting the plasmid DNA, performing standard PCR and then separating the products 
by agarose gel electrophoresis, it was demonstrated that 96.1% +/- 5.3% of all the 
plasmids contained an insert and that insert was an appropriate size. Only the plasmids 
with an insert of the correct size were submitted for sequencing. 
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Figure 5.1- PCR products separated by agarose gel electrophoresis generated using 
the TRVβ3-TRCβ primer pair on plasmid DNA from colonies 1-24, from the 
normal spleen of animal 2 
Reverse transcribed RNA extracted from splenic tissue of normal animal 2 was 
amplified using a high fidelity Taq polymerase and the product inserted into a plasmid 
vector, which then transformed bacteria. Twenty four colonies were picked and grown 
and subsequently the plasmid DNA was extracted. Each individual colony included a 
unique plasmid insert which was the nucleotide sequence of the CDR3 β-chain of a 
TCR found in the normal spleen. Standard PCR reactions were carried out using the 
TRVβ3-TRCβ primer pair and the 24 different samples of extracted plasmid DNA. The 
products were separated by agarose gel electrophoresis to demonstrate that all 24 
cloning reactions were successful with 24 similar sized PCR products being generated 
of around 200bp. The difference in the sizes of the products was due to the assortment 
of Dβ and Jβ gene segments used by each T cell and the addition and deletion of 
junctional nucleotides. No product was demonstrated in the NTC lane confirming no 
contamination of the reaction with DNA. 
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5.3 Sequencing of the TCR CDR3 region of renal and splenic lymphocytes 
The TCR CDR3 sequences found in the kidney and spleen of both UUO and normal 
animals were assessed to investigate the presence of a dominant sequence and by 
inference a clonal T cell population.  For each of the eight mice between 24 and 50 
different samples of plasmid DNA per tissue were sent for sequencing to a commercial 
company (Macrogen). Between 19 and 49 successful T cell CDR3 sequences were 
acquired from the plasmid DNA samples. Therefore overall 91.9% +/- 8.3% of the 
plasmid DNA was successfully sequenced and contained a CDR3 nucleotide sequence.  
Comparison was then made between the CDR3 sequences generated from an individual 
kidney or spleen to determine which TRJβ gene segment was expressed and whether 
there were multiple identical sequences suggesting that this sequence was highly 
expressed. 
 
5.3.1 CDR3 sequences from experimental UUO kidney 
In all of the three day 14 UUO mice (A3, A6 and A9) there was one predominant TRJβ 
gene segment in the CDR3 region however, this TRJβ gene segment varied between the 
different animals. In the D14A3 mouse this was the TRJβ2.4*01 gene segment, in 
D14A6 TRJβ2.2*01 and in D14A9 the predominant gene segment was TRJβ2.7*01. 
However, not all these CDR3 sequences were the same despite containing the same 
TRJβ. 
The CDR3 sequences were further analysed to determine how many were identical. In 
the single mouse examined after 7 days of UUO, the dominant identical sequence 
accounted for 12/39 (31%) of the total sequences examined and expressed TRJβ1.3*01 
(Figure 5.2 (a)). In the day 14 UUO mice: the dominant identical sequence in the 
D14A3 kidney accounted for 8/39 (21%) of the total sequences and contained the 
TRJβ2.4*01 gene segment (Figure 5.2 (b)), in D14A6 10/45 (22%) were identical and 
contained TRJβ2.2*01 (Figure 5.2 (c)) and in the D14A9 kidney 14/46 (30%) were the 
same and expressed TRJβ2.7*01 (Figure 5.2 (d)). 
A very large number of cDNA templates were available for amplification and cloning. 
Assuming that amplification across the CDR3 region and cloning were equally efficient 
for all sequences then this suggested that 21% - 31% of the initial cDNA templates 
expressing TRVβ3 were identical and demonstrated the presence of a clone of T cells 
with an identical TCR CDR3 region within the UUO kidney. In addition, as illustrated 
from Figures 5.2 (a-d), there were smaller numbers of identical sequences seen in the 
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kidney of day 7 and 14 UUO mice however, these accounted for no more than four 
identical sequences.  
In the one day 28 UUO mouse it was not possible to demonstrate a dominant population 
of identical plasmid sequences from the 23 colonies examined, the largest identical 
number of sequences seen was a triplet (Figure 5.2 (e)). 
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Figure 5.2- Using UUO kidney cDNA expressing TRVβ3, TRJβ gene segment 
usage and the total number of identical sequences were determined in five mice (a) 
Day 7 A2, (b) Day 14 A3, (c) Day 14 A6, (d) Day 14 A9 and (e) Day 28 A2 
TCR CDR3 gene sequences from UUO kidney at three time points were analysed: 7 
days (n=1), 14 days (n=3) and 28 days (n=1). The total number of identical CDR3 β-
chain sequences, categorised by the TRJβ segment they expressed, is shown. Each of 
the day 7 and 14 UUO kidneys demonstrated a dominant CDR3 nucleotide sequence 
which accounted for 21% - 31% of the plasmid inserts sequenced for that kidney. There 
were also smaller numbers of identical CDR3 sequences identified in these mice. By 
comparison the mouse sacrificed after 28 days of UUO had fewer identical sequences, 
the maximum being 3/23 which accounted for 13% of the total number sequenced. 
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 (b) Day 14 Animal 3 UUO Kidney 
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(c) Day 14 Animal 6 UUO Kidney 
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(d) Day 14 Animal 9 UUO Kidney 
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(e) Day 28 Animal 2 UUO Kidney 
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5.3.1.1 Cumulative frequency curves for UUO kidneys 
An alternative method of illustrating this sequence data would be to examine the 
cumulative frequency of identical CDR3 sequences found in the experimental UUO 
kidneys (Figure 5.3).  This would depend upon whether a particular sequence occurred 
only once, or whether there are pairs, triplets, quadruplets or >4 identical sequences 
found. There was a dominant CDR3 TRVβ3 sequence demonstrated in the day 7 and 14 
UUO kidneys accounting for 21% – 31% of all the colonies sequenced, where there 
were >4 identical sequences. Furthermore, in three out of four animals <55% of the 
sequences were unique.  
This was very different that that seen in the day 28 animal were no more that 3 identical 
sequences were demonstrated and 78% of the CDR3 sequences were unique single 
sequences. This suggested that in the mouse obstructed for 28 days there was no longer 
a dominant TRVβ3 CDR3 sequence. 
 
Figure 5.3- Cumulative frequency of identical TCR sequences in experimental 
animals 
The cumulative frequency graph illustrates the differences in the numbers of identical 
CDR3 sequences in the UUO kidney at the three time points. 
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5.3.2 CDR3 sequences from experimental UUO spleen 
Analysis of the TCR CDR3 sequences from the spleen of all five UUO mice 
demonstrated no more than one triplet of identical sequences (3/25 identical colonies 
sequenced from the D14A3 UUO spleen and 3/46 in the D14A9 UUO spleen) 
suggesting there was no dominant TCR CDR3 sequence and no T cell clone expressing 
TRVβ3 as illustrated in the corresponding UUO kidneys (Figure 5.4). 
 
Figure 5.4- CDR3 sequences demonstrated in five experimental UUO spleens 
The bar chart illustrates the number of identical CDR3 sequences demonstrated in the 
UUO spleen as a percentage of the total number of sequences. Between 64% and 92% 
of the CDR3 sequences in UUO spleens were unique and no more than a triplet of 
identical sequences were identified. 
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5.3.3 Comparison of the CDR3 sequences from UUO kidney and spleen 
Differences between the number of identical CDR3 sequences within UUO kidney and 
spleen are shown in Figure 5.5. In three out of the four day 7 and 14 mice there were 
more individual unique CDR3 sequences within UUO spleen than obstructed kidney, as 
well as no dominant large identical CDR3 sequence within the UUO splenic colonies 
sequenced. In the day 28 UUO mouse there were no more than three repeated CDR3 
sequences within kidney or spleen. 
When comparing the proportion of identical sequences found in the kidney and spleen 
of an individual UUO mouse the Chi squared test was used (Figure 5.6). The D7A2, 
D14A6 and D14A9 mice showed a significantly greater proportion of ≥3 identical 
sequences in the kidney compared to the spleen (p<0.05). There were less significant 
differences in the proportion of ≥3 identical sequences between UUO kidney and spleen 
seen in the D14A3 and D28A2 animals (p= 0.38 and 0.07 respectively). However, for 
all day 7 and 14 UUO mice there was a significantly greater proportion of ≥4 identical 
sequences in the kidney compared to the spleen (p<0.05).  
When comparison was made between the CDR3 nucleotide sequences identified within 
the UUO spleen and kidney of the same mouse, very few were identified in both organs.  
In the day 14 A6 mouse one pair of identical CDR3 sequences in the spleen were the 
same as the eight identical sequences found in that UUO kidney and one splenic 
sequence in the day 7 UUO mouse was the same as twelve in that UUO kidney. Three 
unique CDR3 sequences found in the day 14 A3 spleen were identical to three unique 
sequences in the UUO kidney of that mouse. Otherwise there were no similarities 
between the CDR3 nucleotide sequences identified in the UUO kidney and spleen of an 
individual mouse. 
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Figure 5.5- Cumulative frequency of identical TCR sequences in kidney and spleen 
of UUO animals expressing TRVβ3  
The cumulative frequency graphs compare the differences in the numbers of identical 
CDR3 sequences in the UUO kidney and spleen which expressed TRVβ3 at day 7 (a), 
14 (b) and 28 (c). 
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(c) Day 28 
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Figure 5.6- Comparison of the number of identical CDR3 sequences identified in 
UUO kidney and spleen  
The day 7 and two of the day 14 mice (A6 and A9) showed a significantly greater 
proportion of ≥3 identical sequences in the UUO kidney compared to the spleen 
(*p<0.05). Less significant differences in the proportion of ≥3 identical sequences were 
found in the UUO kidney and spleen of the day 14 A3 and the day 28 mouse. 
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5.3.4 CDR3 sequences from normal kidney 
The TCR CDR3 TRVβ3 sequences found in the kidneys of two normal C57Bl/6 mice 
(A2 and A3) were analysed to determine which TRJβ gene segment were expressed and 
if the CDR3 sequences were identical.  These were the same mice whose TRVβ gene 
segment expression profile was examined by real time PCR in 4.5.1. The kidney from 
normal animal 1 (A1) was not used for cloning and sequencing as inadequate tissue was 
available. In both A2 and A3 kidneys there was one predominant TRJβ gene segment 
contained in the CDR3 region and was the same in both kidneys, TRJβ1.3*01. 
In A2, the dominant identical sequence accounted for 6/20 (30%) of the total sequences 
and expressed TRJβ1.3*01 (Figure 5.7 (a)). There were also five other sequences that 
expressed TRJβ1.3*01 but had different nucleotide sequences to the dominant 
population and were three unique sequences and one pair of identical sequences. In A3, 
again there was a dominant identical sequence accounting for 7/19 (37%) of the total 
sequences and also expressed TRJβ1.3*01 (Figure 5.7 (b)).  There were four other 
CDR3 sequences in the normal kidney of A3 which expressed TRJβ1.3*01 however, 
they all had unique nucleotide sequences. There were no other identical groups of 
nucleotide sequences demonstrated in the other colonies sampled from this normal 
kidney. 
When the nucleotide sequences for the two dominant sequences were compared from 
A2 and A3, they were not the same. Furthermore, the dominant TCR sequences seen in 
the normal kidney were not seen in the spleen of these animals. This makes 
contamination by DNA or PCR product from the other animal unlikely. Again assuming 
that amplification across the CDR3 region and cloning were equally efficient for all 
sequences, this suggests that 30% - 37% of the initial cDNA templates expressing 
TRVβ3 in these two normal kidneys were identical, supporting the presence of a clone 
of T cells with an identical TCR CDR3 region. 
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Figure 5.7- Using normal kidney cDNA expressing TRVβ3, TRJβ gene segment 
expression and the total number of identical sequences were determined in two 
mice  
Plasmid DNA sequences were analysed from the kidney of two normal mice.  Each 
animal expressed a dominant TRJβ1-3*01 segment and dominant but different 
nucleotide sequence accounting for 30% (A2) and 37% (A3) of the total sequences. All 
the other CDR3 sequences examined from the two animals were unique apart from a 
single pair of sequences in A2, which also expressed TRJβ1-3*01. 
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(b) Animal 3 
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5.3.4.1 Cumulative frequency curves for normal kidneys 
The cumulative frequency of identical CDR3 sequences in the normal kidney of A2 and 
A3 demonstrated that around 60% of all the CDR3 sequences were unique in both 
animals (Figure 5.8). However, 30% and 37% of the sequences in the kidney of A2 and 
A3 respectively, which expressed TRVβ3, had an identical CDR3 region. These profiles 
were similar to the cumulative frequencies of identical CDR3 sequences in the day 7 
and 14 UUO kidneys. 
 
Figure 5.8- Cumulative frequency of identical TCR sequences in normal kidney  
The cumulative frequency graph illustrates the differences in the numbers of identical 
CDR3 sequences in the kidney of two normal mice.  
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5.3.5 CDR3 sequences from normal spleen 
Splenic tissue was available from all three normal animals whose TRVβ gene segment 
expression profile was analysed by real time PCR in Chapter 4. In all three normal 
spleens there was no single dominant CDR3 sequence present in contrast to the 
dominant sequences seen in normal kidneys, which accounted for around one third of 
the sequences. The cumulative frequency graph in Figure 5.9 illustrates the number of 
identical CDR3 sequences found in the spleens of the three normal mice. The profiles 
seen A1 and A2 are very similar to those seen for UUO spleens, with 80% - 94% of the 
sequences being unique and individual. Only pairs of identical sequences were 
demonstrated despite 33 and 49 different plasmid inserts being sequenced in A1 and A2 
respectively. Although the CDR3 sequences from the spleen of A3 did not demonstrate 
a large dominant sequence of the size demonstrated in kidney, there were five identical 
sequences (5/45) which accounted for 11% of the total number of sequences. A pair and 
two triplets of identical sequences were also found in this spleen however, not one of 
these repeated identical sequences were seen in the kidney of that mouse or in the 
spleen of the other mice. When comparing all the CDR3 nucleotide sequences examined 
in the kidney and spleen of an individual normal mouse, none were the same.  
Figure 5.9- Cumulative frequency of identical TCR sequences in normal spleen 
The cumulative frequency graph illustrates the differences in the numbers of identical 
CDR3 sequences in the spleen of three normal mice. 
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5.4 T cell populations within kidney and spleen 
Using the real time PCR data from Chapter 4 which calculated the percentage of the 
total T cell population which expressed TRVβ3 and the maximum number of identical 
sequences determined using the cloning technique, an estimate could be made of the 
percentage of the total T cell population within the kidney or spleen of an animal which 
were identical and expressed TRVβ3 (Table 5.1). 
In the day 7 and 14 UUO kidneys, the largest identical population of T cells expressing 
TRVβ3 accounted for 3.6% - 4.9% of the total T cell population in that kidney. 
Similarly in the normal kidneys an identical population of T cells accounted for 2.8% 
and 3.7% of the total population. As shown in Chapter 3, T cells were uncommon in 
normal kidney and large numbers were demonstrated in UUO kidney, therefore the 
absolute number of T cells expressing the same TCR would be far greater in the UUO 
kidney. 
In contrast the percentage of identical T cells expressing TRVβ3 within UUO and 
normal spleen was between 0.4% and 1.2% of the total T cell population in that spleen. 
This high percentage of identical CDR3 sequences and therefore T cells within the 
spleen of normal and UUO animals, around 1%, would be unusual given the spleen 
should contain millions of different sequences/T cells. This result may be artefactual 
and generated because of the relatively small numbers of colonies/ TCRs sequenced out 
of the vast repertoire of T cells present in the spleen. The difference between the 
percentages of identical T cells within kidney and spleen were statistically significant 
(p=0.007). 
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Table 5.1- Percentage of the T cell population within kidney and spleen which 
expressed TRVβ3 and were identical 
The table illustrates the largest percentage of the total T cell population in the kidney or 
spleen of normal and UUO mice that were identical and expressed TRVβ3.  
 
  Animal T cells expressing 
TRVβ3 using RT 
PCR data (%) 
Maximum number of 
identical sequences / 
total number cloned 
Identical T cell 
population 
expressing 
TRVβ3 (%) 
UUO Kidney Day 7 A2 14.9 12/39 4.6 
 Day 14 A3 17.5 8/39 3.6 
 Day 14 A6 22.0 10/45 4.9 
  Day 14 A9 14.4 14/46 4.4 
  Day 28 A2 12.8 3/23 1.7 
UUO Spleen Day 7 A2 11.2 2/25 0.9 
  Day 14 A3 10.0 3/25 1.2 
  Day 14 A6 10.3 2/37 0.8 
  Day 14 A9 10.8 3/46 0.7 
  Day 28 A2 9.5 2/23 0.8 
Normal Kidney A2 12.2 6/20 3.7 
  A3 7.6 7/19 2.8 
Normal Spleen A1 8.5 2/33 0.5 
  A2 10.8 2/49 0.4 
  A3 8.0 5/45 0.9 
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5.5 Analysis of CDR3 amino acid sequence 
The amino acid sequence of the TCR spanning the CDR3 region was determined for all 
the duplicate TRVβ3 sequences demonstrated in the kidney and spleen of UUO and 
normal mice and aligned to allow comparison (Figure 5.10). The amino acid sequences, 
derived from the dominant nucleotide sequence demonstrated in each animal, were 
grouped together (Figure 5.10 (a)), as were the amino acid sequences derived from any 
duplicated nucleotide sequence from the kidney and spleen of an individual mouse 
(Figure 5.10 (b)). This demonstrated similarities in the CDR3 region at the amino acid 
level between animals. Figure 5.10 illustrates a number of conserved amino acid 
sequences (highlighted in yellow) in identical positions within the CDR3 region. These 
particular amino acids were found within the TRJβ gene segment: they were likely 
related to the high degree of sequence homology between different TRJβ gene segments 
and may represent hinge regions in the CDR3 structure. They were also present in 
sequences from normal spleen (Figure 5.11). 
A group of three amino acids RRS or arginine, arginine, serine (highlighted in red), was 
demonstrated within the highly variable nucleotide region found between the final 
section of the TRVβ gene segment and the beginning section of the TRJβ segment and 
which spans TRDβ. This RRS grouping was predominantly present in the multiple 
identical nucleotide CDR3 sequences, which included the dominant sequence in six out 
of the seven kidneys examined from both UUO and normal mice. This RRS amino acid 
motif was only found in the UUO spleen when the same sequence was identified in the 
UUO kidney of that mouse. This RRS motif was not identified in any of the sequences 
from a normal spleen (n=42). 
On further examination the nucleotide sequences which coded for the arginine and 
serine amino acids in this RRF motif were not the same in the dominant sequence from 
different animals. This could be explained by redundancy in codons (Table 5.2). 
Table 5.2- Nucleotide sequence coding the RRS amino acid motif  
Nucleotide sequence coding for amino acid Animal 
R R S 
D7A2K CGG CGT TCT 
D14A6K AGA AGG TCC 
D14A9K CGG CGC TCC 
D28A2K AGG AGG AGT 
NkidneyA2 AGG CGT TCT 
NkidneyA3 CGG CGT TCT 
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Figure 5.10- Aligned amino acid sequences of the CDR3 region derived from the multiple identical nucleotide sequences 
(a) Amino acid sequence derived from the dominant nucleotide sequence demonstrated in the kidney and spleen of an individual animal  
The dominant nucleotide sequence found in the kidney and spleen of each UUO and normal animal was converted into the corresponding amino acid 
sequence and aligned. Within the TRJβ gene segment region there were repeated amino acid sequences in both kidney and spleen (highlighted in 
yellow). However in the most variable area of the CDR3 region a repeated RRS amino acid motif (highlighted in red) was seen in the dominant 
sequence of six out of the seven kidneys examined, but in none of the dominant splenic sequences. 
 
Animal  TRJB           End of TRVB3..............CDR3.......................Beginning of TRCB 
           C A S S[...TRDβ....][...........TRJβ...........]E D L 
UUO Kidney 
D7A2       J1-3*01   n=12K+1S  C A S S T G R R S G N T L Y F G E G S R L I V V E D L 
D14A3      J2-4*01   n=8K+2S   C A S S L G R G R Q N T L Y F G A G T R L S V L E D L 
D14A6      J2-2*01   n=10K     C A S S P Q R R S T G Q L Y F G E G S K L T V L E D L 
D14A9      J2-7*01   n=14K     C A S S P G - R R S Y E Q Y F G P G T R L T V L E D L 
D28A2      J2-4*01   n=3K      C A S S L G R R S Q N T L Y F G A G T R L S V L E D L 
UUO Spleen 
D7A2       J2-7*01   n=2S      C A S S L P D S S - Y E Q Y F G P G T R L T V L E D L 
D14A3      J2-7*01   n=3S      C A S S L K G Q G - Y E Q Y F G P G T R L T V L E D L 
D14A6      J2-7*01   n=2S      C A S S L – D W P – Y E Q Y F G P G T R L T V L E D L 
D14A9      J2-7*01   n=3S      C A S S Q - - D R V Y E Q Y F G P G T R L T V L E D L 
D28A2      J2-7*01   n=2S      C A S S L G L G G – N E Q Y F G P G T R L T V L E D L 
Normal kidney 
nkidneyA2  J1-3*01   n=6K      C A S S L G R R S G N T L Y F G E G S R L I V V E D L  
nkidneyA3  J1.3*01   n=7K      C A S S S G R R S G N T L Y F G E G S R L I V V E D L  
Normal spleen 
nspleenA1  J1-1*01   n=2S      C A S S T G – A G – T E V F F G K G T R L T V V E D L 
nspleenA2  J2-7*01   n=2S      C A S S L G G G A – R E Q Y F G P G T R L T V L E D L 
nspleenA3  J1-3*01   n=5S      C A S S L E G T G G N T L Y F G E G S R L I V V E D L
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(b) Amino acid sequences derived from nucleotide sequences where there were >1 identical copy in the kidney and spleen of an individual 
animal 
Within the TRJβ gene segment region there were repeated amino acid sequences seen in both the kidney and spleen derived from the TRJβ gene 
segment (highlighted in yellow). The repeated RRS amino acid motif (highlighted in red) was predominantly seen in the dominant sequence identified 
in the kidneys of both UUO and normal animals. However, it was seen in less commonly identified nucleotide sequences within the kidney and in a 
few UUO splenic sequences that were identified in the kidney of that animal. No amino acid sequence identified only in the spleen demonstrated the 
RRS motif. 
Animal  TRJB           End of TRVB3..............CDR3.......................Beginning of TRCB 
           C A S S[...TRDβ....][...........TRJβ...........]E D L 
nspleenA1  J1-1*01   n=2S      C A S S T G – A G – T E V F F G K G T R L T V V E D L 
nspleenA2  J2-7*01   n=2S      C A S S L G L G - - F E Q Y F G P G T R L T V L E D L 
nspleenA2  J2-7*01   n=2S      C A S S L G G G A – R E Q Y F G P G T R L T V L E D L 
nspleenA2  J2-7*01   n=2S      C A S S L G G G - - - E Q Y F G P G T R L T V L E D L 
nspleenA2  J2-7*01   n=2S      C A S S P - - G - - Y E Q Y F G P G T R L T V L E D L 
nspleenA3  J1-3*01   n=5S      C A S S L E G T G G N T L Y F G E G S R L I V V E D L  
nspleenA3  J2-3*01   n=3S      C A S S K G L G W A E T L Y F G S G T R L T V L E D L  
nspleenA3  J2-3*01   n=3S      C A S S L G W V S A E T L Y F G S G T R L T V L E D L   
nspleenA3  J2-7*01   n=2S      C A S S S D - - - S Y E Q Y F G P G T R L T V L E D L   
nkidneyA2  J1-3*01   n=2K      C A S S L A R R S G N T L Y F G E G S R L I V V E D L  
nkidneyA2  J1-3*01   n=6K      C A S S L G R R S G N T L Y F G E G S R L I V V E D L  
nkidneyA3  J1.3*01   n=7K      C A S S S G R R S G N T L Y F G E G S R L I V V E D L  
D7A2       J1-3*01   n=12K+1S  C A S S T G R R S G N T L Y F G E G S R L I V V E D L 
D7A2       J1-3*01   n=2K      C A S S S D R - G G N T L Y F G E G S R L I V V E D L 
D7A2       J2-3*01   n=2K      C A S S R T P S A - E T L Y F G S G T R L T V L E D L 
D7A2       J2-4*01   n=3K      C A S S L G R G R Q N T L Y F G A G T R L S V L E D L 
D7A2       J2-7*01   n=2S      C A S S L P D S S - Y E Q Y F G P G T R L T V L E D L 
D14A3      J1-1*01   n=K+S     C A S S P G Q A N - T E V F F G K G T R L T V V E D L 
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D14A3      J1-3*01   n=K+S     C A S S T G R R S G N T L Y F G E G S R L I V V E D L 
D14A3      J1-4*02   n=K+S     C A S S R S N E - - - R L F F G H G T K L S V L E D L 
D14A3      J2-1*01   n=2K      C A S S Y V T D - - A E Q F F G P G T R L T V L E D L 
D14A3      J2-4*01   n=8K+2S   C A S S L G R G R Q N T L Y F G A G T R L S V L E D L 
D14A3      J2-5*01   n=2S      C A S S L D W G G H G T Q Y F G P G T R L L V L E D L 
D14A3      J2-7*01   n=2S      C A S S L A D R G - L E Q Y F G P G T R L T V L E D L 
D14A3      J2-7*01   n=2K      C A S S L V P G G S Y E Q Y F G P G T R L T V L E D L 
D14A3      J2-7*01   n=3S      C A S S L K G Q G - Y E Q Y F G P G T R L T V L E D L 
D14A6      J1-1*01   n=3K      C A S S L R R A - - - E V F F G K G T R L T V V E D L 
D14A6      J1-1*01   n=4K      C A S S L T G A N - T E V F F G K G T R L T V V E D L 
D14A6      J1-5*01   n=3K      C A S S L G R R N Q A P L – F G E G T R L S V L E D L 
D14A6      J2-1*01   n=2S      C A S L Y - - - - - A E Q F L G P G T R L T V L E D L 
D14A6      J2-1*01   n=3K      C A S R G G R H - - A E Q F F G P G T R L T V L E D L 
D14A6      J2-2*01   n=10K     C A S S P Q R R S T G Q L Y F G E G S K L T V L E D L 
D14A6      J2-7*01   n=2K      C A S S N - - R G – R E Q Y F G P G T R L T V L E D L 
D14A6      J2-7*01   n=2S      C A S S L – D W P – Y E Q Y F G P G T R L T V L E D L 
D14A9      J1-3*01   n=2S      C A S S P Q – V S G N T L Y F G E G S R L I V V E D L 
D14A9      J1-6*01   n=2K      C A S S R - - Q D N S P L Y F A A G T R L T V T E D L 
D14A9      J2-1*01   n=2S      C A S S L - - R G A A E Q F F G P G T R L T V L E D L 
D14A9      J2-1*01   n=2S      C A S S E - - T N Y A E Q F F G P G T R L T V L E D L 
D14A9      J2-1*01   n=2K      C A S S L G – E N Y A E Q F F G P G T R L T V L E D L 
D14A9      J2-7*01   n=2S      C A S S T - - D R G R E Q Y F G P G T R L T V L E D L 
D14A9      J2-7*01   n=3S      C A S S Q - - D R V Y E Q Y F G P G T R L T V L E D L 
D14A9      J2-7*01   n=3K      C A S S L G – L G S Y E Q Y F G P G T R L T V L E D L 
D14A9      J2-7*01   n=14k     C A S S P G - R R S Y E Q Y F G P G T R L T V L E D L 
D28A2      J1-1*01   n=2S      C A S S S G – V N – T E V F F G K G T R L T V V E D L  
D28A2      J2-1*01   n=2K      C A S S L D W G G – A E Q F F G P G T R L T V L E D L 
D28A2      J2-4*01   n=3K      C A S S L G R R S Q N T L Y F G A G T R L S V L E D L 
D28A2      J2-7*01   n=2S      C A S S L G L G G – N E Q Y F G P G T R L T V L E D L 
D28A2      J2-7*01   n=2S      C A S S L - - G P – Y E Q Y F G P G T R L T V L E D L 
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Figure 5.11- Amino acid sequences derived from the CDR3 nucleotide sequences identified in the spleen of normal animal 2 
Within the TRJβ gene segment region, a proportion of the repeated amino acid sequences identified earlier in the UUO animals were also seen in the 
sequences examined from this normal spleen (highlighted in yellow). The repeated RRS amino acid motif predominantly seen in the dominant 
nucleotide sequences identified in kidney was not evident in any of the sequences examined from normal spleen.  
 
TRJB gene      Sequence   End of TRVB3..............CDR3.......................Beginning of TRCB 
           C A S S[...TRDβ....][...........TRJβ...........]E D L 
TRBJ1-1*01 Sequence4       C A S S - S W - D N T E V F F G K G T R L T V V E D L 
TRBJ1-1*01 Sequence11      C A S S L H R - G N T E V F F G K G T R L T V V E D L 
TRBJ1-2*01 Sequence6       C A S S L D - - N S D Y T – F G S G T R L L V I E D L 
TRBJ1-2*01 Sequence26      C A S S L G G - D S D Y T - F G S G T R L L V I E D L 
TRBJ1-2*01 Sequence43      C A S S F G - A N Y D L S - F G S G T R L L V L E D L 
TRBJ1-3*01 Sequence1       C A S S L G N - S G N T L Y F G E G S R L I V V E D L 
TRBJ1-4*02 Sequence29      C A S S L G R G G N E R L F F G H G T K L S V L E D L 
TRBJ1-5*01 Sequence13      C A S S L G - V N N Q A P L F G E G T R L S V L E D L 
TRBJ1-6*01 Sequence9       C A S S P P - - - - - P L Y F A A G T R L T V T E D L 
TRBJ2-1*01 Sequence10      C A S S P - - - - - - - G V F G P G T R L T V L E D L 
TRBJ2-1*01 Sequence22      C A S S L T G V N Y A E Q F F G P G T R L T V L E D L 
TRBJ2-1*01 Sequence32      C A S S L G — — N Y A E Q F F G P G T R L T V L E D L 
TRBJ2-1*01 Sequence50      C A S S R D G D A — — E Q F F G P G T R L T V L E D L 
TRBJ2-2*01 Sequence47      C A S S E T P - N T G Q L Y F G E G S K L T V L E D L 
TRBJ2-3*01 Sequence12      C A S S L G - S S A E T L Y F G S G T R L T V L E D L 
TRBJ2-3*01 Sequence20      C A S S P P Q - G T E T L Y F G S G T R L T V L E D L 
TRBJ2-3*01 Sequence24      C A S S H R G S A - E T L Y F G S G T R L T V L E D L 
TRBJ2-3*01 Sequence41      C A S S L G T T S A E T L Y F G S G T R L T V L E D L 
TRBJ2-4*01 Sequence3       C A S S L A G - - G D T L Y F G A G T R L S V L E D L 
TRBJ2-4*01 Sequence27      C A S S L S G - - G D T L Y F G A G T R L S V L E D L 
TRBJ2-4*01 Sequence30      C A S S L Q G L - Q N T L Y F G A G T R L S V L E D L 
 197 
TRBJ2-5*01 Sequence19      C A S S L G W G V Q D T Q Y F G P G T R L L V L E D L 
TRBJ2-5*01 Sequence21      C T S S L A P - Q D T Q Y - F G P G T R L L V L E D L 
TRBJ2-7*01 Sequence2       C A S S L - - - A Y - E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence5       C A S S H R G L S - Y E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence7       C A S S H D G - - - - R V F F G K G T R L T V L E D L 
TRBJ2-7*01 Sequence8       C A S S L G - G G A R E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence16      C A S S L G - - L G F E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence17      C A S S S D R - - - N E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence18      C A S S L G – G G A R E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence23      C A S S L - - K Q G L E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence33      C A S S L G - - L G F E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence35      C A S S P - - - - G Y E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence36      C A S S P - - - - G Y E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence37      C A S S P T - - - G D E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence39      C A S S L G – G G - - E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence40      C A S S L L G - - - - E R Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence42      C A S S L G – G G - - E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence44      C A S S L - - - D S – E Q Y F G P G T R L T V L E D L 
TRBJ2-1*01 Sequence45      C A S S L D R V D Y A E Q F F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence46      C A S S L E - - V Y – E Q Y F G P G T R L T V L E D L 
TRBJ2-7*01 Sequence48      C A S S L - - E G G – E Q Y F G P G T R L T V L E D L 
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5.6 Determining whether T cell clonality in the UUO kidney was in a CD4+ or 
CD8+ population 
In order to determine whether the multiple identical CDR3 TRVβ3 sequences in the 
cDNA from whole kidney were derived from a CD4+ or CD8+ T cell population, 
lymphocytes were FACS sorted into two populations. However, due to the recovery of 
limited numbers of T cells there was an inadequate amount of mRNA to perform real 
time PCR on the individual CD4+ and CD8+ populations with all twenty two TRVβ 
primer pairs, so the whole UUO kidney was divided into halves. One half was 
processed, as explained in Chapter 4, using real time PCR to define the TRVβ gene 
segment that was over expressed in the kidney compared to the spleen. CDR3 
sequences containing this over expressed TRVβ gene segment were then determined 
using whole tissue. The other half of the kidney was digested and T cells sorted into 
CD4+ and CD8+ populations by FACS before the CDR3 sequences containing the over 
expressed TRVβ gene segment were ascertained. 
5.6.1 Determining which TRVβ gene was over expressed in the UUO kidney 
The D14A9 UUO kidney demonstrated TRVβ3 gene segment over expression (Figure 
5.12). Therefore, cDNA from whole UUO kidney was amplified using the TRVβ3-
TRCβ primer pair and the products cloned into plasmid vectors and sequenced. Of the 
colonies, or CDR3 sequences, 14 out of the total 46 nucleotide sequences were identical 
(30%). They expressed the TRJβ2.7*01 gene segment and had the sequence shown in 
Figure 5.13. 
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Figure 5.12- Relative use of TRVβ gene segments from the Day 14 A9 UUO mouse 
Over expression of the TRVβ3 gene segment was demonstrated in the day 14 A9 UUO 
kidney. 
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Figure 5.13- Dominant TCR CDR3 nucleotide sequence identified from whole 
UUO kidney tissue of the D14 A9 UUO mouse 
The nucleotide sequence is outlined with the position of the primer annealing sites and 
position of the TRJβ2.7*01 gene segment. 
 
Vb3 primer site on antisense strand]            
------------Vb3 gene segment----------------------------]                     [-----------     
CACTGGAGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCTGGACGGCGCTCCTATG 
 
------------J2.7*01 gene segment--------------------][-------Cb gene segment----- 
AACAGTACTTCGGTCCCGGCACCAGGCTCACGGTTTTAGAGGATCTGAGAAATGTGACT 
 
                                                                              [-----Cb primer site--------- 
----------- Cb gene segment------------------------------------------------------------ 
CCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACAAAAGG 
 
-------] 
-------- 
CTACC 
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5.6.2 Sorting the CD4+ and CD8+ populations from the Day14 A9 UUO kidney 
The other half of the D14A9 kidney was digested with collagenase and 
deoxyribonuclease. An estimated total of 4.8 x 10
6
 cells were acquired by the digestion 
process, with >50% of the cells being viable as assessed by Trypan blue staining. The 
CD45+, CD4+ and CD8+ cells were stained with fluorochrome linked antibodies to 
APC-Cy7, FITC and PerCP respectively. This allowed the CD4+ and CD8+ populations 
of cells to be sorted using flow cytometry as shown in Figure 5.14. Figure 5.15 
demonstrates the isotype controls used for the fluorochrome labelled antibodies, 
demonstrating no significant non-specific fluorochrome binding.  
 
Figure 5.14- FACS sorting CD4+ and CD8+ lymphocytes from digested D14A9 
kidney tissue 
CD45+, CD4+ and CD8+ populations of cells, fluorochrome stained with APC-Cy7, 
FITC and PerCP respectively, were sorted by FACS. Approximately 1,300 CD4+ (P2) 
and CD8+ (P4) lymphocytes were obtained from the kidney. 
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Figure 5.15- Flow cytometry performed on naive splenocytes using both a labelled 
antibody and its isotype control 
These three histograms show overlapping populations of naive splenocytes with the 
same fluorescent intensity when flow cytometry was performed on cells alone and with 
cells labelled with the fluorochrome isotype-control antibody demonstrating there was 
no non-specific fluorochrome binding. 
 
(a) APC-Cy7 label for CD45+ cells  (b) PerCp label for CD8+ cells 
    
(c) FITC label for CD4+ cells 
    
 
 
 
 
----- Cells only 
----- Isotype for APC Cy7 
----- CD45 APC Cy7 
----- Cells only 
----- Isotype for FITC 
----- CD4 FITC 
 
----- Cells only 
----- Isotype for PerCP 
----- CD8 PerCP 
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5.6.3 Sequencing the CD4+ or CD8+ lymphocyte populations from UUO kidney 
In order to determine whether the dominant population of T cells found in the UUO 
kidney were CD4+ or CD8+, their CDR3 regions were sequenced. 
 
5.6.3.1 Generating sufficient cDNA to use in the cloning reactions 
To perform the cloning reactions using the cDNA from the sorted CD4+ and CD8+ cell 
populations, adequate PCR product must be generated. This was confirmed by 
separating the products using agarose gel electrophoresis generated after 35 cycles of 
PCR under standard conditions using the TRVβ3-TRCβ primer pair. An appropriately 
sized band of around 200bp was demonstrated (Figure 5.16).  
Despite using the majority of the cDNA generated from the sorted CD4+ and CD8+ 
cells and 35 cycles of PCR, the bands on the gel were weak. The amount of amplicon 
was limited by the total number of cells that could be extracted and sorted. In addition 
to using the PCR product demonstrated on the gel in Figure 5.16 for the cloning 
reactions, it was used in a further round of PCR reactions performed using the same 
primer pair for a further 20 cycles. This PCR product was separated by electrophoresis 
on the agarose gel shown in Figure 5.17 and was of the appropriate size and therefore 
also used in the cloning reactions to sequence the CDR3 region of the sorted CD4 and 
CD8+ lymphocyte populations. 
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Figure 5.16- PCR product separated by agarose gel electrophoresis using cDNA 
from the sorted CD4+ and CD8+ populations of cells 
Faint bands of amplicon were separated by agarose gel electrophoresis after high 
fidelity Taq polymerase and the TRVβ3-TRCβ primer pair was used for 35 cycles of 
PCR with cDNA from the sorted CD4+ and CD8+ cell populations. 
 
 
 
Figure 5.17- PCR product separated by agarose gel electrophoresis using cDNA 
that had already undergone 35 cycles of PCR 
PCR products were separated by agarose gel electrophoresis after 20 cycles of PCR. 
The starting cDNA was that illustrated in Figure 5.16, which had been generated after 
35 cycles of PCR and originated from the sorted CD4+ and CD8+ populations. 
 
 
       Ladder       CD4           CD4           CD8          CD8          NTC 
       Ladder       CD4        CD4         NTC        NTC         CD8         CD8       NTC 
200bp 
200bp 
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5.6.3.2 Cloning and sequencing reactions using cDNA originating from the sorted 
CD4+ and CD8+ populations 
Cloning reactions were performed using the standard method with the PCR products 
shown in Figures 5.16 and 5.17.  Upon completion of the cloning reactions standard 
PCR reactions were performed using the plasmid DNA from all the different colonies to 
confirm an appropriate sized insert. Both the plasmid DNA generated from the DNA 
that had just one round of PCR (35 cycles) and that which had two rounds of PCR (35 
cycles followed by a further 20) seemed equally successful at generating an appropriate 
sized insert. Overall the success rate for generating an insert was less than when cDNA 
extracted from whole tissue was used for the cloning reactions. Therefore <50% of the 
plasmid DNA was sent for sequencing, which totalled 27/50 CD4+ colonies and 15/50 
CD8+ colonies. The sequencing was successful in 14/27 of the sorted CD4+ TCR 
sequences and 11/15 of the sorted CD8+ TCR sequences.  
Of the four sequences generated from the CD4+ cells which expressed TRJβ2.7*01, 
none were identical to the dominant sequence from whole kidney however, four out of 
the eight CD8+ CDR3 sequences which contained TRJβ2.7*01were identical to those 
14 identical TCR sequences from whole kidney seen in that mouse. This suggested that 
approximately 30% of the T cell population from whole tissue which expressed TRVβ3 
and 36% of the sorted CD8+ T cell population expressing TRVβ3 were identical. The 
dominant TRVβ3 sequence identified in whole kidney was exclusively found in the 
CD8+ population. In addition this sequence also contained the CDR3 RRS amino acid 
motif seen in other UUO mice and illustrated in Figure 5.10. 
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5.7 Discussion 
This aim of this chapter was to determine whether there were identical T cell 
populations within UUO kidney. The experimental data from the last chapter 
demonstrated a disproportionate increase in TRVβ3 expressing T cells within the kidney 
compared to the spleen in UUO mice. This was not seen in normal mice where the 
expression of TRVβ3 in kidney and spleen was similar. The literature has demonstrated 
consistent expression of TRVβ gene segments in unrelated normal mice and so our 
results should be representative for all mice (Heeger, Smoyer et al. 1996). Therefore, 
the difference in TRVβ3 gene segment expression in the UUO animal must be due to 
the effects of obstructive injury and imply a population of T cells had expanded in the 
obstructed kidney: by sequencing these T cells the clonality of the infiltrate could be 
determined. If a dominant population of identical sequences was discovered, which 
would be dependent upon T cells recognising a single antigenic epitope, this would 
suggest a T cell population had expanded in response to a renal autoantigen or 
neoantigen generated by the obstructive injury. However, if the expanded UUO kidney 
T cell population expressing TRVβ3 was found to be a varied population of T cells with 
unique TCR sequences, this would imply either: a population of bystander T cells with 
different TCRs had expanded in the kidney activated by the inflammation generated by 
UUO or the T cell infiltrate was attracted to the kidney in an antigen-independent 
manner by chemokine mediated attraction from the circulating pool. 
In order to investigate the possibility of a clonal population of T cells the TCR CDR3 
TRVβ3 sequences from UUO kidney were examined. DNA from UUO kidney was 
amplified by PCR using the TRVβ3-TRCβ primer pair and the amplicon cloned into 
plasmid vectors, which then transformed bacteria. Each colony of bacteria that 
developed was assumed to contain a plasmid with an individual PCR product and 
therefore the CDR3 β-chain sequence for an individual T cell. 
From the results of the UUO experiments conducted on mice obstructed for 7 and 14 
days one single dominant CDR3 nucleotide sequence was seen in each kidney, this was 
different in each individual mouse, and accounted for 21% - 31% of the CDR3 TRVβ3 
sequences examined. This would be consistent with 21% - 31% of all the TRVβ3 T 
cells within the UUO kidney utilising the same TCR CDR3 β-chain. This equated to an 
identical T cell population within the UUO kidney (assuming the α-chain was the same) 
which accounted for between 3.6% and 4.9% of the total T cell population. The 
dominant CDR3 sequence identified within the UUO kidney was rarely seen in UUO 
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spleen. This would suggest that this population of T cells expanded in response to 
obstructive injury and the recognition of either renal autoantigen or neoantigen. For this 
to occur there must have been a break in self-tolerance since there is no alloantigen in 
UUO. 
The presence of a dominant identical clone implies there was proliferation of this 
population, which follows antigen recognition and accompanies activation to an effector 
phenotype. This implies this clone of T cells had effector function but does not prove it 
actively contributed to injury. This activated population may have either a destructive or 
regulatory role or, despite activation, be passive in the process of renal injury. There 
may be other identical clones of T cells within the kidney, since we only looked at T 
cells expressing TRVβ3, which have different effector functions or recognise other 
antigenic epitopes. As demonstrated in the literature, in traditional AIDs it is likely that 
tolerance is lost to multiple antigenic epitopes as the disease process develops. 
In the day 28 mouse the sequencing results were different to the earlier time points and 
there were single individual sequences or a low frequency of repeated sequences, 
without a large dominant sequence. This would support the phenomenon of epitope 
spreading, as described by Heeger and explained in Chapter 4, which develops after 
progressive injury where there is no dominant clone (Heeger, Smoyer et al. 1996). 
Alternatively, there could have been chemokine mediated recruitment of polyclonal T 
cells into the area of injury, on a background of earlier antigen-dependent T cell 
proliferation, as shown at day 7 and 14. The third possible explanation would be the 
generation of a population of regulatory T cells which suppressed the immune response 
within the UUO kidney. All three mechanisms are not mutually exclusive. 
When TRVβ3 T cells from a UUO kidney were extracted and sorted the dominant 
sequence was exclusively found within the CD8+ population and was identical to the 
dominant sequence identified from the whole kidney of that animal. This demonstrated 
that this clone was CD8+ but does not imply that all T cell clones within the kidney 
would be. This could be investigated further by looking at other CDR3 TRVβ sequences 
within UUO kidney where the TRVβ gene segment was over expressed in the UUO 
kidney, such as TRVβ26 in the D14A2 mouse, and performing similar sequencing and 
cell sorting experiments to those illustrated in this chapter. From the literature, two 
groups using the UUO model have shown fibrosis was dependent upon the presence of 
a CD4+ T cell population (Tapmeier, Fearn et al. 2010; Niedermeier, Reich et al. 2009). 
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However it is possible that the CD8+ T cells identified in the UUO kidney were acting 
in a similar way to those demonstrated in transplantation by Robertson et al, in adhering 
to TEC, presenting TGFβ, inducing EMT and causing interstitial fibrosis (Robertson, 
Ali et al. 2004). Most likely multiple T cell subtypes play a role in UUO injury, some of 
which are profibrotic whilst others are protective.  
For comparison purposes CDR3 TRVβ3 sequences were analysed for normal mice, with 
unexpected results: a dominant CDR3 sequence and thus large proportion of identical T 
cells, was demonstrated in the kidney of two normal mice similar to that seen in UUO 
kidneys. This accounted for 30% and 37% of the CDR3 TRVβ3 sequences and for 2.8% 
and 3.7% of the total T cell population within those normal kidneys. A dominant 
sequence was not seen in normal spleen. Other groups have demonstrated resident αβ T 
cells within normal kidney tissue although there is no definite evidence in the literature 
to suggest a clonal population of resident T cells (Ascon, Ascon et al. 2008). The 
function of these lymphocytes is unclear but they may be involved in immune 
surveillance and homeostasis in the normal kidney. Griffin’s group showed that within 
three days of UUO injury activated memory T cells were present within the kidney in 
association with dendritic cells (Dong, Bachman et al. 2008). This suggests that these T 
cells differentiated into their memory phenotype prior to the induction of UUO injury 
due to the rapidity of their appearance and the inflammatory environment generated by 
injury allowed swift activation of these memory cells to perform effector functions. This 
work would complement our findings, since the T cell clone within our normal kidneys 
may be the resting memory population seen in Rabb’s work. An alternative explanation 
for identical populations of T cells within normal mouse may have been pyelonephritis 
or inadequate removal of a circulating clone of T cells. However, with both these 
explanations similar populations would be expected in the spleen. 
When the amino acid sequences of the dominant CDR3 sequences from UUO kidney 
were examined, there were recurrent amino acid motifs demonstrated within the CDR3 
region despite containing different TRJβ gene segments. Some of these identical amino 
acid sequences lay within the TRJβ gene segment and were most likely due to the high 
degree of homology between these J gene segments at the amino acid level despite 
having different nucleotide sequences. This suggestion is supported by the finding that a 
proportion of these sequences were also seen in the CDR3 sequences examined from a 
normal spleen.  
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However, a recurrent arginine, arginine, serine (RRS) motif was identified in the most 
variable region of the CDR3 sequence where multiple nucleotide additions and 
deletions occur outside the TRJβ gene segment. This motif was identified in the 
dominant sequence seen in four out of five UUO kidneys and only in UUO spleen when 
the same sequence was identified in the UUO kidney of that mouse. It was also 
demonstrated in the dominant population of CD8+ sorted T cells and seen in both 
dominant CDR3 TRVβ3 sequences found in the two normal kidneys. This demonstrated 
that groups of T cells with identical amino acid CDR3 β-chain regions were present 
within the kidney of different UUO and normal mice and suggested they recognised the 
same antigenic epitope. Assuming these clones of T cells developed in response to renal 
antigen and since they were found in both normal and UUO kidney, they must recognise 
native renal antigens, rather than antigens modified by injury. This would support the 
work showing Tamm-Horsfall proteins and albumin can be presented by DCs to T cells. 
It also refutes the other possible explanations for identical T cell populations in normal 
kidney, since all the UUO and normal mice cannot have had pyelonephritis or an 
identical circulating lymphocyte population. 
The results from the CDR3 TRVβ3 sequence analyses from normal and UUO spleens 
were similar: no dominant sequence was identified. Diversity of the CDR3 region 
allows the TCR to recognise a wide range of structurally different antigenic epitopes. It 
has been estimated that there are 5-8 x 10
5
 different β-chain nucleotide sequences which 
make up the TCRs of lymphocytes in naive spleen (Casrouge, Beaudoing et al. 2000). 
The naive mouse spleen harbours around 2 x 10
6
 clones of T cells of about 19 cells 
each. Therefore it is unlikely that any one single sequence would be repeated in this 
polyclonal T cell repertoire that I sampled in UUO or normal spleen. This was generally 
the case with the UUO and normal spleen sequences sampled, where single unique 
sequences were found and only occasionally were repeated sequences described and this 
was very different to the sequences generated from the normal and UUO kidneys. Even 
though there were few duplicate sequences in the colonies I sampled, there was an 
apparently high percentage of identical CDR3 β-chain sequences within the spleen of 
normal and UUO mice which accounted for around 1% of the total T cell population. 
This result may be artefactual and could be due to the method used. Relatively small 
numbers of colonies/ T cells were sequenced out of the vast repertoire of T cells present 
in the spleen. Although the assumption remains that only one CDR3 sequence was 
found in each colony and represented a single T cell, cDNA from one original T cell 
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had been amplified through successive PCR reactions. It could have been possible that 
two identical PCR products originating from the same initial DNA sample were cloned, 
and subsequently two colonies had the same CDR3 insert.  
An alternative explanation for identifying identical CDR3 sequences in the spleens of 
normal and UUO mice may be due to accidental or aerosolised contamination of DNA. 
Great efforts were made to try to prevent cross contamination between samples 
throughout all the experiments. Different areas and rooms were used for RNA 
extraction and reverse transcription, PCR set-up, cloning, PCR product analysis and 
plate preparation for sequencing. The samples and reagents were all stored in different 
locations to minimise cross contamination. UV irradiation hoods were used prior to 
setting up all PCR experiments. When comparing all the duplicate sequences seen in the 
spleens of the seven mice, only one pair of CDR3 sequences seen in the day 14 A3 
UUO spleen was also seen in that UUO kidney and none of the duplicate sequences 
demonstrated in the spleens were seen in any other mouse. This suggested that the 
presence of identical sequences within the spleen was not due to DNA contamination.  
Another technical issue important to discuss was the process of digesting UUO kidney. 
Extracting adequate numbers of lymphocytes from the network of fibrosed tissue in the 
UUO kidney proved difficult and the yield was low, despite multiple attempts to modify 
and improve the method. Although some T cells were successfully extracted, they may 
not have been representative of the whole T cell population infiltrating the kidney. T 
cells within areas of fibrotic injury would have been the most difficult to access as they 
were bound by the dense collagen network and activated and proliferating T cells may 
have been more liable to damage during the long digestion process. Therefore the 
population of sorted T cells whose TCR CDR3 I sequenced may have been a skewed 
population of T cells and may not be representative of the total T cell population or the 
population contributing to injury. I had hoped to look at the CD4+ and CD8+ 
populations in more detail by flow cytometry to study markers of proliferation and 
activation but the low cell numbers prevented this. I attempted to improve the yield by 
collecting the sorted cell populations into plastic tubes, rather than glass, which tend to 
encourage cells to adhere to their surface and prevent maximal RNA extraction. They 
were also collected directly into lysis buffer containing carrier cells to discourage RNA 
binding to the side of the tube. Despite this I was unable to increase the yield beyond 
~2,000 CD4+ or CD8+ cells from half a UUO kidney. 
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Overall I believe this work provides evidence of a clonal proliferation of T cells within 
UUO kidney consistent with antigen recognition and these T cells may have existed 
within the normal kidney prior to the induction of injury, albeit at a much lower 
frequency. This would reflect a break in peripheral self-tolerance within the injured 
kidney, which may be to unmodified renal antigen since T cells in both normal and 
UUO kidney were recognising the same epitope. Just how this activated T cell infiltrate 
goes on to propagate or modify fibrosis and tubular cell death is unclear. I predict that 
there is an interaction between the T lymphocyte population and dendritic cell network, 
along with macrophages, which act to promote or regulate injury. 
 211 
Chapter 6. Conclusions and Summary 
 
The body of work from the literature suggests that T lymphocytes play a pathological 
role in the tubulointerstitial injury seen in chronic kidney disease. Therefore, using the 
well recognised unilateral ureteric obstruction model of tubulointerstitial injury and 
fibrosis I set out to examine the role of T lymphocytes within the UUO kidney. 
Infiltration with both CD4+ and CD8+ lymphocytes, as well as macrophages, correlated 
with markers of renal injury including expansion of the interstitial compartment, α-
SMA staining and collagen I deposition. Also, CD4+ and CD8+ lymphocytes within the 
UUO kidney demonstrated an activated and memory phenotype and showed evidence of 
proliferation. Traditionally activation and proliferation only occurs when T cells have 
recognised their cognate antigen, suggesting loss of tolerance to self antigen in UUO. 
When analysing the TRVβ gene segment profile of infiltrating T cells there was over 
expression of the TRVβ3 segment in seven out of the ten UUO kidneys compared to 
their respective spleens. This was not seen in normal mice, suggesting this variation was 
related to UUO injury. The diversity of expression between gene segments could not be 
explained by differences in the efficiencies of the primer pairs. 
In the day 7 and 14 UUO kidneys one single dominant CDR3 TRVβ3 sequence was 
demonstrated suggesting that an identical population of T cells was present within that 
kidney, dominant clones were not seen in UUO spleen. These populations accounted for 
between 3.6% and 4.9% of the total T cell population within the UUO kidney. Identical 
CDR3 sequences were also demonstrated in normal kidney, but not spleen, suggesting 
there were also identical populations of T cells within normal kidney and these 
accounted for 2.8% and 3.7% of the total T cell population within that kidney. Other 
groups have described T cells within normal kidney but none previously shown clones 
of T cells. No dominant clone was identified at the later time point of 28 days post 
obstruction, suggesting an expanded T cell repertoire due to multiple antigenic epitopes. 
When the amino acid sequences of the CDR3 TRVβ3 region were determined for the 
infiltrating T cells, a common arginine, arginine, serine (RRS) motif was demonstrated 
in the dominant sequence identified in both UUO and normal kidney. The RRS motif 
was only found in UUO spleen when the same sequence was identified in the UUO 
kidney of that mouse. This suggested that the dominant populations of T cells in the 
UUO and normal kidney recognised a common antigenic epitope. In response to UUO 
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injury the resident population of T cells may proliferate and this would explain why the 
T cells in UUO and normal kidney have the same RRS motif and potentially recognise 
the same antigenic epitope.  
This thesis supports the hypothesis that T cells play an active role in renal injury in the 
UUO model. Lymphocyte infiltration correlated with markers of renal fibrosis and T 
cells were activated and proliferating, which typically occurs in response to antigen 
recognition. Since there is no alloantigen in the UUO model, antigen recognition must 
occur due to a break in self-tolerance. Clones of T cells were demonstrated in UUO 
kidney implying they had recognised antigen and developed effector function.  
Questions still need to be answered about the antigen/s to which T cells lose tolerance in 
this model. Since the UUO lymphocyte population may be derived from a population of 
resident T cells within normal kidney, it would follow that T cells lost tolerance to a 
native unmodified renal antigen. To investigate this further, proliferation assays could 
be performed using UUO lymphocytes and APCs with homogenised normal kidney, 
UUO kidney or specific renal antigens.  T cell proliferation, as demonstrated by the 
uptake of tritiated thymidine into DNA, would determine whether modified or 
unmodified renal antigens drive loss of T cell tolerance.  
From my own work I was unable to determine the role these particular clonal 
populations of T lymphocytes were playing in UUO kidney. Clonal populations suggest 
the presence of effector T cells however, whether they had a pathological role in 
promoting tubulointerstitial injury and fibrosis or whether they were regulatory in 
nature was not clear. A single dominant TRVβ3 expressing clone was seen in the UUO 
kidneys examined. From the results of Chapter 4, multiple TRVβ gene segments were 
over expressed in UUO kidney, which suggests that sequencing T cells with other over 
expressed TRVβ gene segments may reveal further clonal T cells populations. Most 
likely there were multiple clones of T cell in UUO kidney, which may have different 
effector functions.  
An additional discovery was the presumed populations of NKT cells within normal 
kidney, as identified by the invariant TCR β-chains; TRVβ13.2, 29 and 1 (IMGT 
classification) or 8.2, 7.1 and 2 (Arden classification). They may have a role in 
producing cytokines, which shape the lymphocyte response depending upon the 
particular combination of cytokines produced and form a link between innate and 
adaptive immunity. 
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There are a number of limitations in the methods used and possible pitfalls. The UUO 
model itself does not perfectly replicate the multiple aetiologies of CKD seen in man, 
which most commonly cause a progressive decline in renal function. In men with 
chronic outflow obstruction once the obstruction is relieved there is often a stabilisation 
in renal function which can last for many years and thus the progressive decline 
associated with CKD is not seen. Therefore this model may not be the most translatable 
model of human CKD. 
From the IHC and IF work from Chapter 3, only an association between activated 
lymphocyte infiltration and renal injury can be made. Small groups of animals were also 
used which may have prevented statistically significant results. The size of the groups 
used for TRVβ gene segment assessment in Chapter 4 were also small, which only 
allowed observations to be made rather than a statistical assessment. In Chapter 5 the 
assumption was made that each CDR3 nucleotide sequence inserted into a plasmid 
vector represented a TCR on an individual T cell and that the sequences generated were 
representative of the lymphocyte population within the kidney. This may not be true due 
to biases in lymphocyte extraction and preferential cloning of specific sequences into 
the plasmid. 
There are many different directions in which this work could be developed with more 
time. Assuming that T cells are activated in response to antigen, studies which track the 
movement of T lymphocytes into and out of the kidney would be very informative. This 
would allow us to gain a better understanding of where antigen recognition takes place: 
either in the draining lymph node or perhaps in areas of lymphangiogenesis within the 
kidney itself. Tracking experiments could be performed by labelling lymphocytes with 
fluorescent dyes. Also adoptive transfer of lymphocytes from congenic B6 Thy1.1 UUO 
mice into either UUO or naive C57bl/6 mice would identify whether lymphocytes 
homed to both normal and injured or only injured kidney. This would help to determine 
whether UUO lymphocytes recognise renal self antigens and home even to normal 
kidney where there is no inflammation.  
In order to explore the possibility that bystander T cells are activation due to the 
inflammatory environment created by UUO rather than antigen recognition, OTII mice 
with a transgenic TCR specific for ovalbumin peptide could be crossed with RAG-1 KO 
mice. T cells from the OTII-RAG-1 KO mice are unable to respond to antigen other 
than ovalbumin. If UUO is performed in these mice, and T cell responses are antigen 
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dependent, you would expect a reduction in injury. However, if similar levels of injury 
are seen to WT mice this would suggest that antigen independent T cell activation 
occurs. 
Further work to look in more detail at the subtypes of CD4+ T cells which are involved 
in UUO injury would be very interesting. This would only be possible by flow 
cytometery if more T cells could be extracted from UUO kidney. One possible method 
to increase yield may be to use a magnetic bead separation kit. The beads are coated 
with antibody e.g. CD90.2, which bind T cells and allow their separation. IHC could 
also be performed to identify the different subtypes. The alternative approach to looking 
at the specific CD4 subtype would be to examine the cytokines produced in the 
obstructed kidney. An interesting experiment would be to evaluate the IL-6 and TGFβ 
cytokine profiles in the UUO kidney at successive time points post UUO. One might 
expect high early levels of IL-6 and high later levels of TGFβ. This would suggest the 
early involvement of proinflammatory Th17 cells and later the presence of 
CD4+CD25+ T regulatory cells with both anti-inflammatory and pro-fibrotic properties. 
Very early time points, including the first few days, should be examined to investigate 
whether very rapid activation of T cells occurs post UUO injury. This would support the 
hypothesis that populations of activated T cells are present within the normal kidney 
that are able to respond very quickly after injury. 
Therapeutic agents that target this T cell inflammatory infiltrate could lead to advances 
in retarding the progression of most chronic renal diseases. This includes using 
immunomodulatory treatments for renal diseases which are not traditionally thought to 
be immunologically mediated such as diabetic nephropathy or obstructive uropathy. If 
we were able to slow the rate of decline in renal function by only a few years for 
common renal diseases such as diabetic nephropathy this might delay or even prevent 
the need for renal replacement therapy and its associated treatment burden in the large 
number of patients.  
The rationale for using agents already in common use for modulating the immune 
system e.g. mycophenolate mofetil in these chronic renal diseases is becoming apparent 
with the increasing body of evidence supporting the pathological role of T lymphocytes 
in tubulointerstitial injury. Also more novel agents which provide chemokine blockade, 
alter the pro-fibrotic cytokine profile, promote the development of a regulatory T cell 
population or prevent the co-stimulatory signals from APCs to T cells are all possible 
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methods by which this inflammatory infiltrate could be manipulated. A clear 
understanding of the role of the different subpopulations of T lymphocytes during 
different stages of the fibrotic disease process is fundamental to ensuring that agents are 
used only in the appropriate context and at an appropriate time to ensure favourable and 
not deleterious effects on the fibrotic process to improve outcomes for patients with 
chronic renal insufficiency. 
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